Analysis of NMDA receptor regulated gene expression by Begg, Alison Jane
ANALYSIS OF NMDA RECEPTOR REGULATED GENE EXPRESSION
Alison Jane Begg
-koi'fix)
A Thesis Submitted For The Degree Of Doctor Of Philosophy
The University of Edinburgh
2004
Analysis of NMDA Receptor Regulated Gene Expression
DECLARATION
I declare that the work presented in this thesis is my own, except where noted in the
text and as detailed below.
Kevin Robertson (Scottish Centre for Genomic Technology and Informatics,
University of Edinburgh) labelled RNA samples and performed subsequent
microarray hybridisations in accordance with Affymetrix protocols.
Marie Craigon (Scottish Centre for Genomic Technology and Informatics, University
of Edinburgh) performed the liquid handling of oligonucleotides and set up the
spotting of custom microarrays. She used SpotCheck for quality control assessment
of the spotted arrays.
Alan Ross (Scottish Centre for Genomic Technology and Informatics, University of




Analysis of NMDA Receptor Regulated Gene Expression
ACKNOWLEDGEMENTS
Firstly, I would like to thank my supervisor, Seth Grant, for all his support and advice over
the course of my PhD. In addition, massive thanks to all members of the Grant Lab, past
and present, for always giving me help when I've needed and providing me with plenty
entertainment along the way. In particular, thanks to Doug for teaching me beginner's
molecular biology, for being there when all we had to listen to was Moby and all his help
throughout. Also, cheers to Nobby Hennakao, for his steady dissecting hands, Kris, for her
motivational chats and help through all the cultures, Paul, for letting me in on the magic of
multi-electrode arrays, Bence, for all the tomfoolery (complete with sound effects) and Karen
and Jane for always keeping me in line.
Thank you to the other members of the Neuroscience Division who've given me advice and
assistance, and also to Peter Ghazal and everyone at the SCGTI who helped me with the
microarray work, particularly Kevin Robertson for knowing all things Affymetrix!
On the social side, 3 cheers to those of you who had to share an office with me. You kept me
bordering on sanity and taught me valuable life lessons -1 now know all I will ever need to
about backgammon strategy and that coffee and chunky kit kats can cure anything! Outwith
the realms of science, I'd like to thank my friends and flatmates for always providing me
with amusement and suitable distractions from the lab. A special 'Big Up' to the Nairn crew
(particularly the Dream Team), Anna and Sonia for all the good times and for being there
when the going got tough.
Finally, Mum, Dad, Karen, Dr Fish and associated pets - hoooooge thanks for all your
support throughout my career as a student. I know you look forward to me joining the 'real




Analysis of NMDA Receptor Regulated Gene Expression
4AP 4-amino pyridine
ADG Activity dependent gene
AMPA a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
API Activator protein 1
APV Amino-5-phosphonovalerate
BLAST Basic Local Alignment Search Tool
CaMKII Calcium/calmodulin dependent kinase II
CaMKIV Calcium/calmodulin dependent kinase IV
CBP CREB binding protein
cDNA Complimentary DNA
CRE cAMP response element
CREB cAMP response element binding protein
C, Cycle threshold
DIV Days in vitro
DNA Deoxyribonucleic acid
ERK Extracellular signal regulated kinase
EST Expressed sequence tag
GABA y-aminobutyric acid
IEG Immediate early gene
IRES Internal ribosome entry site
LTP Long term potentiation
MAGUK Membrane associated guanylate kinase
MEA Multi electrode array
MECS Maximal electro convulsive seizures
NMDA N-methyl-D aspartate
NRC NMDA receptor complex
PKA Protein kinase A
PSD95 Postsynaptic density protein 95
PTZ Pentylenetetrazole
QRT-PCR Quantitative reverse transcription- polymerase chain reaction
RNA Ribonucleic acid
RT-PCR Reverse transcription- polymerase chain reaction
SCGTI Scottish Centre for Genomic Technology and Informatics
SRE Serum response element
SRF Serum response factor
TCF Ternary complex factor
TTX Tetrodotoxin
UTR Untranslated region
VDCC Voltage dependent calcium channel
iv
Analysis of NMDA Receptor Regulated Gene Expression
ABSTRACT
The N-methyl-D-aspartate (NMDA) subtype of glutamate receptors is central in spatial
learning, pathological conditions such as neuropathic pain and stroke and is required for
experimental paradigms of synaptic plasticity e.g. long term potentiation. These diverse and
sustained cellular effects are accompanied by coordinated changes in gene expression and
transcription has been shown essential in NMDA receptor dependent phenomena. The
NMDA receptor is found bound to an intracellular complex of proteins that includes
molecules with known involvement in signalling pathways downstream of receptor
activation, including ones that can modulate gene expression.
Mutation of two NMDA receptor complex proteins, PSD95 and SynGAP, results in altered
phenotypes in NMDA dependent phenomena. As components of the receptor complex,
necessary for NMDA mediated signalling, mutation of these proteins may alter pathways
that regulate gene expression.
Affymetrix microarray analysis of RNA from PSD95_/- forebrain and SynGAP+/- hippocampi,
compared to wildtype samples, revealed significant changes, greater than 1.5 fold, in a
limited numbers of genes. Of the 12000 transcripts analysed 0.22% were significantly altered
in PSD95 mutant tissue and 0.35% were significantly changed in SynGAP mutant tissue.
The genes altered in each genotype were distinct apart from an overlap of 3 genes that were
similarly found at lower levels in PSD95'- forebrain and SynGAP+/- hippocampi.
To study activity regulated gene expression an in vitro method of NMDA receptor
stimulation was sought. NMDA and bicuculline treatment of primary cultured cortical
neurons proved ineffective methods of inducing activity dependent gene induction as
measured by cfos expression. However, AP5 treatment of primary cultured neurons was
found to decrease activity dependent gene expression. Electrophysiological analysis of the
cultures revealed that bicuculline treatment had no significant effect on culture activity,
where as AP5 treatment caused a significant decrease in neuronal activity.
Microarrays are useful technique as they allow the simultaneous analysis of many
transcripts. Custom microarray chips can be advantageous as they allow specification of the
genes that are represented on the arrays, unlike in commercial systems. A custom chip was
designed, containing approximately 250 genes of interest. Oligonucleotides, 55 base pairs in
length, were designed specifically for these target genes and printed onto slides along with
control probes. The slides were validated and hybridised with RNA from PSD95'- and
matched wild type forebrain.
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1. INTRODUCTION AND AIMS
Sensing patterns of neuronal firing is fundamental to nerve function. Trains of
stimulatory input potentially cause long lasting changes in neuronal properties.
Understanding how a post synaptic cell detects activity and couples this to
downstream effecter pathways is essential to appreciating how the brain transmits
the information essential to it's function.
Ligand gated ion channels respond in vivo to particular neurotransmitters causing
the channels to open, allowing the movement of ions. The influx of ions to the
neuron can initiate signal transduction pathways with wide ranging targets that can
lead to prolonged effects within the cell. These pathways include ones that can alter
the neuron at a transcriptional level, regulating gene expression. Thus, changing
levels of mRNA can be used to study postsynaptic cellular signalling response to
stimulatory input.
The rapid advancement of molecular biological techniques has changed the way
signal transduction can be studied, with technologies being developed that enable a
global view of cell activity and behaviour. Microarray based techniques are being
used, with increasing popularity, to simultaneously analyse the levels of thousands
of RNAs. This 'snapshot' of transcriptional activity of cells under given conditions
can be exploited to study effects such as differential gene expression in different
tissues, cellular response to particular stimuli and changes in gene expression in
diseased or mutated tissue.
Given that transcriptional analysis can be used to examine the regulation of gene
expression in a neuron, microarrays could be employed to study activity of
pathways stimulated by synaptic activity. Combining this with animals carrying
mutations in molecules involved in signalling pathways allows the analysis of the
contribution of these proteins to the regulation of gene expression.
Chapter 1 - Introduction and Aims
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1.1 THE NMDA RECEPTOR SIGNALING COMPLEX
1.1.1 Function and Structure of the NMDA Receptor
Ionotrophic glutamate receptors are responsible for the majority of excitatory
transmission in the central nervous system (CNS). There are 3 classes of ligand
gated ion channels that respond in vivo to glutamate in the CNS; a-amino-3-
hydroxy-5-methylisoxazole-4-propionic acid (AMPA), N-methyl-D-aspartate
(NMDA) and kainate receptors. The NMDA receptor is found, predominantly, at
postsynaptic sites in the CNS. It plays a role in behavioural tasks such as spatial
learning, has function in pathological conditions such as neuropathic pain and is
required for experimental paradigms of synaptic plasticity, e.g. long term
potentiation (LTP) (Collingridge et al., 1983; Morris et al., 1986; Mayer et al., 1999).
The NMDA receptor subunits were cloned in the early 1990s (Moriyoshi et al., 1991;
Kutsuwada et al., 1992; Meguro et al., 1992). The receptor is made up of at least one
obligatory NR1 subunit and at least 2 NR2(A-D) subunits and is thought to be
tetrameric in structure. The receptor is cation selective and, in particular, it is its
permeability to Ca2+ ions that is important in the activation of signalling pathways
within the neuron.
The NMDA receptor is critical for viability and animals that constitutively lack the
NR1 or NR2B subunits die neonatally (Forrest et al., 1994; Kutsuwada et al., 1996).
Animals lacking the NR2A receptor subunit are viable, but have reduced LTP in the
hippocampus and impaired spatial learning (Sakimura et al., 1995). By restrictive
knockout of the NR1 subunit in the CA1 region it has been demonstrated that NR1
is required for CA1 LTP and spatial memory (Tsien et al., 1996). In addition, it has
been demonstrated that over expression of the NR2B subunit can improve
performance in spatial learning tasks (Tang et al., 1999).
Chapter 1 - Introduction and Aims
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1.1.2 Composition of the NRC
The intracellular C termini of NMDA receptor subunits can bind postsynaptic
proteins and many components of a NMDA Receptor Complex (NRC) have been
isolated (Husi et al., 2000). At least 77 proteins have been identified to be within the
NRC and the proteins within the complex have potentially many more binding
partners.
Proteins of the NRC can be classified by their function. The key components are the
subunits of the NMDA receptor and metabatropic glutamate receptor. The NMDA
receptor subunits can directly bind adaptor proteins such as PSD95, SAP102 and
Yotiao. These molecules have specific domains to facilitate protein-protein
interaction and can act as scaffolding within the complex, with the potential to bind
multiple proteins. Protein kinase A (PKA) subunits, protein kinase C isoforms and
various other signalling proteins are found within the complex, including numerous
molecules of the Ras-ERK pathways. Additionally, multiple cell adhesion and
cytoskeletal proteins are present.
It is unlikely that the NRC exists as a static complex of bound proteins. It is more
probable that NRCs are dynamic structures, the components of which can be
determined by differential protein expression or response to synaptic input. With
the numbers of proteins that have been identified as NRC components this could
result in a wide variety of NRC structures, appropriate to different synaptic
response, in various synapses across the nervous system.
1.1.3 Signalling Molecules Within the NRC
A complex of proteins, including structural, signalling and adaptor molecules, that
can bind NMDA receptor subunits offers an attractive model for the organisation of
postsynaptic signalling. It is hypothesised that the function of the NRC is to
orchestrate the signalling pathways downstream of receptor activation. With
Chapter 1 - Introduction and Aims
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appropriate enzymes and substrates being brought within close proximity of each
other, signal transduction could be coordinated, allowing specificity within the
signalling network. This would enable effective transmission of a signal, initiated
by receptor activation, within the neuron.
Components of several signalling pathways, essential to NMDA receptor mediated
effects, have been identified as NRC proteins (see figure 1.1). For example, CaM
Kinase II (CaMKII) and PKA, both critical for NMDA dependent phenomena such
as LTP and hippocampal based learning (Silva et al., 1992; Huang and Kandel, 1994;
Bach et al., 1995; Mayford et al., 1996; Abel et al., 1997) are found within the NRC.
Another key pathway, downstream of NMDA receptor activity, with molecules
within the NRC is the ras-ERK pathway.
The ras-ERK pathway is critical for NMDA receptor dependent effects. The key
sequential kinase components of the pathway, [ras-raf-MEK-ERK], are all found
within the NRC (Husi et al., 2000). Additionally, SynGAP, a regulator of the
pathway, is also found within the complex. A rasGAP (ras GTPase Activating
Protein) protein, SynGAP promotes the hydrolysis of GTP, maintaining ras in an
inactive, GDP bound state. As such, is thought to be a negative regulator of the ras-
ERK kinase pathway (Kim et al., 1998).
When CaMKII is active it inhibits the activity of SynGAP (Chen et al., 1998),
maintaining ras in an activated GTP bound state. It is hypothesised that, upon
NMDA receptor mediated calcium entry to the cell, CaMKII becomes
phosphorylated causing the inhibition of SynGAP. The removal of this negative
regulation would act to initiate the ras-ERK Kinase pathway.
LTP stimulation and contextual learning activate the ras-ERK pathway (English and
Sweatt, 1996; Atkins et al., 1998) and MEK inhibition impairs the induction of LTP
and causes deficits in spatial memory (Blum et al., 1999; Adams and Sweatt, 2002).
Chapter 1 - Introduction and Aims
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Figure 1.1 - Signalling Molecules Within The NRC. Schematic diagram shows the protein-protein
interactions of signalling molecules within the NRC. CaMKII and PSD95 can both directly interact with the
NMDA receptor. PKA, via AKAP, can interact with PSD95. SynGAP and nNOS both directly bind PSD95.
SynGAP can act to regulate the ERK signalling pathway via Ras.
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Mice lacking ERK2 die during development (Adams and Sweatt, 2002), however
mice lacking ERK1 have reduced hippocampal LTP induced by theta burst
stimulation, although LTP induced by 100Hz stimulation is as wild type
(Mazzucchelli et al., 2002). It is apparent that the ras-ERK pathway is critical for
cellular response to stimulation at the NMDA receptor. The NRC may act to
maintain the molecular components of the pathway in close proximity to each other
and the receptor, ensuring effective activation of the Ras-ERK signalling pathway
upon receptor stimulation.
1.1.4 Effects of Mutating NRC Proteins
The interest in NMDA receptor mediated effects has lead to a wide application of
transgenic analysis in the research of learning and plasticity. This, combined with
behavioural, molecular and electrophysiological studies, has helped elucidate the
function of particular proteins involved in NMDA dependent phenomena,
including learning and memory (reviewed by Matyina et al., 2002). Phenotypes in
NMDA receptor dependent effects are found in mice carrying mutations in NRC
proteins. Mutations of two such proteins, PSD95 and SynGAP, are discussed
further below.
1.1.3.1 PSD95
PSD95 was first identified enriched in rat brain post synaptic densities (Cho et al.,
1992) and was found to be a homolog of Drosophila suppressor gene, dig, product
(Woods and Bryant, 1991). It belongs to a family of proteins known as the
MAGUKs (Membrane Associated GUanvlate Kinases). MAGUKs share a common
structure of 3 PDZ domains, 1GK and 1SH3 domain. These distinct binding
domains enable protein-protein interactions, allowing the MAGUKs to function as
adaptors within protein complexes.
PSD95 is expressed widely across the developing and adult brain (Fukaya et al.,
1999) (see figure 1.2A) and binds directly to NR2A and NR2B subunits (Kornau et
Chapter 1 - Introduction and Aims
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al., 1995; Niethammer et al., 1996). Additional binding partners include other
proteins found in the NRC, e.g. nNOS (Brenman et al., 1996), and PSD95 is thought
integral to the receptor complex in the hippocampus.
Migaud et al., 1998 showed that mice carrying a mutant form of PSD95 have altered
LTP and spatial memory. The mutation was generated by the introduction of a stop
codon to the third PDZ domain resulting in the expression of a truncated protein, no
longer localised to the post synaptic density or capable of binding NMDA receptor
subunits. PSD95_/~ mice have normal synaptic localisation of NMDA receptors and
no alterations in NMDA currents. However, LTP induced at 100Hz is significantly
enhanced in mutant cells. Indeed, across a range of stimulation frequencies, PSD95"
hippocampal slices show increased potentiation as compared to wild type. PSD95"
/- mice also have a marked impairment in the hidden platform transfer test of the
Morris water maze, demonstrating a deficit in spatial memory (Migaud et al., 1998).
The widespread expression of PSD95, localised with NMDA receptors, could
indicate a role for the NMDA-PSD95 interaction in signalling pathways outwith the
hippocampus. Indeed, Fagiolini et al., 2003 showed that PSD95 mutant animals
show impaired NMDA mediated plasticity in the visual cortex. Also, the animals
do not develop hyperalgesia and allodynia in a model of neuropathic pain within
the spinal cord (Garry et al., 2003).
Published data shows mutation of PSD95 can impair NMDA receptor mediated
phenomena in the hippocampus, cortex and spinal cord, showing the necessity of
the NMDA receptor-PSD95 interaction across the nervous system. NMDA receptors
are correctly localised and have wildtype currents in the hippocampus of PSD95_/"
animals (Migaud et al., 1998). This suggests that the mechanism of the mutant
phenotypes is not due to changes in NMDA receptor expression or properties, but
lies downstream of receptor activation.
Chapter 1 - Introduction and Aims
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Figure 1.2 - Expression of PSD95 and SynGAP in the Adult Brain. Images show the expression of
PSD95 (A) and SynGAP (B) in the adult brain. The images show the expression of (3 galactosidase,
measured by LacZ staining, under the regulation of the PSD95 (A) and SynGAP (B) promoters. The
olfactory bulb (O), striatum (S), cortex (C), hippocampus (H), thalamus (Th) and cerebellum (cb) are all
indicated. The expression of PSD95 is widespread in the adult brain, the expression of SynGAP is
more restricted, and is most highly seen in the hippocampus. (Images provided by Karen Porter).
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1.1.3.2 SynGAP
As previously discussed, SynGAP is hypothesised to be a key regulator of the ras-
ERK pathway, downstream of NMDA receptor activation. The expression of
SynGAP in the brain is dynamic through development and overlaps, to degree, with
the expression of PSD95. By adulthood, the expression of SynGAP is much more
restricted than PSD95 and is highly enriched in the hippocampus, with lower
expression in the cortex and amygdala (K. Porter, personal communication; see
figure 1.2B).
Mice, homozygote for mutated SynGAP, die in early postnatal days suggesting a
role for the protein in development (Komiyama et al., 2002; Kim et al., 2003). Due to
the lethality of the mutation, there is a limit to the analysis that can be done on the
homozygote animals, however analysis of SynGAP heterozygote mice does reveal
phenotypes. SynGAP+/- hippocampal slices show diminished LTP, as compared to
wildtype, after 100Hz stimulation. Also, NMDA stimulated SynGAP+/_ hippocampal
slices show higher levels of pERK than in wild type slices, consistent with the
hypothesised action of SynGAP in the Ras-ERK pathway. SynGAP"'" animals have
impaired performance in the Morris water maze, suggesting a hippocampal based
deficit in learning and memory (Komiyama et al., 2002). Additionally, animals
carrying mutations in SynGAP fail to develop clear 'barrels', the discrete patterns,
replicating the whisker pad, formed by layer IV granule cells, in the somatosensory
cortex (P. Kind, personal communication).
Taken together, the data from PSD95 and SynGAP mutant animals demonstrate that
the disruption of NRC proteins leads to the impairment of NMDA mediated effects
downstream of receptor activity. The expression of PSD95 and SynGAP is
overlapping in some areas of the brain (see figure 1.2) and in the hippocampus both
are required for wildtype learning and plasticity. However, in other areas of the
Chapter 1 - Introduction and Aims
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brain the molecules act in independent NMDA receptor mediated phenomena. For
example, SynGAP is not expressed in the spinal cord. Also, despite PSD95
expression in the cortex, PSD95_/~ animals have no barrel cortex phenotype like that
of the SynGAP+/_ animals (P. Kind, personal communication).
It is apparent that PSD95 and SynGAP are required for overlapping and distinct
neuronal functions. Thus, it appears that various molecules and signalling
pathways are key for the various NMDA dependent phenomena in different parts
of the CNS. This would be consistent with the hypothesis that the NRC is a highly
dynamic structure, with its components altering depending on NMDA receptor
function, in a given brain region.
1.2 ACTIVITY DEPENDENT TRANSCRIPTION
NMDA receptor signalling has various downstream effector targets, one of which is
transcription. There is a great deal of evidence of activity regulated gene
expression, i.e. synaptic activity can trigger signalling pathways that regulate
expression of transcripts known as activity dependent genes (ADGs). NMDA
receptor activity is critical for the regulation of particular genes following synaptic
stimulation and alterations in gene expression could be required to facilitate long
term cellular changes in response to stimulatory input. Indeed, transcriptional
inhibitors block the maintenance of NMDA receptor dependent late phase
hippocampal LTP (Nguyen et al., 1994).
1.2.1 Activity Dependent Genes
Table 1.1 details genes known to be regulated by NMDA receptor activity in the
hippocampus or cortex and shows examples of the stimulation protocols used to
establish them as ADGs.
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1.2.1.1 Studying Activity Dependent Gene Expression
NMDA receptor regulated gene expression can be analysed in a variety of ways.
The NMDA receptor can be specifically activated in order to induce transcription
downstream of receptor activity. Many different approaches, both in vivo and in
vitro, have been used to analyse the expression of activity dependent genes
following NMDA receptor stimulation.
In vivo stimulation assays include the induction of LTP by trains of high frequency
in anaesthetised or awake rats (Inokuchi et al., 1996; Matsuo et al., 1998; Konietzko et
al, 1999; Matsuo et al., 2000; Qian et al., 2000). The induction of gene expression
following seizure is also commonly studied. Seizures can be induced in several
ways and activity dependent genes have been studied following electrical
stimulation (Yamagata et al., 1994; Yamagata et al., 1999), perfusion or injection of
NMDA receptor agonist (Shan et al., 1997; Chung et al., 2000), perfusion or injection
of other convulsive drugs (e.g. kainate, metrazol) (Nedivi et al., 1993; Qian et al.,
1993; Kato et al., 1997; Naeve et al., 1997; Konietzko et al., 1999) or mechanical injury
(Dragunow et al., 1996). However, seizures will likely cause activity of several
receptor types, thus genes that are regulated by NMDA receptor activity would
have to be identified by pharmacological isolation. Activity regulated genes have
also been studied following the performance of animals in behavioural learning
tasks such as spatial learning in the Morris water maze, fear conditioning and
inhibitory avoidance tasks (Huang et al., 1998; Guzowski et al., 2001; Cavallaro et al.,
2002; Leil et al., 2002; Ressler et al., 2002).
The most common in vitro method of NMDA receptor stimulation is the
pharmacological treatment of cultured neurons. This can be done using NMDA,
glutamate or by cell depolarisation using KC1 (Bading et al., 1995, Bessho et al., 1994).
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Other methods include the electrical stimulation of brain slices (Cole et ah, 1989) or
chemical stimulation of immortalised neuronal cell lines (Jung et ah, 1998).
A variety of techniques have been employed to analyse changing RNA levels in
response to stimulation. Methods such as northern blotting, in situ hybridisation
and RT-PCR, have been used in studies that have focused on the expression of one
transcript or a limited number of genes in response to stimuli (Qian et ah, 1993;
Bading et ah, 1995; Kato et ah, 1997; Chung et ah, 2000). However, several studies
have used more widespread approaches to identify novel and candidate activity
regulated genes. (Nedivi et ah, 1993) generated a subtracted cDNA library from the
dentate gyrus of rats that have been injected with kainate. 52 'candidate plasticity
genes' were reported, 40% of which were dependent on NMDA receptor activity.
Differential display has been used to identify cDNAs regulated by LTP in vivo. The
expression of 80 bands, out of an approximated 70000, was found modulated by
LTP (Matsuo et ah, 1998).
More recently microarray analysis has been employed to identify activity regulated
genes. 140 genes, of approximately 1300 screened, have been found significantly
altered in the hippocampus following learning in the Morris Water Maze. These
genes encoded a wide variety of neuronal proteins including receptor subunits, ion
channels, signalling enzymes, cytoskeletal molecules, transcription related proteins
and other synaptic molecules (Cavallaro et ah, 2002). Another study identified
transcripts induced in the CA1 region of the hippocampus following electrically
evoked seizure (French et ah, 2001). Of the 9000 genes screened, 14 candidate
activity regulated genes were identified. However, of these, only one, nur77, could
be confirmed induced by in situ hybridisation. Given the number of activity
regulated genes previously identified, it could have been expected that microarray
analysis would detect more than one seizure induced gene. This result may reflect
the method used for the study, that is, extending analysis of seizure induced gene
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expression to areas of the hippocampus beyond the CA1 region may have
identifited more activity regulated genes.
1.2.1.2 Immediate Early Genes
ADGs are split, broadly, into two groups, immediate early gene (IEGs) and late
response genes, based on their temporal profiles and sensitivity to protein synthesis
inhibitors. It has been estimated that between 30 and 40 IEGs exist (Lanahan and
Worley, 1998). IEGs are rapidly and transiently expressed following synaptic
activity. For example, in vitro studies have detected IEG (cfos, junB, egrl and nur77)
expression 15 minutes after glutamate treatment of primary cultured hippocampal
neurons. The expression peaked between 30 and 60 minutes post stimulation and
levels were basal by 4 hours (Bading et al., 1995). In vivo studies during
consolidation of fear conditioning found similar temporal profiles of the expression
for cfos and egrl (Ressler et al., 2002).
IEGs are expressed without requirement for die novo protein synthesis and, as such,
their expression is controlled by constitutive transcription factors. Many of the well-
characterised IEGs encode transcription factors. It is hypothesised that, once
expressed, the encoded transcription factors act to regulate the expression of late
response genes.
1.2.1.2.1 Inducible Transcription Factors
Inducible transcription factors are made up of 3 major families; fos, jun and egr. The
fos family consists of cfos, fosB, Fra-1 and Fra-2. The most studied of these is cfos. In
1987 it was demonstrated, for the first time, that specifically activating NMDA
receptors, in cultured rat cerebellar granule cells, could induce cfos (Szekely et al.,
1987). Since then the induction of cfos has been studied in many NMDA receptor
dependent paradigms of synaptic plasticity in vivo, such as LTP (Cole et al., 1989;
Dragunow et al., 1989) and chemical induced seizure (Murphy et al., 1991; Shan et al.,
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1997), and in vitro, such as studies of glutamate stimulation of hippocampal neurons
(Bading et al., 1995).
Jun family products include junD, cjun and junB. Proteins from this family have
been shown regulated by NMDA receptor activity in several in vivo and in vitro
studies (Cole et al., 1989; Szekely et al., 1990; Murphy et al., 1991; Bading et al., 1995).
Activator protein 1 (API) can be formed by jun family product homodimerisation or
jun/fos heterodimerisation via shared leucine zipper motifs (Gentz et al., 1989). API
can bind gene promoter regions to modulate transcription and its DNA binding
activity is increased in cerebellar neurons following glutamate treatment (Szekely et
al., 1990). Thus IEGs induced by NMDA receptor treatment could act together to
regulate transcription of target genes.
The egr family of IEGs are zinc finger transcription factors. Egrl, egrl, egr3 and egr4
can all be induced by synaptic activity (Yamagata et al., 1994; Bading et al., 1995;
Inokuchi et al., 1996; Honkaniemi and Sharp, 1999). Apart from their common zinc
finger domain, the egr family share little homology and, as such, are hypothesised
to regulate the expression of various targets. Egrl (zif268/krox24) has been the most
studied and is readily induced by in vivo and in vitro stimulation methods (Szekely
et al., 1987; Cole et al., 1989; Bading et al., 1995; French et al., 2001).
Another zinc finger transcription factor that can be regulated by NMDA receptor
activity is nur77. Nur77 was first identified as a growth factor inducible immediate
early gene, (Ryseck et al., 1989) and subsequent studies found it induced by in vitro
and in vivo stimulation of the NMDA receptor (Bading et al., 1995; French et al.,
2001). Nur77 encodes a protein with similarities to the steroid/thyroid hormone
receptor family and, as such, has been hypothesised to act as a ligand activated
transcription factor (Ryseck et al., 1989). Indeed, nur77 has been found to act, in
vitro, as a transcriptional activator and a DNA recognition element, (5' AAAGGTCA
3'), has been identified (Wilson et al., 1991).
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1.2.1.2.2 Other Immediate Early Genes
Many of the IEGs that have been identified encode transcription factors. However,
there are several IEGs that encode proteins with other potential roles in synaptic
plasticity. Examples of such are narp, arcadlin and arg3.1.
Narp is a secreted molecule regulated by synaptic activity (Tsui et al, 1996) that
belongs to the pentraxin family, a group of proteins that can self-multimerize
(Gewurz et al., 1995). Narp can cluster AMPA receptors and the enrichment of the
molecule at pre and postsynaptic sites suggests it may play a role in formation of,
and plasticity at, synapses (O'Brien et al., 1999). Arcadlin is a cadherin protein that
can be induced in the hippocampus by seizure or long term potentiation (Yamagata
et al., 1999). Cadherin molecules have been found localised to synaptic sites (Uchida
et al., 1996; Husi et al., 2000). Cadherins are known to be involved in cell-cell
interactions (Takeichi, 1991) and the regulation of such molecules by synaptic
activity could underlie reorganisation at the synapse in response to stimulation.
Another IEG that does not act as a transcription factor arg3.1 (also known as Arc)
which is expressed and quickly distributed to the dendrites following synaptic
stimulation (Link et al., 1995; Lyford et al., 1995), specifically localising to activated
synapses (Steward and Worley, 2001). It is localised to dendrites in a pattern similar
to F-actin and can interact with actin molecules (Lyford et al., 1995). This is
consistent with a role in activity regulated modulation of dendritic structure.
As discussed, several IEGs encode proteins that can be localised to the synapse.
They have structural and adhesive properties that could be critical for
synaptogenesis or for modulating synapse structure. The induction of these genes
following synaptic activity is consistent with the hypothesis that NMDA receptor
activity regulates the expression of molecules that are required for long term cellular
response to synaptic input.
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1.2.1.3 Late Response Genes
Late response genes have more prolonged profiles of expression compared to IEGs
and are sensitive to translational inhibitors. It is hypothesised that the expression of
these genes relies on the synthesis of induced transcription factors and that target
genes encode proteins that are required to maintain the sustained effects of synaptic
input.
Late response genes are not as well characterised as IEGs however some studies
have tried to identify candidate late response genes. RNA fingerprinting of rat
hippocampal samples found genes that were consistently upregulated in animals
6hrs after Morris water maze training. Two of these transcripts were identified to be
glutamate dehydrogenase, key for the metabolism of glutamate, and ryanodine
receptor type 2, an intracellular Ca2+ releasing channel (Cavallaro et al., 1997).
A more recent publication used a combination of DAzLE (differential analysis of
primary cDNA library expression) and cDNA microarrays to analyse genes
regulated in cultured cortical neurons following NMDA treatment (Hong et al.,
2004). 661 genes were regulated by NMDA treatment, 5% of which had temporal
profiles of expression consistent with immediate early genes. The remaining genes
fitted profiles of prolonged expression of up to 24hrs post stimulation. The proteins
encoded by the induced genes could be categorised by their function and included
cytoskeletal and adhesion molecules, proteins involved in cell metabolism, receptor
subunits, molecules involved in protein synthesis, intracellular signalling proteins
and transcription factors. Comparison to genes induced by MECS stimulation
found that 161 of 418 genes regulated by seizure were also regulated by NMDA
treatment of the cortical neurons (Hong et al., 2004).
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1.2.2 Function of Activity Dependent Genes in NMDA Phenomena
Activity dependent genes encode proteins with a range of cellular functions many
of which have been shown to be required for forms of synaptic plasticity and
learning. Several studies of animals carrying mutations in ADGS have revealed
phenotypes in NMDA receptor mediated phenomena. Jones et al., 2001
demonstrated the requirement of egrl in the maintenance of late LTP and long term
memory, but not their short term counterparts, by analysis of egrl " mice. Analysis
of animals lacking cfos in the brain has shown the transcription factor is required for
LTP induction and spatial learning (Zhang et al., 2002). In addition, hippocampal
slices, from Piml"/_ animals, cannot maintain LTP beyond 2.5hrs (Konietzko et al.,
1999) and somatostatin knock out animals have reduced hippocampal short term
plasticity and LTD, although LTP is not affected (Dutar et al., 2002).
Other studies have used molecular and pharmacological approaches to reveal the
role of ADGs in NMDA receptor dependent effects. For example, use of antisense
has shown the requirement of arg3.1 for the maintenance, though not induction, of
hippocampal LTP and for memory retention in Morris water maze (Guzowski et al.,
2000). Also, antisense of IAP (Integrin Associated Protein) reduces in vivo LTP,
though has no effect on memory retention (Huang et al., 1998). Blocking arcadlin,
by use of an antibody, blocks hippocampal LTP in rats (Yamagata et al., 1999) and
the inhibition of COX by ibuprofen impairs the induction of LTP in anaesthetised
rats and disrupts learning in the MorrisWater Maze (Shaw et al., 2003).
These studies demonstrate that genes induced by synaptic activity have a functional
role in NMDA receptor dependent phenomena such as LTP and spatial learning,
thus emphasising the significance of transcriptional regulation via NMDA receptor
dependent signalling pathways.
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1.2.3 Control of Activity Dependent Transcription
Neuronal gene expression can be activated by the entry of Ca2+ to the cell. Ca2+
enters the neuron by 2 principal methods; via the NMDA receptor upon receptor
activation or via voltage dependent calcium channels (VDCC) following cell
depolarisation. Intracellular signalling molecules respond to this, ultimately
transmitting to the nucleus where the response is a change in gene expression.
Two transcription factor binding sites appear key in controlling gene expression in
response to Ca2+ entry to the cell; the serum response element (SRE) and the cAMP
response element (CRE). SRE and CRE binding sites are found in the promoters of
many activity dependent genes (Montminy et al., 1986; Chavrier et al., 1989; Christy
and Nathans, 1989; Rivera et al., 1990; Gaiddon et al., 1996).
1.2.3.1 Serum Response Element
The SRE binds various transcription factors including dimers of the serum response
factor (SRF) and ternary complex factors (TCF), a family of transcription factors that
includes Elk-1 and SAP1 (reviewed by Platenik et al., 2000).
Glutamate treatment of cultured neurons and in vivo LTP initiate SRE mediated
gene expression (Ghosh et al., 1994; Xia et al., 1996; Davis et al., 2000). The cfos
promoter contains both SRE and CRE binding sites (Berkowitz et al., 1989; Rivera et
al., 1990) and, as such, manipulation of this promoter is often used to study the
regulation of NMDA receptor mediated gene expression. NMDA mediated
expression of cfos, in primary cultured neurons, has been shown to require an intact
SRE binding site (Ghosh et al., 1994; Xia et al., 1996). SRE mediated transcription
requires the binding of SRF, however maximal cfos induction occurs when both SRF
and Elk-1 are bound (Xia et al., 1996).
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Figure 1.3 - NMDA Receptor Regulation of Gene Expression. Diagram shows hypothesised
mechanisms of the regulation of SRE and CRE mediated gene expression following NMDA receptor
stimulation. Calcium entry to the cell activates PKA, the Ras-ERK pathways and CaM Kinases. The
Ras-ERK pathway can regulate the phosphorylation of ELK1 and CREB (via RSK2), with PKA potentially
acting to aid the translocation of ERK to the nucleus. Activated CaM Kinase IV can act to phosphorylate
CREB and CBP. Phosphorylation of Elk1 and binding of SRF can initiate SRE mediated transcription.
The phosphorylation of CREB and CBP can initiate CRE mediated transcription.
CYTOPLASM
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Elk-1 is activated by phosphorylation at Ser383 and Ser389 (Marais et al., 1993). It is
hypothesised that the Ras-ERK pathway, in response to Ca2+ entry to the cell,
phosphorylates Elk-1 at these sites, regulating activity dependent SRE mediated
transcription. Phosphorylation of MAPK and Elk-1, which is rapidly induced by
synaptic activity and regulates SRE mediated expression, is sensitive to inhibition of
the Ras-ERK pathway (Xia et al., 1996; Davis et al., 2000). Figure 1.3 shows a model
that includes the control of SRE mediated gene expression downstream of NMDA
receptor activity.
1.2.3.2 cAMP Response Element
CRE mediated transcription is initiated by the binding of cAMP responsive element
binging protein (CREB), which is active when phosphorylated at residue Ser113
(Gonzalez and Montminy, 1989). This phosphorylation site can be a target of
protein kinases activated by Ca2+ entry to the cell (Dash et al., 1991; Bading et al.,
1993; Impey et al., 1996).
CREB dependent transcription has been shown to be required for long term
memory in a variety of species, including Aplysia, Drosophila and mice
(Bourtchuladze et al., 1994; Yin et al., 1994; Bartsch et al., 1995). Mice lacking a and 5
isoforms of CREB have been demonstrated to have impairments in hippocampal
LTP and long term memory for cued and contextual conditioning, spatial learning
and social transmission of food preference (Bourtchuladze et al., 1994; Kogan et al.,
1997). Furthermore, an inducible CREB repressor protein has shown the
requirement of CREB in the consolidation of new, and stability of reactivated,
conditioned fear memories (Kida et al., 2002).
However, some studies have failed to fully replicate the results of Bourtchuladze et
al., finding no impairment in LTP and spatial learning in the Morris water maze in
mice lacking a and 5 CREB isoforms (Gass et al., 1998; Balschun et al., 2003).
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Analysis of mice lacking all isoforms of CREB in the brain similarly lacked LTP or
spatial learning phenotypes, although the mutant animals did display more wall
hugging behaviour in the Morris water maze than wild type controls (Balschun et
al., 2003). This suggests that the deficit in the CREB mutants previously seen could
be due to the employment of inappropriate strategy in the water maze, as opposed
to a spatial learning impairment.
The conflicting data from the studies of CREB mutants suggests that CREB plays a
role in complex pathways involved in learning and memory processes. The
differences seen in the studies could be due to differences in the genetic background
of the animals and analysis of mutant CREB phenotypes could be confused by
compensatory changes in the levels of other similar transcription factors (Hummler
et al., 1994). The role of CREB in LTP and behavioural learning is still to be clearly
established and as such remains a focus of research.
1.2.3.2.1 Regulation of CRE Mediated Expression
A critical step in CRE mediated expression is the phosphorylation of CREB. Ser133 is
the key regulation site of CREB and is phosphorylated by a variety of stimuli
including KC1 and glutamate treatment of cultured neurons, in vitro LTP and in vivo
LTP (Ghosh et al., 1994; Impey et al., 1996; Davis et al., 2000). CaMKIV, PKA and
Ras-ERK pathways have all been shown capable to phosphorylating Ser133 in
response to Ca2+entry to the cell (Sun et al., 1994; Xing et al., 1998)
A proposed model of the regulation of CREB phosphorylation in response to
synaptic activity involves two key pathways; CaM Kinases and Ras-ERK (Wu et al.,
2001; Hardingham and Bading, 2003) (see figure 1.3). CaM Kinases mediate a rapid
initial phosphorylation of CREB at Ser133 in response to an increase of nuclear Ca2+
(Hardingham et al., 1997). This localised increase of calcium is potentially facilitated
by the translocation of calmodulin to the nucleus, in response to Ca2+ entry via the
NMDA receptor or VDCC (Deisseroth et al., 1998). CaM kinases I, II and IV are all
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capable of phosphorylating CREB (Sheng et al., 1991; Sun et al., 1994), however
CaMKIV is only one prominently expressed in the nucleus of hippocampal neurons
(Bito et al., 1996). As such, CaMKIV is most likely to be the enzyme mediating the
CaM kinase dependent phosphorylation of CREB. Furthermore, animals lacking
CaMKIV or expressing a dominant negative form of CaMKIV have impaired CREB
phosphorylation and CRE mediated gene expression, as well as reduced
hippocampal L-LTP (Ho et al., 2000; Kang et al., 2001).
Following the initial phosphorylation of CREB by CaM kinases, there is a long
lasting phosphorylation of Ser133, mediated by Ras-ERK pathway (Wu et al., 2001).
As discussed previously, the Ras-ERK pathway is activated following NMDA
receptor stimulation. ERKs have no CREB kinase function, however, they can
stimulate Rsk proteins that can phosphorylate CREB at Ser133 (Xing et al., 1998).
Depolarisation of cultured hippocampal neurons causes a robust increase in Rsk2
activity that is sensitive to MEK inhibitors (Impey et al., 1998). Thus, Rsk2 is a good
candidate for the CREB kinase that mediates prolonged phosphorylation of Ser133,
downstream of the Ras-ERK pathway.
There is also evidence that PKA, critical for L-LTP and hippocampal dependent long
term memory (Huang and Kandel, 1994; Abel et al., 1997), has a role in the
regulation of CRE mediated transcription. Inhibition of PKA blocks the induction of
CRE mediated expression in response to LTP and reduces phosphorylation of CREB
in response to depolarisation in hippocampal neurons (Impey et al., 1996; Impey et
al., 1998). It has long been accepted that there is crosstalk between the PKA and
ERK signalling pathways (reviews by Stork and Schmitt, 2002). More specifically,
PKA has recently been shown to be involved in the translocation of ERK to the
nucleus in response to depolarisation of PC12 cell and hippocampal neurons (Impey
et al., 1998). Thus, the role of PKA in CRE mediated expression could lie in an
interaction with the Ras-ERK pathway.
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Sustained phosphorylation of CREB is necessary, but is not sufficient, to induce CRE
mediated expression (Impey et al., 1996). This suggests that there are additional
regulation steps that are required before CRE mediated expression is initiated. One
of these is the recruitment of CREB binding protein (CBP), a co-activator of
transcription by phosphorylated CREB (Chrivia et al., 1993). CBP recruitment can
occur following CREB phosphorylation in response to synaptic activity
(Hardingham et al., 1999; Hu et al., 1999). CBP is regulated by phosphorylation,
which can be mediated by CaM Kinase IV (Chawla et al., 1998; Impey et al., 2002).
This site of regulation has recently been identified as residue Ser301 (Impey et al.,
2002).
1.3 MEASURING GENE EXPRESSION BY MICROARRAY ANALYSIS
Many conventional methods of measuring RNA levels, such as northern blot, in situ
hybridisation or RT-PCR, are restricted to studying limited numbers of genes at a
time. Wider screens can be performed using subtractive hybridisation or
differential display. The advent of microarray technology has offered a new
method that enables large scale analysis, potentially genome wide, of RNA levels of
annotated transcripts.
Microarrays can be used for the simultaneous analysis of thousands of transcripts.
They are powerful, if expensive, tools that enable researchers to perform
experiments to study known genes of interest as well as identify new genes that are
important in the system being studied.
1.3.1 Overview of Technology
Although there are different microarray systems that can be used, their key
principal remains constant. A labelled RNA or DNA sample in solution is
hybridised to an ordered array of immobilised nucleic acid molecules (termed as
probes). The amount of the bound sample at each probe is then determined by laser
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scanning to give a quantitative measure of relative gene expression (Watson et al.,
1998; Harrington et al., 2000).
There are 2 main types of arrays; ones that use oligonucleotide probes and those
that use cDNA based probes (reviewed by Watson et al., 1998; Schulze and
Downward, 2001). Oligonucleotide based arrays can be manufactured by the
spotting of short presynthesised oligonucleotides to the solid substrate of the array.
Alternatively, as some commercial systems use, the oligonucleotides can be
synthesised in situ on the slide surface. Using known sequence information, the
probes are designed specific to each gene. This means they can be produced to
distinguish between genes of high similarity or even differentiate splice variants,
although factors such as the secondary structure of the oligonucleotides must be
considered in the design process. However, a disadvantage of using
oligonucleotide based arrays is that they rely on the availability of accurate
sequence information.
Alternatively, cDNA based systems, using inserts from cDNA libraries or PCR
products as probes, can be employed. Typically, these probes are longer than the
oligonucleotides and are not restricted by a need for sequence information.
Developing cDNA based arrays requires access to cDNA libraries and it is vital to
ensure there is no cross contamination between clones.
1.3.2 Advantages and Applications of Microarrays
The great advantage of using microarrays is that they enable the simultaneous
analysis of thousands of transcripts, allowing genome wide studies of transcription.
The gene expression profile of a cell, or transcriptome, is a key in determining
cellular function and behaviour. Where as the genome of a cell is a constant, the
transcriptome is dynamic and can alter rapidly following stimulus. Microarray
analysis can therefore provide a representation of cell or tissue activity at a given
point in time, under particular conditions.
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The potential of microarray technology is vast and can be applied to wide ranging
studies of different cell types in a variety of conditions. For example, microarrays
have been used to study transcriptional changes through yeast cell cycles (Cho et al.,
1998), the profile alterations in differentiating cells (Ma and Staudt, 2000; Tomczak
et al., 2004) or to reveal expression differences in healthy and diseased tissue
(Kononen et al., 1998; Brown et al., 2001).
An advantage of using microarrays is that they can be used to perform unbiased
wide screens. This may reveal new genes of interest in the particular system that is
being investigated. These transcripts could then be more closely examined, using
other techniques, to identify if they are of significant function. Changes revealed by
microarrays can also be studied in a more global fashion, e.g. to reveal coregulated
genes, which could give insight to the regulatory networks controlling transcription.
1.3.3 Challenges of Using Microarrays
As microarrays examine so many transcripts at once, experiments are susceptible to
false positives, which could arise due to any disparities in sample preparation.
Therefore, in order to obtain meaningful information from microarrays, a great deal
of importance is placed on experimental design (reviewed by Yang and Speed,
2002). To be confident that results are real, experimental design should be kept
simple with as few stages where variability could occur as possible. In order to
validate results from microarray data, the detected patterns of gene expression
should be confirmed by using an alternative method such as Northern blot or RT-
PCR.
One of the greatest challenges of using microarray systems is the analysis of the data
produced. With thousands of data points, a single experiment generates a vast
amount of information. Specialised software is available to deal specifically with
microarray data but analysis of an experiment can remain a daunting task.
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However, the sheer volume of information can allow data to be studied in a variety
of ways to extract meaningful information.
Using microarrays in the field of neuroscience has it's own particular challenges.
The brain is complex, with heterogeneous cell populations, intricate developmental
patterns and defined anatomical architecture. This offers practical problems as the
isolation of desired tissues or cells must be precise, and at appropriate
developmental stages, to avoid contamination from surrounding neuronal
structures. However, the complexity of the central nervous system also means that
it's understanding can be greatly enhanced by the successful application of
microarray techniques. For example, microarrays have been used to analyse
expression in the hippocampus through development and to analyse the differential
of gene expression in different subregions of the hippocampus (Mody et al., 2001;
Lein et al., 2004). Further application of microarray analysis across different brain
structures at various developmental stages could provide insight to how differential
gene expression correlates with the development of structure specific function.
Microarray analysis has also been applied to analyse how particular areas of the
brain following treatment, for example hippocampal gene expression has been
analysed following ischemia, seizure and learning trials (French et al., 2001; Jin et al.,
2001; Cavallaro et al., 2002; Blalock et al., 2003; Newton et al., 2003). Microarrays
offer the potential to further understanding as to how the various areas of the brain
perform their specific functions in response to different input.
1.4 AIMS OF PROJECT
The NMDA receptor is crucial for learning and plasticity and the regulation of gene
expression following receptor activation appears critical for mediating these effects.
The isolation of the NRC and its proteins has identified molecules that potentially
lie in pathways downstream of NMDA receptor activity, however, it has not been
established which of these proteins contribute to the NMDA activated pathways
that regulate transcription.
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The aim of this project was to study the role of NRC proteins in the regulation of
NMDA receptor regulated gene expression. To this end, and as described in this
thesis, neuronal tissue carrying mutations in PSD95 and SynGAP was analysed by
microarray. This large-scale analysis of gene expression could establish if
disrupting the function of these NRC proteins can cause changes at a transcriptional
level.
In order to develop techniques to analyse NMDA receptor mediate gene expression,
in vitro methods of NMDA receptor stimulation have been studied and a custom
microarray, with probes representing selected transcripts relevant to synaptic
plasticity and learning, has been designed. A reliable method of NMDA receptor
activation would enable the analysis of gene expression initiated by NMDA receptor
stimulation in wild type and mutant cells and the custom array could enable the
high throughput analysis of RNA levels.
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CHAPTER 2
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2. MATERIALS AND METHODS
All general reagents were analytical grade or better from BDH, Fischer, Fluka or
Sigma.
2.1 MOLECULAR BIOLOGY METHODS AND TECHNIQUES
Basic molecular biology techniques were performed as described in Sambrook and
Russell (2000).
2.1.1 RNA Preparation
2.1.1.1 Details of Animals Used for Expriments
2.1.1.1.1 Generation of PSD95Mutant Animals
The PSD95 mutant animals used for experiments in this thesis are as those detailed
in Miguad et al., 1998. A targetted mutation was introduced to the PSD95 gene by
the insertion of a premature stop codon to the exon encoding the third PDZ domain
of the protein. This insertion also introduced an IRES (internal ribosome entry site)
driving the expression of a 3-galactosidase reporter gene. The mutation left the
gene sequence outwith the third PDZ domain intact.
2.1.1.1.2 Generation of SynGAP Mutant Animals
The SynGAP mutant animals used in this thesis are as those detailed in Komiyama
et al., 2002. A targetted mutation was introduced to the SynGAP gene by the
insertion of a stop codon to the exon encoding the C2 domain of the protein. The
insertion deleted the C2 and GAP domains of SynGAP and included an IRES
driving the expression of a 3-galactosidase reporter gene.
2.1.1.2 Dissection of Brain Tissue For Sample Preparation For Microarray Analysis
2.1.1.2.1 Dissection ofPSD95Forebrain
All mice used were female adults (at least 3 months old) on a C57/Black6
background. 3 wild type and 3 PSD95-/_ animals were used. The animals were age
matched and, where possible, litter matched.
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Animals were killed by cervical dislocation (schedule 1 procedure, in accordance
with UK Home Office regulations). The animals were then decapitated and brains
removed from the skull. Dissections of the brains were performed on ice and tissue
kept moist with chilled phospho-buffered saline (PBS) (GIBCO). The forebrains
were separated from the cerebellum and brainstem and immediately frozen in
liquid nitrogen. All dissections were performed consecutively, on the same day.
RNA extraction was performed immediately after final dissection.
2.1.1.2.2 Dissection of SynGAPf/~ Hippocampus
All mice used were female adults (at least 3 months old) on a C57/Black6
background. 3 wild type and 3 SynGAP+/- animals were used. The animals were
age matched and, where possible, litter matched.
Animals were killed by cervical dislocation. The animals were then decapitated and
brains removed from the skull. Dissections of the brains were performed on ice and
the tissue kept moist with chilled PBS. The brains were hemisected and the
hippocampi removed from each hemisphere. The hippocampi were immediately
frozen in liquid nitrogen. All dissections were performed consecutively on the
same day. RNA extraction was performed immediately after the final dissection.
2.1.1.3 Isolation of RNA from Tissue
RNA was extracted from animal tissue using QIAGEN RNeasy columns. Midi or
Maxi kits were used based upon the weight of tissue, in accordance with
manufacturers instructions (Midi for hippocampi, Maxi for forebrain). In all cases
tissues was homogenised in the appropriate amount of QIAGEN RLT buffer for
lmin. The protocols were then followed as per manufacturers instructions,
including on the column DNase treatment performed using QIAGEN RNase-Free
DNase set. RNA was eluted in 140pl (Midi kit) or 800pl (Maxi kit) DNase free water
and stored at -80°C.
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2.1.1.4 Isolation of RNAfrom Primary Cultured Neurons
RNA was isolated from primary cultured neurons using QIAGEN RNeasy mini kits
according to manufacturers instructions. Cells were collected from 35mm dishes
using 350pl QIAGEN RLT buffer and disrupted by application to QIAGEN
QIAshredder homogeniser columns and 2mins centrifugation at 13500rpm. RNA
extraction was then performed in accordance with QIAGEN RNeasy protocol. On
the column DNase treatment was performed using QIAGEN RNase-Free DNase set.
RNA was eluted in 40pl DNase free water and stored at -80°C.
2.1.1.5 Precipitation of RNA
To the RNA volume, 0.5 volumes 7.5M NTEAc and 2.5 volumes -20°C ethanol was
added and vortexed. Samples were centrifuged at 12000g at 4°C for 20mins.
Supernatant was removed and 0.5ml 80% -20°C ethanol was added to the pellet.
Samples were centrifuged at 12000g at room temperature for 5mins. The ethanol
was removed, 0.5ml 80% -20°C fresh ethanol was added and the samples
centrifuged again at 12000g at room temperature for 5mins. Ethanol was removed,
the pellets air dried and resuspended in 1 OjLxl RNase free H2O. The concentration of
samples was determined by spectrophotometry and RNA diluted to the appropriate
concentration for specific protocol.
2.1.2 RNA Quality Analysis
2.1.2.1 RNA Formaldehyde Agarose Gel Electrophoresis
lpg RNA was made up to 5pl with DEPC treated H2O and added to 11pi
formamide, 4pl 12.3M formaldehyde and 5pl loading buffer (0.025% bromophenol
blue, 0.025% xylene cyanol, 50% glycerol, ImM EDTA pH8,10% ethidium bromide).
The reaction mixture was heated to 55°C for 15mins and run on a 1% RNA agarose
gel (0.5g agarose, 5ml lOxMOPS buffer [0.4M MOPS, pH7, 0.1M sodium acetate and
0.01M EDTA], 9ml 12.3M formaldehyde made up to 50ml with DEPC H2O) at 80v for
lhr. Gels were visualised using Gene Genius Bioimager (SynGene) with GeneSnap
software (SynGene).
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2.1.2.2 Analysis by Agilent Bioanalyser
RNA was analysed using a Agilent 2100 Bioanalyser Nano Assay kit according to
manufacturers instructions. Briefly, 1 jLtl RNA 6000 Nano dye concentrate was added
to 65pl RNA 6000 Nano filtered gel matrix. This was loaded into a RNA Nano chip.
5pl RNA 6000 Nano Marker was added to each sample well and the ladder well,
lpl RNA 6000 ladder (Ambion Inc.) was denatured at 70°C for 2mins and added to
the ladder well of the Nano chip. RNA samples were heated to 70°C for 2mins and
lpil of each samples added to individual wells. The chips were vortexed at 2400rpm,
inserted to the Agilent 2100 Bioanalyser and assays run using Agilent software.
2.1.3 PCR
2.1.3.1 cDNA 1st Strand Synthesis
First strand cDNA was made from 0.5|ug RNA, using oligo dT primers, with
RETROscript (Ambion Inc.). RNA was made up to lOpil with dH20 and incubated
with 2pl oligo dT for 3mins at 70°C. 4pl lOmM dNTPs, 2pl buffer, lpl RNase
Inhibitor and lpl m-MLV reverse transcriptase was added and samples incubated
for lhr at 42°C. The enzyme was then heat inactivated at 92°C for lOmins.
2.1.3.2 RT-PCR
PCR reactions were performed using Promega Taq Polymerase in Storage Buffer A.
Reaction mix, made up in 0.5ml thin walled tubes, consisted of lpl cDNA, 4pl
2.5mM dNTPs, 2pl lOpM forward primer, 2pl lOpM reverse primer, 3ul 2.5mM
MgCb, 5pl lOx reaction buffer, 0.5pl Taq polymerase (Promega) and 32.5pl dPTO.
PCR reactions were carried out using MJ Research DNA Engine Tetrad (GRI) in the
following conditions: 94°C for 2mins, (94°C for 30s, 56°C for 30s, 72°C for 30s) x 30,
72°C lOmins, 4°C hold. Products were run out on a 4% agarose gel (3g NuSeive low
melting point agarose [Cambrex Bioscience], lg agarose in 100ml TEA buffer [484pg
tris base, 200pl 0.5M EDTA, 144pl glacial acetic acid made up to 100ml with dEEO])
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over lhr at 110V. Gels were visualised using Gene Genius Bioimager (SynGene)
with GeneSnap software (SynGene).
2.1.3.3 QRT-PCR
2.1.3.3.1 RT-PCR Reaction
QRT-PCR was carried out using the DNA Engine Opticon LightCycler (MJ
Research). Reactions were set up as follows. For sample wells 2pl cDNA, 2.5pl
primers (forward and reverse primers at 2.5pM) and 8pl H2O were mixed with
12.5pl 2x Quantitect SYBR Green PCR Master Mix (QIAGEN), containing SYBR
green dye, dNTPs and EiotStarTaq DNA Polymerase. Wells for the standard curve
for each primer pair were set up using 2pl of 1, 2, 4 and 8 fold dilutions of a
standard cDNA from wild type forebrain RNA. These dilutions were attributed the
values of 2000, 1000, 500 and 250 units to represent the amount of cDNA in the
samples.
All reaction conditions were as follows: 95°C for 15s, (94°C for 15s, 55°C for 30s,
72°C for 30s) x 35, then melting curve run from 60°C to 90°C with a read every 1°C;
with a hold for Is between reads. The melting curves were examined to ensure each
primer pair had only one double stranded product.
2.1.3.3.2 Data Analysis
The data generated from the lightcycler reactions was analysed in OpticonMonitor
2.0 software. Standard curves were established using the data from cDNA dilutions
by plotting the log of cDNA quantity against the cycle number. The cycle threshold
lines (Ct) are horizontal lines applied to an amplification plot (accumulated
fluorescence vs. cycle number) at a particular fluorescence from which the cycle
number for each samples is taken. Ct lines were placed where the r2 value of the
regression line through the standard curve was closest to one. Cycle numbers were
then taken from all samples on the amplification plot through the set Ct line.
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Against the standard curves, the relative amount of starting template in each sample
was calculated from the cycle numbers.
The expression data was exported from OpticonMonitor 2.0 to Excel for analysis.
Values for experimental genes were normalised to the levels of GAPDH control
measured in each sample. For experiments comparing gene levels in wild type and
mutant tissue, reactions in each sample were run in triplicate. The average values of
transcript expression in each sample were used in t tests to compare expression in
wildtype and mutant samples.
For experiments measuring gene expression in cultured neurons following drug
treatment reactions were run in duplicate. The average value of transcript
expression was used to calculate treated :untreated ratios. These values were used
to assess the significance of changes by t test.
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2.1.4 Microarray Hybridisation and Analysis
2.1.4.1 Affymetrix Hybridisation
Dr. Kevin Robertson at the Scottish Centre for Genomic Technology and Informatics
(SCGTI) used the following Affymetrix protocols for hybridisation of Affymetrix
U74av2 arrays. All reactions were carried out according to the manufacturers
instructions (www.affymetrix.com/support/technical/manual/expression_manaul.affx) and
the basics of the protocols are covered below.
2.1.4.1.1 Labelling of RNA
Briefly, the first strand cDNA synthesis from the RNA samples was performed with
a Superscript II kit (Invitrogen Life Technologies), using a GeneChip T7-dT<24)
primer and 10pg starting material. Second strand synthesis was performed using E.
coli DNA polymerase (Invitrogen Life Technologies), resulting in a double stranded
cDNA product that was cleaned with a phenol-chloroform extraction, followed by
ethanol precipitation.
An in vitro transcription reaction was performed on the double stranded cDNA with
biotin labelled ribonucleases using T7 RNA polymerase and the Affymetrix
EnzoBioArray High Yield RNA Transcription labelling kit. The resulting biotin
labelled cRNA was fragmented for hybridisation. The cRNA was checked using the
Agilent BioAnalyser to ensure the samples contained small fragments before
proceeding to hybridisation.
2.1.4.1.2 Hybridisation
The hybridisation cocktail with final concentrations of lOOmM MES, 1M Na+, 20mM
EDTA and 0.01% Tween was made up and contained the cRNA samples and
additional spiked controls. 01igoB2, which hybridises to a synthetic sequence
spotted along the edges of the arrays, was included to align the array upon
scanning. BioB, BioC and BioD oligos that hybridise to probes designed to E. coli
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genes in the biotin pathway were included at 1,5pM, 5pM and 25pM to analyse the
efficiency of the hybridisation reaction. The samples, in the hybridisation cocktail,
were hybridised to the chips for 16hrs at 45°C at 60rpm.
2.1.4.1.3 Washing, Staining and Scanning
Following hybridisation, the arrays were stained with SAPE (streptavidin-
phycoerythirin) and washed several times before scanning. Arrays were scanned
with the Affymetrix GeneChip Scanner 2500.
2.1.4.1.4 Bioinformatic Analysis
Analysis was performed using the Affymetrix MAS 5.1 software in accordance with
Affymetrix protocols (www.affymetrix.com/auth/support/downloads/manuals/
mas_manuals.zip). All arrays were scaled to an average overall intensity of 100.
Scatter plots and box and whisker plots of the data were produced in S-Plus
software (Insightful Corporation) to confirm all arrays appeared to detect similar
ranges of expression values.
To analyse the data further it was exported into Microsoft Excel and expression
levels of each transcript compared, in wild type and mutant samples, by Welch t test
to identify transcripts expressed at significantly altered levels in mutant tissue
compared to wild type. Wild type gene expression in forebrain and hippocampal
samples was compared by Welch t test to identify genes expressed at a significantly
higher level in one tissue type compared to the other.
Chromosomal locations for genes were obtained from NetAffx
(http://www.affymetrix.com/analysis/index.affx) and NCBI Entrez Gene
(http://www.ncbi.nlm.nih.gov). Analysis of chromosomal clustering of significantly
altered genes was performed by Chi square analysis. The observed frequency of
genes per chromosome was compared to the expected frequency of genes per
chromosome.
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2.1.4.2 Custom Array Protocol 1
This following protocol was used for initial validation and hybridisation of custom
arrays.
2.1.4.2.1 Labelling of RNA
25pg RNA, in llpl DEPC water, was incubated at 70°C for lOmins with 4ul Oligo-dT
(Invitrogen) then snap cooled on ice for 5mins. To this 6pl 5x first strand buffer
(Invitrogen), 3pl 0.1M DTT, 0.6pl each of dATP, dTTP and dGTP, 3pl cy3 labelled
dCTP (Amersham) and 2pl Superscript II (Invitrogen) was added. Samples were
incubated at 42°C for 2hrs. 15pl 0.1M NaOH was then added and incubated for
lOmins at 70°C before 15pl 0.1M HC1 was added. 20pl COT1 human DNA was
added. Samples were washed twice with H2O through Microcon YM-30 columns
(Milipore) and reduced to a volume of approximately 8pl then made up to 16pl with
H2O. To this 3.5pl 20xSSC (3M NaCl, 300mM sodium citrate) and 0.6pl 10% SDS
was added and samples heated at 100°C for 2mins before incubation at 37°C for
30mins.
2.1.4.2.2 Slide and Coverslip Preparation
Slides, spotted with oligonucleotides, were prepared for hybridisation by incubation
in a solution of 3g succinic anhydride in 175ml N-methyl-2-pyrolidinone (NMP)
with 7.5ml of borate buffer (30.9g boric acid in 500ml H2O, pH8) for 15mins with
constant stirring. The slides were then put in boiled water for 2mins, before being
cleaned by dunking in absolute alcohol.
Coverslips (Erie Scientific Company) were soaked in 0.1% SDS for 15mins, then
rinsed in H2O and soaked in 70% Ethanol for 5mins. The coverslips were dipped in
acetone and left to air dry.
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2.1.4.2.3 Hybridisation and Washes
Prepared slides were put in Al-biotech dual hybridisation chambers and coverslips
placed over the area of the array. Labelled RNA samples were applied below the
coverslips. 50pl 20xSSC was pipetted under the slides to prevent the chamber
drying during hybridisation, the chambers were sealed and incubated overnight in
hybridisation ovens at 50°C.
Slides were rinsed in lxSSC/0.2% SDS (20xSSC, 10ml 10% SDS in 500ml) to remove
coverslips and then washed in fresh lxSSC/0.2% SDS for 5mins. Slides were washed
for 5mins in 0.1xSSC/0.2% SDS then vigorously rinsed in O.lxSSC. Slides were dried
by lmins spin at lOOOrpm.
2.1.4.2.4 Scanning and Analysis
Arrays were scanned using Affymetrix 428 Array Scanner and QuantArray (GSI
Lumonics) was used to extract intensity levels from the scanned images. Data from
arrays was exported to Excel and thresholds of expression calculated as the average
expression at the buffer spots plus 2 standard deviations of the buffer expression
values. Box and whisker plots of the average expression values of genes of interest,
positive controls, negative controls and buffer spots were generated in S-Plus.
2.1.4.3 Custom Array Protocol 2 - RLS
Alan Ross at the SCGTI, University of Edinburgh used the following protocols for
hybridisation and analysis of the custom arrays.
2.1.4.3.1 Labelling of RNA
RNA labelling was performed using QIAGEN LabelStar kit. Briefly, RNA samples
were concentrated to 2.27pg/pl and 2pl (4.54ug) of the samples were denatured.
Reverse transcription reactions were performed using biotin-dUTP to label the
cDNA. The labelled cDNA was cleaned using QIAGEN MiniElute columns.
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2.1.4.3.2 Hybridisation and Washes
Slides were treated with HiLight Prehybridisation Solution (QIAGEN) at 42°C for
lOmins and washed twice for 10s in deionised H2O, then dried under N2 gas. A
hybridisation cocktail was made with HiLight Hybridisation Solution (QIAGEN),
salmon sperm DNA and labelled cDNA and heated to 95°C. This mix was applied,
under lifterslips, to the slides and hybridised overnight at 42°C.
Slides were washed twice for lOmins at 42°C with Wash Solution 1 (QIAGEN), then
washed for lOmins at room temperature with Wash Solution 2 (QIAGEN) and
finally washed twice for lmin at room temperature with Wash Solution 3
(QIAGEN).
2.1.4.3.3 HiLight Particle Binding and Wash
Following washing, slides were incubated at room temperature for 2mins in HiLight
Blocking Buffer (QIAGEN). 30ul RLS particles and 15ul particle dilutent (QIAGEN)
was added, under lifterslips, to each slide and incubated for lhr at room
temperature. Slides were washed over with Wash Solution 2, then washed 3 times
for lmin at room temperature with Wash Solution 3. Finally, slides were rinsed
with deionised H2O and dried under N2 gas.
2.1.4.3.4 Scanning and Analysis
Slides were scanned with HiLight reader (QIAGEN) and QuantArray was used to
extract expression level data from the images. Data was exported into Excel and
background expression, calculated as the mean expression at the buffer spots, was
subtracted from expression levels. The 75th percentile expression value for each
array and across all arrays was calculated. The average 75th percentile value for all
arrays was divided by individual 75th percentile values for each array and used as a
scaling factor. All expression values on each array were then multiplied by the
appropriate scaling factor. Thresholds of expression level were set for individual
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arrays using the 80th percentile value of the negative controls on each particular
array.
Using Excel, the median values for transcripts on each array were used to calculate
the average expression of genes in wildtype and mutant tissues. Box and whisker
plots of the average expression values of genes of interest, positive controls and
negative controls in wildtype and mutant tissues were generated in S-Plus. All
expression values (3 per arrays) were used in t Tests to identify transcripts
significantly altered in mutant tissue compared to wild type.
2.1.5 Oligonucleotide Design
2.1.5.1 Primer Design
cDNA sequences for target genes for RT-PCR were obtained from the National
Centre for Biotechnology Information (NCBI) nucleotide site
(http://www.ncbi.nlm.nih.gov/nucleotide). Using the Basic Local Alignment Search
Tool (BLAST; http://www.ncbi.nlm.nih.gov/BLAST), intron and exon boundaries were
identified by comparing cDNA sequence with mouse or, where this information
was unavailable, human genomic sequence. RT-PCR primers were designed using
online primer design programme Primer 3.0 (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi) and positioned to span introns, with a bias to the 3'end
of the sequence. The only exception was the primers designed to PSD95 which were
not intron spanning as they were specifically designed to the 3' region of the gene
where the probes on the Affymetrix U74A chip were positioned. All primers were
chosen to give products of between 150 and 350 base pairs.
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2.1.5.2 Custom Array Oligonucleotide Design
Oligonucleotides, 55 base pairs in length, were designed using Oligo 6 software
(LifeScience). Target sequences for chosen genes of interest were obtained from
www.ncbi.nlm.nih.gov/nucleotide. Where available, murine sequence was used
and if not, rat sequence was used.
Target sequences were input to Oligo 6 and oligonucleotides were searched for.
Melting temperature criteria was set between 90 °C and 100°C and oligonucleotides
were searched for within 1000 bases of the 3' end of the input sequences. Of the
suggested oligonucleotides returned those with loop A G smaller than -3 kcal/mol
were rejected. Oligonucleotides were chosen from those remaining to be, ideally,
around 500 base pairs from the terminal polyA tail and with minimum secondary
structure. For genes of high homology or to distinguish splice variants, similar
sequences were compared pairwise using BLAST (www.ncbi.nlm.nih.gov/BLAST)
to identify areas of diversity and oligonucleotides designed to the most 3' of these
areas.
The chosen 55mers were checked for homology to other sequences using nucleotide-
nucleotide nBLAST (nr database). Any oligonucleotide with more than 15
contiguous base pairs common to a gene other than the one it was designed to was
discarded and redesigned.
2.2 TISSUE CULTURE
2.2.1 Preparation of Surfaces For Plating Primary Cultured Neurons
Primary cultured neurons were grown on 6 well 35mm dishes, 1cm glass coverslips
in 24 well 10mm dishes or multi electrode arrays (MEA) depending on the final use
of the cells. Before incubation with cells all surfaces were treated with poly-D-lysine
(Sigma), diluted to O.Olmg/ml in ice cold PBS (GIBCO), for 30mins and washed with
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PBS. Laminin (Sigma) at approximately 5pg/ml was pipetted over surfaces and
plates incubated at 37°C until use. Immediately before cell plating, laminin coated
surfaces were washed with PBS.
2.2.2 Primary Culture of Cortical Neurons
Cortices were dissected from El7.5 mouse pups and cells disaggregated in
approximately 2ml cold PBS. Any remaining clumps were allowed to settle over 5
minutes, the supernatent removed and made up to 10ml with Neurobasal with
penicillin/streptomycin. Cells were centrifuged at 700rpm for 5 mins. The cell pellet
was resuspended in Neurobasal with penicillin/streptomycin and spun again at
700rpm for 5mins. Cells were resuspended in Plating Media (2ml B27 (GIBCO),
0.25ml 200mM glutamine, 1ml penicillin/streptomycin per 100ml Neurobasal). Cells
were counted and volume adjusted to give a final plating density of 1 x 10s cells/cm2.
The cells were plated on the poly-d-lysine/laminin coated substrates and incubated
at 37°C 95% oxygen, 5% CO2. The cells plated on 6 well plates were used for
stimulation assays measuring gene expression, those plated on 1cm glass coverslips
were used for immunofluorescent staining and those on MEAs were used for
electrophysiological analysis.
2.2.3 Pharmacological Treatment of Cultured Neurons
2.2.3.1 NMDA Stimulation
Primary cultured E17.5 mouse cortical neurons were plated on 6 x 35mm well plates
and grown for 10-12 DIV. 2hrs before stimulation, the wells were treated with lpM
tetrodotoxin (TTX) (TOCRIS) to reduce basal activity and cells incubated at 37°C.
For stimulation, the media in the wells was replaced with Mg2+ free Locke's Solution
(140mM NaCl, 3mM KC1, 15mM HEPES, lOmM Glucose, 2.5mM CaCh and NaOH
to pH to 7.4) containing lOOpM NMDA and IOjuM glycine for stimulation and
incubated at 37°C. RNA was extracted 30mins post stimulation.
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2.2.3.2 Bicuculline Stimulation
Primary cultured E17.5 mouse cortical neurons were plated on 6 x 35mm well plates
and grown for 10-12 DIV. Plating media on was changed to 2.5ml stimulation
media (per 100ml, 88ml SGG [5mM NaCl, 7.5% NaHCCb, 3mM KC1, ImM MgCk,
ImM CaCk, ImM HEPES, ImM glycine, 2.5mM glucose, O.lmM Na Pyruvate, 0.5%
phenol red], 10ml MEM, 0.5ml penicillin /streptomycin, 1.5ml lxITS [insulin-
transferrin-sodium selenite media supplement]) and cells incubated at 37°C for
24hrs before treatment. Stimulated wells were treated with 50pM bicuculline
(TOCRIS) and unstimulated wells treated with media. For control purposes some
wells were treated with lOpg/ml Actinomycin D or 50pM amino-5-
phosphonovalerate (APV) (TOCRIS) 1 hour prior to bicuculline treatment. RNA
was extracted from cells lhr after bicuculline application.
2.2.3.3 APV Treatment
Primary cultured El7.5 mouse cortical neurons were plated on 6 x 35mm well plates
and grown for 10-12 DIV. Plating media on was changed to 2.5ml stimulation
media (as detailed above) and cells incubated at 37°C for 24hrs before treatment.
Wells were treated with 50pM APV lhr before RNA extraction.
2.2.4 Immunoflourescent Staining of Cultured Neurons
Primary cultured E17.5 mouse cortical neurons were grown on 1cm glass coverslips
for staining. At DIV12, cells were washed with PBS and fixed for lOmins, on ice,
with 500pl -20°C methanol. For the remainder of the protocol coverslips were kept
in the dark at room temperature. The coverslips were washed with PBS and
incubated in 500pl blocking buffer (tris buffered saline[TBS], 0.5% Tween, 5% goat
serum) for 30mins. The coverslips were then incubated for lhr with mouse MAP2B
1° antibody (Transduction Laboratories) diluted 1:100 in blocking buffer and then
given 3 x 5min washes with TBS, 5% Tween. 2° antibody, cy3-goat anti-mouse,
(Jackson Laboratories) was diluted 1:200 in TBS, 5% Tween, and incubated on the
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coverslips for lhr. Coverslips were given 3 x 5min washes with TBS, 5% Tween.
Coverslips were then dipped in dFLO, air dried and mounted inverted onto glass
slides with Fluromount mountant (Sigma). The slides were stored at 4°C.
2.2.5 DAPI Staining of Cultured Neurons
E17.5 mouse cortical neuron cultures were grown on 1cm glass coverslips for
staining. At DIV12, cells were washed with PBS and fixed for lOmins, on ice, with
500ul -20°C methanol. The coverslips were kept in the dark at room temperature
and 1ml O.lpg/ml DAPI (4',6-diamidino-2-phenylindole), diluted in TBS, applied to
each coverslip for 30mins. The coverslips were washed 3 x 5mins with TBS, dipped
in dThO, air dried and mounted inverted onto glass slides with Fluromount
mountant (Sigma). The slides were stored at 4°C.
2.3 ELECTROPHYSIOLOGY
2.3.1 Multi Electrode Array SetUp
Elecrophysiology experiments were conducted using Multi Channel Systems arrays.
The Multi Electrode Arrays (MEA) were 8x8 grids of 300 diameter electrodes, set
200pm apart. Primary cultured cortical neurons were grown on the MEAs. For
recording, MEAs were mounted in an amplifier and extracellular activity recorded
in real-time using the MC_Rack software (Multi Channel Systems).
2.3.2 MultiElectrode Array Recording
Recordings were taken from primary cultured E17.5 cortical neurons, 10-13 DIV.
Arrays were removed from the incubator and put into the recording equipment.
The volume of the arrays is approximately 1ml and the cells were perfused with
Mg2+ containing Locke's Solution (140mM NaCl, 3mM KC1, 15mM HEPES, lOmM
Glucose, 2.5mM CaCh, ImM MgCL and NaOH to pFl to 7.4) at a rate of lml/min.
The perfusion and base plate of array were maintained at 30°C. Extracellular
recordings, measuring spike rate, were performed continuously.
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2.3.2.1 Bicuculline Treatment of Cultured Neurons
Perfusion with Locke's solution was maintained for at least lOmins to record control
activity. 50pM bicuculline was added to the perfusion solution and activity
recorded for at least lOmins. 50pM 4AP was then added to the Locke's/bicuculline
solution and activity recorded for at least lOmins. The cells were then washed by
perfusion with Locke's solution for at least lOmins and were then perfused with
Locke's solution containing lpM TTX. Activity was recorded throughout control,
bicuculline treated, 4AP treated, wash and TTX periods.
2.3.2.2 APV Treatment of Cultured Neurons
Perfusion with Locke's solution was maintained for at least lOmins to record
activity. 50pM APV was added to the perfusion solution and activity recorded for
at least lOmins. Following a wash period by perfusion with Locke's solution, the
cells were perfused with Locke's solution containing lpM TTX. Activity was
recorded throughout control, APV treatment, wash and TTX periods.
2.3.3 MultiElectrode Array Analysis
The recorded data was played back using Replayer function of the MCJRack
software. Channels from the arrays showing activity were chosen for analysis.
Baseline noise levels were assessed as the signal recorded from TTX treat cells.
Spike thresholds were set accordingly for each array to ensure spikes were counted,
but background noise was disregarded. The data from the selected channels was
replayed and Spike Detector recorded the spike rate vs. time.
The spike frequency data was imported to Excel and the average activity during
different drug conditions calculated for each channel. Control activity at each
channel was adjusted to 100 and all other activity measured at each channel
normalised to this level. T tests were used to compare the activity on an array in
conditions of drug treatment to control.
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3. GENE EXPRESSION IN PSD957 AND SYNGAP+/~ TISSUE
The NRC contains signalling molecules that act in pathways that can regulate gene
expression. However, it remains unclear what role many NRC molecules may play
in controlling transcription. To examine this, gene expression was analysed in
tissue from animals carrying mutations in PSD95 and SynGAP.
As discussed in the introduction, both PSD95_/" and SynGAP+/" animals have deficits
in NMDA receptor dependent behavioural and electrophysiological paradigms
(Migaud et al.r 1998; Komiyama et al., 2002). As a structural component of the NRC,
PSD95 could be hypothesised to have a role in regulating signalling downstream of
the NMDA receptor. It's function, facilitating protein-protein interactions, could
enable binding partners, involved in signalling, to be at a spatially advantaged
position for effective signal transduction. Disruption of PSD95 could, therefore,
interfere with multiple pathways downstream of NMDA receptor activity. The
action of SynGAP as a GTPase activating protein means it could be involved in
transcription via its role in the ras-ERK pathway.
To test whether mutations in these proteins cause transcriptional disruption, RNA
levels in mutant and matched wild type tissues were assessed by microarray. The
simultaneous analysis of thousands of transcripts revealed the global effect of
PSD95 and SynGAP mutations on gene expression in neuronal tissue.
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3.1 MICRORARRAY HYBRIDISATION AND QUALITY CONTROL
3.1.1 Isolation and Quality Assessment of RNA
Microarray analysis simultaneously assesses the levels of thousands of RNA
transcripts. As such, the method is susceptible to false positive results. The
dissection of tissue and subsequent RNA extraction was, therefore, performed to
strict protocol criteria in order to minimise variation between samples.
Total RNA was isolated from the forebrains of 3 female adult PSD95_/_ mice and 3
age and sex matched wild type animals. The forebrain was chosen for these
samples as PSD95 is widely expressed in this area of the brain and to ensure
adequate tissue for RNA isolation. RNA was also extracted from the hippocampi of
3 female adult SynGAP+/- animals and 3 age and sex matched wild type mice. For
these samples the hippocampus was chosen as a source of RNA as SynGAP has a
restricted expression pattern in the adult brain, but is highly expressed in this region
(K. Porter, personal communication). Due to postnatal lethality of SynGAP~/_
animals, heterozygotes were used.
Dissections of PSD95"/_ and matched wildtype forebrains were performed
consecutively, on the same day, and tissue immediately frozen in liquid nitrogen.
Dissections of SynGAP+/" and matched wildtype hippocampi were performed
similarly, on a different date, but at the same time of day as PSD95"/_ samples. For
both sets of samples, RNA isolation was performed on the same day as tissue
dissection. Total RNA extraction, including DNase treatment, was performed on
QIAGEN RNeasy spin columns and was eluted in 800pl (forebrain) or 140pl
(hippocampi) DNase free water. RNA concentration was determined by taking A260
and A280 readings using a spectrophotometer (see table 3.1).
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1 -/- 1.693 344 275.2
2 -/- 1.701 392 313.6
3 +/+ 1.671 414 331.2
4 +/+ 1.835 482 385.6
5 -/- 1.665 445 356.0
6 +/+ 1.744 458 366.4
SynGAP RNA Samples
1 +/+ 2.038 64 8.96
2 +/+ 2.046 72 10.02
3 +/+ 1.807 80 11.23
4 +/- 1.905 76 10.67
5 +/- 1.885 78 10.98
6 +/- 1.668 109 15.32
Table 3.1 - A260:A280 Ratios and RNA Concentrations. Genotypes of the samples are shown.
A26o:A28o ratios and concentrations are taken from spectrophotometer readings. Total RNA extracted
is calculated from concentration and volume of water for elution (800pl for PSD95 forebrains, 140pl
for SynGAP hippocampi).
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For microarray analysis, it is important that high quality starting material is used.
For the PSD95 samples, the integrity of the RNA was assessed by running lpg of
each sample on an agarose gel and by use of the Agilent 2100 bioanalyser, a
machine that uses 'lab-on-a-chip' technology to accurately analyse small amounts of
RNA electrophoretically. Due to the limited amount of RNA extracted from
hippocampi, the SynGAP RNA samples were analysed by Agilent bioanalyser
alone. Figures 3.1 and 3.2 show this data for PSD95"/_ and SynGAP+/_ samples
respectively.
Figure 3.1A is an image of an agarose gel showing the PSD95 samples to have the
two expected bands of 18s and 28s ribosomal RNA. Figure 3.1B and figure 3.2 show
the profiles of the samples generated by the Agilent 2100 bioanalyser for PSD95 and
SynGAP samples. A marker added to each sample causes the initial peaks of each
graph. The two peaks in the centre of the graphs represent the 18s and 28s
ribosomal RNAs, the ratios of which can be calculated by comparing the areas
under each respective peak. In all cases distinct ribosomal peaks were present,
indicating the RNA is intact.
3.1.2 Microarray Hybridisation
Affymetrix U74Av2 GeneChip arrays were used to analyse the RNA extracted from
PSD95 and SynGAP mutant brain tissue. These arrays contain oligonucleotide
probe sets specific for approximately 12000 different transcripts. Around 6000 of
these target known mouse genes present in the mouse Unigene database, build 74,
and the remainder are specific to EST (expressed sequence tag) sequences. Samples
from each animal were hybridised to individual chips (therefore, 12 arrays in total).
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Figure 3.1 - Analysis of RNA Extracted from PSD95"'" and Wild Type Forebrains. A. Agarose gel
showing the 18s and 28s ribosomal RNA bands of the RNA extracted from PSD95"'' and Wild Type
forebrains. B. Graphs generated by Agilent Bioanalyser 2100. The two peaks in the graph represent
the 18s and 28s ribosomal RNA.
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Figure 3.2 - Analysis of RNA Extracted from SynGAPw" and Wild Type Hippocampi. Graphs
generated by Agilent Bioanalyser 2100 for samples 1 -6. The two peaks in the graph represent the 18s
and 28s ribosomal RNA.
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RNA labelling and hybridisation was carried out by Kevin Robertson at the Scottish
Centre for Genomic Technology and Informatics (SCGTI), University of Edinburgh.
RNA was prepared in accordance with Affymetrix protocols. Briefly, the RNA was
primed with a primer encoding the T7 promoter with oligo-dT(24) used to initiate 1st
strand synthesis from the polyA tails of mRNA. 1st strand cDNA synthesis was
performed using reverse transcriptase (M-MLV). Using this template, second
strand cDNA was synthesised by E. coli DNA polymerase. An in vitro transcription
reaction was then performed by T7 RNA polymerase with biotin labelled
ribonucleases. The labelled cRNA product was fragmented and hybridised to
microarrays overnight. Following hybridisation the arrays were washed and
stained with streptavidin phycoerythirin. The arrays were scanned using the
Affymetrix GeneChip scanner 2500 and image analysis and quantitation undertaken
using Affymetrix MAS 5.1 software according to standard Affymetrix protocols.
Figure 3.3 shows examples of the scanned arrays. Figure 3.3A is an array
hybridised with wild type forebrain sample and figure 3.3B is an array hybridised
with sample from SynGAP+/- hippocampi.
Expression data from all arrays were normalised by scaling to an overall target
intensity of 100. After normalisation, scaling factors for all the arrays were within
an accepted range (i.e. within a 3 fold of each other). The result of normalisation
was a spreadsheet of expression levels for all transcripts on the arrays, with a P
(present), M (marginal) or A (absent) call as assigned by Affymetrix software.
Absent transcripts have an expression below the threshold of detection and, if there
is uncertainty about the presence of a transcript, it is called as marginal. The
expression levels and presence/absence calls for all transcripts analysed in the
PSD95 and SynGAP experiments are in Appendix 1 and Appendix 2 respectively.
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Figure 3.3 - Images of Scanned Arrays. Images show examples of scanned Affymetrix U74A
arrays. A is an array hybridised with a sample from wild type forebrain used in the PSD95
experiment. B is an array hybridised with a sample from SynGAP+/" hippocampi. The colour
intensity at a given spot is indicative of the amount of sample bound to that probe, with lighter
colours representing increased amounts of binding.
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3.1.3 Quality Control Data
3.1.3.1 Levels of Control Transcripts
The Affymetrix chips include several control probes, used to assess the quality of
the reactions. Levels of positive control transcripts, (3Actin and GAPDH, were
measured by oligonucleotides designed to 5', mid and 3' regions of the genes. The
ratio of 3' and 5' levels would ideally be close to 1 and it is recommended by
Affymetrix that a ratio greater than 3 be considered unacceptable. As shown in
table 3.2, for all 12 chips, (3Actin ratios range from 0.96 to 1.02 and those for GAPDH
range from 0.96 to 1.01. These ratios indicate that the RNA used was undegraded
and subsequent treatments were efficient.
To assess the quality of the hybridisations, the levels of spiked controls, at known
concentrations, were measured. The spike with the lowest concentration, 'bioB' was
detected present in all reactions (see table 3.2), indicating hybridisation, washing,
staining and scanning were optimal.
Sample PActin (375') GAPDH (375') BioB Level BioB Call
PSD95 Arrays
1. +/+ 1.02 0.99 358.4 Present
2. +/+ 1.03 0.99 333.3 Present
3. +/+ 0.99 0.98 397.6 Present
4. -/- 1.02 0.99 288 Present
5. -/- 1.01 0.97 289.3 Present
6. -/- 1.01 1.01 312.2 Present
SynGAP Arrays
1.+/+ 0.96 0.99 169.1 Present
2. +/+ 1.02 0.98 136.9 Present
3. +/+ 0.98 0.96 172.5 Present
4. +/- 0.99 1.00 141.4 Present
5. +/- 0.98 0.95 167.7 Present
6. +/- 1.02 0.93 165.1 Present
Table 3.2 - Control Gene Ratios and Spiked Control Levels. Table shows the 375' ratios of
PActin and GAPDH transcripts for each sample array. Also, the levels of BioB, the spiked control
of lowest concentration, and presence call are shown for each array.
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3.1.3.2 Distribution of Transcript Expression Levels
To analyse the performance of the arrays, prior to data analysis, scatter plots were
produced using Insightful SPLUS software (Insightful Corporation) (figures 3.4 and
3.5). To compare the range of expression and consistency of all arrays, the
expression levels for all transcripts on each array were plotted against those of every
other array. These plots show the data, from both the PSD95 and SynGAP
experiments, have a symmetrical 'flared' distribution and a dynamic uninterrupted
range of expression values from low to high signals. The symmetry of the plots,
about the 45° line, indicates that the hybridisation of the arrays and subsequent
normalisation of the data was consistent across all arrays. The flared distribution at
lower levels occurs as a result of increased variation as signal levels decrease and is
typical of data normalised in the manner described (K. Roberston, personal
communication).
To further investigate the signal distribution across all arrays, a 'box-and-whiskers'
representation of log2 expression levels was produced in SPLUS (figure 3.6). The
plots show the lower quartile, median and upper quartile values for each array, as
well as the range of expression values. After normalisation, the data from PSD95
and SynGAP experiments shows symmetry across all chips.
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Figure 3.4 - Scatter Plots of Expression on All Arrays Against Each Other (PSD95
Experiment). Scatter plots are of the log2 expression levels of all transcripts on each array
plotted against every other array. The plots show a symmetrical, flared distribution of
expression.
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SynGAP Data
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Figure 3.5 - Scatter Plots of Expression on All Arrays Against Each Other (SynGAP
Experiment). Scatter plots are of the log2 expression levels of all transcripts on each array
plotted against every other array. The plots show a symmetrical, flared distribution of
expression.
Chapter 3 - Gene Expression in PSD95"'" and SynGAP*'" Tissue 70










-i 1 1 1 1 1 1 1 1 [-











i 1 1 1 r
Mutant Mutant Mutant
Figure 3.6 - Box and Whiskers Plots Of PSD95 and SynGAP Data. Plots
illustrate the range of log 2 expression values across each chip and show the lower
quartile, median and upper quartile values for each array .
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3.1.3.3 Numbers of Transcripts Detected
Affymetrix microarray chip reports contain information about the number of
transcripts considered to be present, absent and marginal by Affymetrix MAS 5.1
software. Table 3.3 shows summary of this data for all arrays. It was found that, for
the PSD95_/" chips (both mutant and wild type), an average of 5831 transcripts were
detected present, 46.75% of the total probes present. 6333 transcripts (50.75% of the
total probes) were called as absent. For the SynGAP^- chips, on average, 5355
transcripts were present, 42.93% of the total on the array, and 6808 (54.58% of total
probes) were absent.
Sample # Present % Of Total
Probes
# Absent % Of Total
Probes
# Marginal % Of Total
Probes
PSD95 Samples
1.+/+ 5809 46.6 6336 50.8 328 2.6
2. +/+ 5857 47.0 6304 50.5 312 2.5
3. +/+ 5578 44.7 6587 52.8 308 2.5
4. -/- 6239 50.0 5917 47.4 317 2.5
5. -/- 5860 47.0 6314 50.6 299 2.4
6. -/- 5640 45.2 6541 52.4 292 2.3
Average 5831 46.75 6333 50.75 263 2.5
SynGAP Samples
1. +/+ 5752 46.1 6411 51.4 310 2.5
2. +/+ 5420 43.5 6757 54.2 296 2.4
3. +/+ 5472 43.9 6670 53.5 331 2.7
4. +/- 5178 41.5 6977 55.9 318 2.5
5. +/- 4991 40.0 7174 57.5 308 2.5
6. +/- 5317 42.6 6858 55.0 298 2.4
Average 5355 42.93 6808 54.58 310 2.5
Table 3.3 - Numbers of Detected Transcripts. Table shows the number of genes detected present,
absent and marginal on each microarray and this represented as a % of the total probes on each chip.
The average for each genotype set is also shown.
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3.2 GENES SIGNIFICANLTY ALTERED IN MUTANT TISSUE
3.2.1 Analysis and Sorting of Data
Control data and analysis of expression distribution indicated that the labelling and
hybridisation reactions were all successful. Thus, the data from these reactions were
further analysed. To identify genes expressed at significantly different levels in
mutant tissue, as compared to wild type, data was imported into Microsoft Excel
and Welch t tests, which do not assume equal variance, were performed.
Figure 3.7 shows scatter plots of the PSD957' data. The graphs show, on a logio scale,
the average expression level in mutant tissue versus wild type expression for each
probe on the Affymetrix array. Spots on the line at 45° that passes through the point
of origin are unchanged in mutant tissue, the other two parallel 45° lines represent 2
fold changes up and down.
Figure 3.7A shows data from all transcripts on the array. The dots representing the
transcripts are coloured according to their expression, ranging from blue at low
levels to yellow at high levels. A greater deviation from the unchanged line is seen
in transcripts of lower expression. This is due to the increased variability of
measurements at extreme low levels. Figure 3.7B shows transcripts that were found
expressed at significantly different levels in PSD95~/_ tissue, compared to wild type
(p<0.05, as measured by Welch t test). 644 transcripts were found differentially
expressed with a p value less than 0.05.
Figure 3.8 shows scatter plots for the SynGAP+/_ data in the same was as shown for
the PSD95 data. For the SynGAP samples, 658 transcripts were found to have a p
value of less than 0.05.
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Figure 3.7 - Average Expression Levels On PSD95"'" and Wild Type Arrays. Scatter
plots show, on a log scale, the average expression levels of transcripts on PSD95"'" and
wild type arrays. A shows all transcripts and B shows transcripts expressed at significantly
different levels on PSD95"
Welch t test.
and wild type arrays with a p value <0.05, as measured by
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Figure 3.8 - Average Expression Levels On SynGAP*' and Wild Type Arrays. Scatter
plots show, on a log scale, the average expression levels of transcripts on SynGAP+/" and
wild type arrays. A shows all transcripts and B shows transcripts expressed at significantly
different levels on SynGAP+/" and wild type arrays with a p value <0.05, as measured by
Welch t test.
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To identify, from this data, differentially expressed transcripts that may be of
biological significance, particular criteria were set. Transcripts that were altered
greater than 1.5 fold, with a p value less than 0.05, were considered to be
significantly altered. Also, probes that were called absent by Affymetrix MAS 5.1 in
both wild type and mutant tissue were discarded. To be considered expressed in
tissue from a particular genotype, the transcript had to be called present on all 3
relevant chips.
3.2.2 Genes Significantly Altered in PSD957" Forebrain
3.2.2.1 Genes Significantly Altered in PSD95"'" Forebrain
Using the set criteria, the PSD95_/~ versus wild type data was analysed. Table 3.4
details genes that showed significant change (p<0.05), greater than 1.5 fold, between
wild type and PSD95_/" RNA. This analysis revealed changes in a limited number of
transcripts. 11 transcripts (0.19% of transcripts detected present) were down
regulated in mutant tissue. 3 transcripts (0.05% of those present) were found at a
higher level in PSD95_/" forebrain.
Of the downregulated transcripts in PSD95_/" forebrain, 4 are genes regulated by
NMDA receptor activity (nur77, cfos, egr2 and junB; highlighted in table 3.4). The
other genes found at a lower expression in the mutant tissue were Perl, GADD45B,
cyln2 and PSD95 itself. The probes used by Affymetrix to detect the PSD95
transcript are designed to the 3' end of the gene, sequence that is left intact
following the targetted mutation of PSD95. As such, it is not alarming that PSD95
transcript is detected by these probes in the PSD95~/_ samples. 3 unknown ESTs were
found down regulated in the mutant tissue.
3 transcripts were found at higher levels in PSD95 '" forebrain. The gene showing
the greatest level of up regulation is Atp7a, encoding a Cu++ transporting ATPase.
The other altered transcripts were syntenin and serine palmitoyltransferase, subunit 2.
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AFFYMETRIX ID GENE GENBANK NO. FOLD CHANGE
Lower in Mutant
104175_at PSD 95 D50621 3.4
102371_at nur 77 X16995 2.39
160901_at cfos V00727 2.22
102661_at egr2 M24377 2.19
93619_at perl AF022992 2.16
102362_i_at junB U20765 1.97
99432_at CYLN2 AJ228865 1.97
161666_f_at GADD45B (EST) AV138783 1.75
94555_at EST AI845579 1.57
96242_at EST AW 125751 1.55
96756_at EST AA693236 1.52
Higher in Mutant
102854_s_at Atp7a U03434 1.74
100893_at serine palmitoyltransferase, subunit 2 U27455 1.57
93017_at syntenin AF077527 1.56
Table 3.4 - Genes with Altered Expression in PSD95"'" Forebrain. Table shows Affymetrix IDs of
transcripts significantly altered, >1.5 fold, p value <0.05, in mutant tissue. Gene names, Genbank accession
numbers and fold change are all shown. EST following gene name indicates Affymetrix probes were
designed to an EST that has subsequently been annotated. Transcripts shown in bold are activity regulated
genes.
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3.2.2.2 Expression Levels of Genes Significantly Altered in PSDGS ' Forebrain
Table 3.5 shows the expression levels of significantly altered transcripts in PSD957"
tissue. The table also indicates whether the transcripts were called as present (P) or
absent (A). All, but one, transcripts were present in both wild type and PSD957"
samples. The Cu" transporting ATPase was found to be absent in wild type
samples, but was expressed, at low level, in PSD957- forebrain. Figure 3.9 is a bar
graph showing the expression levels of significantly altered transcripts.
3.2.3 Genes Significantly Altered in SynGAP +/" Hippocampi
3.2.3.1 Genes Significantly Altered in SynGAP+/" Hippocampi
Table 3.6 shows genes expressed at significantly different levels in wild type and
SynGAP7 hippocampi with a fold change greater than 1.5. As with the PSD95 data,
changes were seen in a limited number of genes. 16 transcripts (0.30% of those
present) were expressed at lower levels in SynGAP+/- hippocampi. 4 (0.07% of those
present) transcripts were up regulated in mutant tissue.
Of the genes down regulated, 3 {egr2, cfos and nur77) are regulated by NMDA
receptor activity (highlighted in table 3.6). The other genes down regulated include
two .potassium channels, one belonging to subfamily K (TWIK1) and one to
subfamily H (m-eag). The other genes with reduced expression in mutant tissue are
soxll, DUSP6, erythroid differentiation factor, glucoses-6-phosphate dehydrogenase, Nrdl,
UDP-glucuronosyltransferase 8, N-glycan alpha 2,8-siayltransferase and Elovl6. 3 ESTs
were found at a lower level in the SynGAP+/" hippocampi. It should be noted that
there were no probes representing SynGAP present on the arrays used.
Of the transcripts up regulated in SynGAP+7 hippocampi, one was an EST. The
others encode NADH dehydrogenase, glyoxalase 1 and ribosomal protein L44.
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GENE WILD TYPE





PSD 95 472.57 37.23 P 138.9 4.51 P 0.004
nur 77 256.9 21.81 P 107.2 22.78 P 0.001
cfos 247.8 38.4 P 111.4 9.69 P 0.002
egr2 92.73 9.94 P 42.43 15.67 P 0.014
perl 120.3 23.23 P 55.6 11.85 P 0.024
junB 238.7 30.88 P 121.0 6.12 P 0.019
CYLN2 66.93 10.85 P 34.13 6.94 P 0.017
GADD45B 57.43 7.56 P 32.8 6.89 P 0
EST (94555_at) 497.53 60.58 P 317.17 50.16 P 0.014
EST (96242_at) 31.07 3.36 P 18.07 4.01 A 0.013
EST (96756_at) 65.8 9.61 P 43.27 7.44 P 0.036
Higher in Mutant
Atp7a 21.47 1.89 A 37.33 5.05 P 0.021
serine palmitoyltransferase 42.6 5.5 P 66.7 7.65 P 0.014
syntenin 25.37 3.57 P 39.6 2.45 P 0.007
Table 3.5 - Levels of Genes with Altered Expression in PSD 95"'" Forebrain. Table shows the
average expression levels and standard deviations for significantly altered genes in wildtype and
mutant tissue. The 'call' column shows whether the transcript was judged present (P) or absent (A) by
Affymetrix MAS 5.1. P values were calculated by comparing wild type and mutant expression levels
by Welch t Test.
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■Wild Type Average
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Figure 3.9 - Graphed Expression Levels of Transcripts Significantly Altered in PSD95"'"
Forebrain. Graph shows the average expression levels, with standard deviations indicated, of
significantly altered transcripts in wild type and mutant forebrain.
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AFFYMETRIX ID GENE GENBANK NO. FOLD CHANGE
Lower in Mutant
102661_at egr2 M24377 3.19
96215_f_at EST AM 53421 2.79
93669_f_at SOX 11 (EST) AW 107922 2.71
98525_f_at erythroid differentiation factor AJ007909 2.25
160901_at cfos V00727 2.17
93285_at DUSP6 (EST) AI845584 1.92
96833_at EST AW048468 1.67
94966_at glucose-6-phosphate dehydrogenase Z11911 1.61
102371_at nur 77 X16995 1.61
102335_at K+ channel, subfamily K, 1 AF033017 1.59
96661_at Nrd1 (EST) AA734806 1.59
98380_at voltage gated K+ channel, subfamily H, 1 U04294 1.58
98872_at UDP-glucuronosyltransferase 8 U48896 1.58
102318_at N-glycan alpha 2, 8-sialyltransferase NM_008430 1.53
95451_at EST AA855382 1.53
103665_at Evovl6 (EST) AW 122523 1.51
Higher in Mutant
100775_at EST C81070 1.67
93562_at NADH dehydrogenase (EST) AI854366 1.60
93269_at Glyoxalase 1 AI848952 1.57
160081_at ribosomal protein L44 (EST) AW045418 1.57
Table 3.6 - Genes with Altered Expression in SynGAP*'" Hippocampi. Table shows Affymetrix IDs of
transcripts significantly altered, >1.5 fold, p value <0.05, in mutant tissue. Gene names, Genbank
accession numbers and fold change are all shown. EST following gene name, indicates Affymetrix probes
were designed to an EST that has subsequently been annotated. Transcripts shown in bold are activity
regulated genes.
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3.2.3.2 Expression Levels of Genes Significantly Altered in SynGAP+/" Hippocampi
Table 3.7 details the expression level of all transcripts significantly altered in
SynGAP+/- hippocampi and indicates whether they were present (P) or absent (A).
Apart from 2, all transcripts were called present in both wild type and mutant
samples. Egr2 and an EST (96833_at) were only present in wild type tissue. Figure
3.10 is a bar chart showing the levels of the significantly altered genes.
GENE WILD TYPE
Ave. St. Dev Call
SynGAP+/"
Ave. St. Dev Call
P VALUE
Lower in Mutant
Egr 2 77.77 19.25 P 24.37 12.4 A 0.021
EST (96215_f_at) 398.87 76.17 P 142.87 82.16 P 0.017
Soxl 1 75.73 5.35 P 27.93 7.72 P 0.002
Erythroid Differentiation Factor 192.9 14.03 P 85.8 31.72 P 0.016
cfos 105.67 18.3 P 48.6 2.9 P 0.03
DUSP6 281.27 4.68 P 146.7 26.34 P 0.011
EST (96833_at) 88.13 12.16 P 52.67 15.18 A 0.037
Glucose 6 phosphate dehydrogenase 53.23 1.97 P 33.03 7.36 P 0.034
nur77 179.9 17.2 P 111.43 8.96 P 0.009
K+ channel, subfamily K, 1 332.2 42.55 P 208.87 28.54 P 0.019
Nrd1 221.97 23.99 P 139.33 26.46 P 0.016
voltage gated K channel, subfamily H1 94.07 5.57 P 59.63 11.29 P 0.019
UDP-glucuronosyltransferase 8 31.6 4.69 P 18 6.04 A 0.04
N-glycan alpha 2, 8-sialyltransferase 69.37 6.87 P 45.37 7.11 P 0.014
EST (95451_at) 209.57 17 P 136.53 12.71 P 0.005
Evovl6 121 14.09 P 80.03 9.44 P 0.018
Higher in Mutant
EST (100775_at) 29.1 2.77 P 48.73 5.6 P 0.013
NADH dehydrogenase 362.83 52.02 P 580.5 89.36 P 0.032
Glyoxalase 1 249.27 9.05 P 390.7 20.98 P 0.003
Ribosomal Protein L44 52.5 14.12 P 82.43 10.12 P 0.046
Table 3.7 - Levels of Genes with Altered Expression in SynGAP+/" Hippocampi. Table shows the
average expression levels and standard deviations of significantly altered genes in wildtype and
mutant tissue. The 'call' column shows whether the transcript was judged present (P) or absent (A). P
values were calculated by t test, comparing wild type with mutant expression levels.
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■Wild Type Average
Figure 3.10 - Graphed Expression Levels of Transcripts Significantly Altered in SynGAP"'
Forebrain. Graph shows the average expression levels, with standard deviations indicated, of
significantly altered transcripts in wild type and mutant hippocampi.
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3.3 MICROARRAY DATA CONFIRMATION USING RT-PCR
To be confident microarray results are accurate, confirmation by an alternative
method of RNA analysis method is required. This has been done using RT-PCR.
3.3.1 Primers Used for RT-PCR
Intron spanning primers were designed to genes of interest using Primer 3.0. Figure
3.11 details the primers used for RT-PCR and shows their products were of expected
size when used in an RT-PCR reaction with cDNA from wild type forebrain.
3.3.2 Confirmation of Microarray Data by RT-PCR
Using conventional RT-PCR, RNA samples from PSD95_/" and wild type forebrain
were amplified with PSD95, cfos and nur77 primers, using GAPDH primers as a
control. Figure 3.12 shows the resulting products, run out on a 4% agarose gel.
GAPDH was used as a loading control. It should be noted that the PSD95 primers
used for the RT-PCR reactions were designed to the 3' region of the gene to which
the Affymetrix probes were designed. As such the results from these primers
should be comparable to the data from the Affymetrix analysis. For the reactions
with PSD95 and cfos primers, the bands in the PSD95V~ lanes (samples 1, 2 and 5)
appear less intense than wild type. For the nur77 reaction, the PSD95_/" samples in
lanes 1 and 2 appear less intense than wild type samples. However, there is little
difference between the mutant sample in lane 5 and wild type lanes.
The PSD95 and cfos data confirms the differential expression levels seen by
microarrays in PSD95_/" and wild type forebrain. In the nur77 reaction, the band
intensity in only two of the three PSD957" sample lanes appear consistent with lower
nur77 expression levels in mutant tissue. It may be that, in the given conditions, the
reactions are reaching saturation. If this were the case differential expression of
nur77 in mutant samples may only be clearly detectable at an earlier stage of
reaction.
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A
GENE FORWARD PRIMER REVERSE PRIMER
PRODUCT (BP)
Primers used for RT-PCR
GAPDH GTGTTCCTACCCCCAATGTG ATGTAGGCCATGAGGTCCAC 292
cfos CTTTATCCCCACGGTGACAG CTGCAGCCATCTTATTCCGT 298
nur77 TTCTGCTCAGGCCTGGTACT GATTCTGCAGCTCTTCCACC 199
PSD 95 TAAGACTCCTACCCCTGCCC AGGTGGGAGGTGTGTGAAAG 312
Additional primers used for QRT-PCR
egr2 AAGGCCGTAGACAAAATCCC CTAGGTGCAGAGATGGGAGC 344
Syntenin AGGTGAACGGACAGAACGTC AGGTGTCTGGAATGGAGTGG 177
MAP2 TGGCTCACTTGACAATGCTC TGACATCCTCAGCCAAAGTG 236
RL44 GAACATGGTGAACGTGCCTA CATCCTCTTAGATCTGCAGTTGG 250
Figure 3.11 - Primers Used for RT-PCR. A shows the details of the primers used for RT-PCR and QRT-PCR
and their expected product size. B shows gels from RT-PCR reactions. The primers used are detailed above
each lane, cDNA from wild type forebrain was used as a template for the reaction. The 1st lanes are 1kb ladder
with the relevant band sizes noted on the left.
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Figure 3.12 - RT-PCR of PSD95"'" and Wild Type RNA. Gels show the products of RT-
PCR reactions performed with GAPDH, PSD95, cfos and nur77 primers and PSD95"'" and
wild type forebrain RNA samples. The first lane is a water control, the rest are samples 1 - 6
± reverse transcriptase. Samples 1, 2 and 5 are from PSD95"'" forebrain. 3, 4 and 6 are wild
type samples.
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3.3.3 Confirmation By Microarray Data by QRT-PCR
To overcome the concerns of RT-PCR reaction saturation, and to quantify the level
of RNAs in the samples, quantitative RT-PCR (QRT-PCR), using a lightcycler was
employed. SYBR green, which fluoresces in the presence of double stranded nucleic
acids, is used to measure the accumulation of double stranded product over the
course of a PCR reaction. This is advantageous, compared to regular RT-PCR, as
enzyme saturation is not an issue since measurements are taken throughout the
reaction. Also, the level of a particular RNA in a sample can be calculated relative
to a standard curve of RNA concentrations enabling quantification.
The primers used for QRT-PCR reactions were those detailed in figure 3.11, as used
for conventional RT-PCR. Primer products were melted at the end of reactions to
confirm the presence of one double stranded product.
3.13A shows a graph of standards, for a particular gene, marked in black. The plot,
generated using dilutions of cDNA, is of cDNA quantity against cycle number.
3.13B shows an amplification plot, where the various sigmoidal curves represent the
reactions of different samples, with the cycle threshold line marked Or. Where the
sample plots cross the Ct line, the cycle number is taken. The cycle number is then
used to calculate the amount of template present using the standard curves. The Ct
threshold line is set using the plot of the standards. Adjusting the position of the Ct
line alters the regression line through the standard curve, such as figure 3.13A. The
Ct is set to where the r2 value of the line through the standard values is closest to 1.
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Ct
Figure 3.13 - Graphs from QRT-PCR. Figures show examples of graphs generated by
QRT-PCR. A shows log quantity vs. cycle number for standards of diluted cDNAs run
with 3 different primers. The points in black represent the data from one set of primers
and the r2 value of the line through the points is 0.999. B shows an amplification plot of
reactions plotted as fluorescence vs. cycle number. C shows the melting plots
(fluorescence vs. temperature) of 4 reaction products, 2 using GAPDH primers and 2
using PSD95 primers.
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The melting curves calculated at the end of QRT-PCR reactions graph the loss of
fluorescence at different temperatures while the reaction products are heated. The
peaks of the graph are at the product melting point. Graph 3.14C shows plots of
melting curves for 4 samples, 2 amplified with PSD95 and 2 with GAPDH primers.
The melting profiles are individual, and reproducible, for each primer pair and can
be used to verify that the reactions have produced only one double stranded
product.
3.3.3.1 Confirmation of PSD957" Data
For confirmation experiments, RNA from 3 PSD95_/_ forebrains and matched wild
type tissue was extracted as detailed before. 2pl RNA was used for reverse
transcription reactions using Ambion RT protocol. Each cDNA sample was run in
triplicate with each primer pair (GAPDH, PSD95, cfos, nur77, egr2, syntenin and
MAP2) using the QIAGEN Quantitect SYBR Green PCR kit and DNA Engine
Opticon LightCycler (MJ Research). The expression level of every gene in each
sample was calculated relevant to a standard curve.
The expression levels of the genes were obtained in triplicate for each sample. The
average level of the genes in each sample was then calculated and divided by the
average GAPDH level for that sample. Fold changes between wild type and mutant
samples were calculated and a t test used to identify the significance of any
differences. Table 3.8 details these results for PSD95. The level of PSD95 is 3.94
times higher in wild type forebrain as compared to PSD95~/_ tissue (p=0.028).
Table 3.9 shows the summary of the data for the rest of the genes compared to the
results from the microarray analysis. All genes analysed that were found
significantly altered by microarray were found similarly changed by QRT-PCR. The
expression of MAP2, which was found unchanged by microarray analysis, was not
significantly different in wild type and PSD95_/~ samples.
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1. +/+ 2423 (70) 2944(360) 0.823
2. +/+ 10947(1114) 741 8(475) 1.476
3. +/+ 3951(454) 5076(219) 0.778
Ave 1.026
4. -/- 2790(70) 8642(129) 0.323
5. -/- 508(133) 2441(53) 0.208
6. -/- 1371(294) 5492(438) 0.250
Ave 0.260
Wildtype Ave-PSD95"'" Ave Ratio 3.94
P value 0.028
Table 3.8 - QRT-PCR Of PSD95 Levels in Wildtype and PSD95"'" Forebrain. Table shows the
average GAPDH and PSD95 levels in 3 wild type and 3 PSD95"'" samples (levels averaged from 3
replicates). The average PSD95:GAPDH ratios are shown for each sample and calculated from
each geneotype. The average wildtype:PSD95"A is shown, along with the p value of the differences
between wild type and mutant samples as calculated by t test.
AVE. WT AVE. PSD95"'"
QRT-PCR DATA




PSD95 1.026 0.260 3.94 0.028 3.40
cfos 2.06 0.282 7.30 0.033 2.22
egr2 0.090 0.022 4.09 0.047 2.19
nur 77 0.022 0.0068 3.24 0.046 2.39
Up Regulated
syntenin 0.0005 0.0019 3.80 0.047 1.56
Unchanged
MAP2B 0.655 0.557 1.18 0.67 1.08
Table 3.9 - QRT-PCR Of Gene Levels in Wildtype and PSD95"'" Forebrain. Table shows the average
levels of PSD95, cfos, egr2, nur77, syntenin and MAP2B in wildtype and PSD95"'" forebrain (calculated
from triplicate values from 3 wild type and 3 mutant samples, normalised by GAPDH levels). The fold
change and p value for each gene is shown, along with the fold change measured by Affymetrix
analysis.
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3.3.3.2 Confirmation of SynGAP+/" Data
Confirmation of the SynGAP+/" data was performed in the same way as for PSD95A
RNA was extracted from 3 SynGAP+/" and 3 matched wild type hippocampi. 2pl
RNA from each sample was reverse transcribed to cDNA. Each cDNA was run in
triplicate with each primer pair (GAPDH, cfos, nur77, egr2, ribosomal protein L44
and MAP2). The expression levels were normalised using GAPDH levels and the
differences between wild type and mutant samples assessed by t test.
Table 3.10 is a summary of QRT-PCR data from SynGAP+/_ samples compared to the
results from the microarray analysis. All genes analysed were found altered in a
similar way to that found by microarray.
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Table 3.10 - QRT-PCR Of Gene Levels in Wildtype and SynGAP*'" Hippocampi. Table shows
the average levels of cfos, egr2, nur77, ribosomal protein L44 and MAP2B in wildtype and PSD957"
forebrain (calculated from triplicate values from 3 wild type and 3 mutant samples, normalised by
GAPDH levels). The fold change and p value for each gene is shown, along with the fold change
measured by Affymetrix analysis.
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3.4 BIOINFORMATIC ANALYSIS OF MICROARRAY DATA
The results from the microarray analysis of PSD95/_ forebrain and SynGAP+/"
hippocampus were confirmed by RT-PCR methods. This means that the data can be
considered reliable and analysed further.
3.4.1 Comparison of Genes Altered in PSD95 and SynGAP +/" Tissue
PSD95 and SynGAP are both found in the NRC and there are parts of the brain
where the expression of the two genes overlap. The phenotypes of animals carrying
mutations in PSD95 and SynGAP suggest that, in some instances, the proteins
function in same phenomena, such as spatial learning. PSD95 and SynGAP could,
therefore, act in pathways that regulate common genes. The analysis of PSD95_/~ and
SynGAP+/- mutant tissue was carried out using different brain regions (forebrain in
PSD95, hippocampus in SynGAP). As a result, the data from both experiments
cannot be directly compared. Nevertheless, studying the two data sets in parallel is
useful to reveal any genes with common misregulation in both genotypes.
Figure 3.14 is a comparison of the genes significantly altered, greater than 1.5 fold,
in PSD95_/" and SynGAP+/~ tissue. The diagram shows the names and number of
genes up and down regulated in both genotypes and any crossover between. An
overlap of 3 genes, commonly down regulated in mutant tissue, is found between
the two data sets. All three genes, cfos, nur77 and ergZ, are regulated by NMDA
receptor activity. Other than these genes, the remaining significantly altered genes
were changed uniquely in either PSD95/_ and SynGAP+/- tissue.
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Figure 3.14 - Comparison of Genes Significantly Altered in PSD95"' and SynGAP*"
Tissue. Venn diagram shows the comparison of data from PSD95 and SynGAP experiments.
3 genes are found commonly downregulated in both genotypes. Tables show the names of the
significantly altered genes and how they are changed.
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3.4.2 Expression Levels of Activity Dependent Genes
In both genotypes examined a limited number of genes were found significantly
changed, greater than 1.5 fold, in mutant tissue as compared to wild type (0.24% in
PSD957" tissue, 0.37% in SynGAP+/_ tissue). The genes with altered expression in
PSD957- and SynGAP+/" tissue included several activity dependent genes, three of
which were similarly down regulated in both genotypes. Furthermore, the activity
regulated genes altered in PSD957" and SynGAP+/" tissues were all immediate early
genes.
It has previously been estimated that there are between 30 and 40 immediate early
transcripts (Lanahan and Worley, 1998) which is consistent with the numbers of
transcripts with temporal profiles of immediate early genes found regulated by
seizure induction in rats, contextual fear conditioning in mice and NMDA treatment
of cultured cortical neurons (Newton et al., 2003; Hong et al., 2004; Levenson et al.,
2004). Ensembl predicts there to be 26762 genes in NCBI Mousebuild 32 of the
mouse genome (www.ensembl.org), therefore immediate early genes could be
estimated to make up approximately 0.149% (40/26762 x 100) of the genes in the
mouse genome. Of the 27 different transcripts found altered in PSD957- and
SynGAP+/- tissue, 4 (14.8%) encode immediate early genes. Thus, the frequency of
immediate early genes in this data set is, approximately, 100 times greater than that
found in the genome.
There appears to be a significant enrichment of immediate early genes in the
transcripts significantly altered, greater than 1.5 fold, in PSD957" and SynGAP+/_
tissue. To establish whether there were additional significant changes in activity
regulated genes, which had previously been unidentified due to being lower than
1.5 fold, the microarray data was re-examined. The levels of known activity
regulated transcripts, represented on the array, were compared in wild type and
mutant tissues. Table 3.11 details the ratios of expression of these genes in wild type
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tissue compared to mutant and the p values indicating the significance of the
change. Positive ratios indicate higher expression levels in mutant tissue, negative
values indicate a down regulation of the transcript in the mutant sample. Changes
of expression, in wild type and mutant tissue, with p values smaller than 0.05 are
considered significant.
In PSD95_/" forebrain, in addition to those significantly altered with a greater than 1.5
fold change (nur77, cfos, egrl and junB), fosB was found to be 1.32 fold down
regulated (p value 0.04) as compared to wild type tissue. No other activity
regulated genes were found significantly changed.
In SynGAP+/- hippocampi, cfos, nur77 and egrl were found significantly changed
greater than 1.5 fold. In addition to these transcripts, BDNF (ratio -1.49, p=0.019)
and somatostatin (ratio 1.07, p=0.034) were found significantly altered, though it
should be noted that the fold change of somatostatin is subtle. It is interesting to note
that junB, significantly down regulated 1.97 fold in PSD95_/~ forebrain, is found 1.66
fold lower in SynGAP+/- hippocampi with a p value of 0.073. This is close to being
statistically significant and, as such, junB could represent a fourth immediate early
gene that is similarly down regulated in PSD95_/" and SynGAP+/- tissue.
Further analysis of the microarray data found few additional activity regulated
genes to be significantly altered. Thus, the immediate early genes misregulated in
PSD95"'" and SynGAP+/~ tissues appear to represent a specific subset of activity
regulated genes.
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GENE AFFYMETRIX ID
PSD 95 (-/-) DATA SynGAP (+/-) DATA
WT:MUT ratio P value WT:MUT ratio P value
BDNF 102727_at -1.04 0.609 -1.49 0.019
cfos 160901 _at -2.22 0.02 -2.17 0.03
ChopIO 101429_at -1.09 0.269 1.05 0.867
c-jun 100130_at 1.16 0.479 1.18 0.396
CNS1 99891 _at -1.24 0.121 -1.07 0.785
Cox 2 104647_at -1.11 0.389 -1.42 0.190
Egr1 98579_at -1.32 0.106 -1.53 0.108
Egr2 102661 _at -2.19 0.014 -3.19 0.021
Fos B 103990_at -1.32 0.040 -1.29 0.100
GAP45 102389_s_at 1.12 0.156 1.14 0.305
GR33 101629_at 1.12 0.306 1.2 0.167
IER5 92773_at -1 0.995 -1.06 0.699
Jun B 102362_l_at -1.97 0.019 -1.66 0.073
Narp 2 94099_at 1.18 0.111 1.45 0.270
NMDAR 2a 100726_at 1.08 0.766 1.11 0.808
NT3 92420_at 1.23 0.664 -1.11 0.766
nur77 102371 _at -2.39 0.001 -1.61 0.009
Pim1 104533_at -1.06 0.479 1.13 0.319
Pim2 101926_at 1.09 0.536 1.36 0.250
Pip92 99109_at -1.34 0.120 -1.13 0.589
Presenilin 102201_s_at -1.01 0.789 -1.05 0.460
Somatostatin 95436_at 1.03 0.580 1.07 0.034
tPA 170031 _f_at -1.21 0.102 -1.46 0.137
TrkB 99069_at -1.13 0.495 1.28 0.676
Table 3.11 - Levels of Activity Dependent Gene Expression in PSD95"'" Forebrain and SynGAP+/"
Hippocampus. Table shows the wildtype to mutant ratio of the average expression levels of activity
dependent genes in PSD 95"'" forebrain and SynGAP+/" hippocampus. A positive ratio indicates expression
levels in the wildtype tissue was higher, a negative value that expression was higher in mutant samples.
Changes, significant with p< 0.05 are in bold.
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3.4.3 Chromosomal Location of Significantly Altered Genes
Analysis of gene expression in human and Drosophila studies has found groups of
genes, clustered together on the same chromosomes, that are similarly expressed in
given conditions (Caron et ai, 2001; Spellmen and Rubin, 2002; Versteeg et al, 2003).
The chromosomal location of transcripts significantly altered in PSD95 and SynGAP
mutant tissue was therefore analysed to see if there was any evidence of these genes
being clustered to particular chromosomes.
Tables 3.12 and 3.13 show the chromosomal positions of genes significantly altered
in PSD95"/_ and SynGAP"- tissues, those on the same chromosome are highlighted in
the same colours. Table 3.14 shows this data for the PSD95 and SynGAP data sorted
by chromosome. In this table the targeted genes are highlighted in blue and genes
with hypothesised roles in learning or plasticity are highlighted in yellow (see
discussion 3.5.3 for details). Figure 3.15 shows graphs showing the number of
significantly altered on each chromosome for PSD95 and SynGAP data.
Of the genes significantly altered in PSD95 mutant forebrain, several appear to be
clustered to the same particular mouse chromosomes. Syntenin and EST 96756_at
are both on chromosome 4. Egr2, GADD45B and EST 96242_at are found on
chromosome 10. PSD95, Perl and an EST 94555_at are all found on chromosome 11,
whilst cfos and serine palmitolytransferase both lie on chromosome 12. In the
SynGAP"" data there is also evidence of clustering. Voltage gated K+ channel HI, N-
glycan alpha 2,8-sialtransferase, NADH dehydrogenase and an EST 96833_at are all on
chromosome 1. UDP-glucuronosyltransferase 8, Elovl6 and ribosomal protein L44 lie on
chromosome 3. Egr2 and DUSP6 are both on chromosomelO. Soxll and cfos are
both present on chromosome 12, while EST 95451_at and glyoxalase 1 both lie on
chromosome 17.
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Using the chi square test, the data was analysed to see if there was statistically
significant evidence of clustering of significantly altered genes to particular
chromosomes. Analysis gave a p value of 0.101 for the PSD95 data and a p value of
0.031 for the SynGAP data. Thus, the grouping of significantly altered genes to
particular chromosomes is statistically significant for the SynGAP data. The PSD95
data shows no significant clustering, nevertheless, there appears to be a trend of
clustering. The lower n number of significantly altered genes in the PSD95-/" data
may contribute to the non-significant p value from the chi square test.
AFFYMETRIX ID GENE CHROMOSOMAL LOCATION
Lower in Mutant
104175_at PSD 95 chrl 1: 70631458-70632003 (+) 1 1 B4
102371 _at nur77 chr15: 102231569-102231972 (+) 15 F
160901 _at cfos Chrl 2: 80178548-80178747 (+) 12 D1
102661 _at egr2 ChrlO: 67591056-67591375 (+) 10 M
93619_at perl chrl 1: 69690481-69690978 (+) 11 B
102362_i_at junB chr8: 84678118-84678624 (-) 8C2-D1
99432_at CYLN2 chr5: 133094769-133098935 (-) 5 G
161666_f_at GADD45B chrl 0: 80760805-80760949 (+) 10C1
94555_at EST chrl 1: 71238585-71238877 (+) 11 B4
96242_at EST chrl 0: 6610076-6610297 (+) WM
96756_at EST Qh<4: m
Higher in Mutant
102854_s_at Atp7a chrX: 91052240-91052484 (+) XD
100893_at serine palmitoyltransferase chrl 2: 82023718-82028034 (-) 12 E
93017_at syntenin Ctor4: 5872494-5872730 (+) in
Table 3.12 - Chromosomal Location of Genes Significantly Altered in PSD 95"'" Forebrain Table
shows the mouse chromosomal locations known for transcripts significantly altered in PSD 95" forebrain.
Genes which appear clustered a region of the same chromosome are highlighted (green= chromosome 4,
blue = chromosome 10, yellow = chromosome 11, pink = chromosome 12)
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AFFYMETRIX ID GENE CHROMOSOMAL LOCATION
Lower in Mutant
102661 _at egr2 Chr10: 67591056-67591375 ■ 10B5
96215_f_at EST NOT KNOWN
93669J_al SOX 11 ■
98525_f_at Erythroid Differentiation Factor NOT KNOWN
160901 _at cfos Chr12: 80178548-80178747 (+) ■M
93285_at DUSP6 chr10: 99499994-99500239 (+)v / 10CS3
96833_at EST chrl: 132229216-132230887 (+) 1 E4
94966_at glucose-6-phosphate dehydrogenase chrX 57622845-57623443 (-) X A2-A3
102371 _at nur77 chr15: 102231569-102231972 (+) 15 F
102335_at K+ channel, subfamily K, 1 chr8: 126037677-126037972 (+) 8 E2
96661 _at Nrd1 chr4: 106807384-106808579 (+) 4C7
98380_at voltage gated K+ chamel, subfamily H, 1 Chr1: 194039168-194039746 (+) 1 H6
98872_at UDP-glucuronosyltransferase 8 wmm
102318_at N-glycan alpha 2, 8-sialyltransferase chrl: 96120517-96121080 (-) 1 D
95451 _at EST Mi
103665_at Evovl6 chr3: 130137795-130138309 (+) SNSS
Higher in Mutant
100775_at EST NOT KNOWN
93562_at NADH dehydrogenase chrl: 59181202-59190525 (+) 1 C1.3
93269_at Glyoxalase 1 17A3.3
160081_at ribosomal protein L44
Table 3.13 - Chromosomal Location of Genes Significantly Altered in SynGAP*'" Hippocampus Table
shows the mouse chromosomal locations of genes significantly altered in SynGAP+/' Hippocampus. Genes
which appear clustered a region of the same chromosome are highlighted (yellow = chromosome 1, green=
chromosome 3, blue = chromosome 10, pink = chromosome 12, red = chromosome 17)
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A PSD95 Data
CHROMOSOME GENES PRESENT
4 syntenin EST (96756_at)
5 cyln2
8 jun B
10 egr2 GADD45B EST (96242_at)
11 PSD 95 perl EST (94555_at)

















8 K* channel, subfamily K, 1
10 egr2 DUSP6
12 cfos Sox 11
15 nur77





EST (100775_at) EST (96215_f_at)
Table 3.14 - Significantly Altered Genes Sorted by Chromosome. A shows the genes, significantly
altered in PSD95"'" forebrain, sorted by the murine chromosomes they are present on. B shows the same
for the genes significantly altered in SynGAP+/' hippocampi. The targeted genes are highlighted in blue,
genes with hypothesised roles in plasticity are highlighted in yellow.
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Distribution of Genes Significantly Altered in PSD95-/- Forebrain
1 2 3 4 5 7 8 9 10 11 12 13 14 15 16 17 18 19 X
Chromsome
Distribution of Genes Significantly Altered in SynGAP+/- Forebrain
4 I
Chromosome
Figure 3.15 - Chromosomal Distribution of Significantly Altered Genes. Graphs show the
number of significantly altered genes on each chromosome for PSD95"'" (A) and SynGAP+/~ (B)
tissue.
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3.4.4 Gene Expression in Wild Type Forebrain and Hippocampus
The only difference in experimental design and analysis between PSD95 and
SynGAP experiments, other than the genotypes used, was the tissue source of RNA.
As a result the wild type data from the two experiments can be used to compare
gene expression in forebrain to that of the hippocampus alone. Identification of
transcripts highly expressed in, or with expression restricted to, particular brain
areas could be valuable in determining the roles of these genes in the associated
brain region function. It also furthers understanding of global gene expression
across the brain.
Some genes are widely and evenly expressed in all/most brain regions, e.g. GAPDH,
flActin and PSD95. The levels of these genes should, therefore, be unchanged in
wild type forebrain and hippocampal samples. Table 3.15 details the levels of these
genes in the wild type tissues, as measured by Affymetrix analysis, and shows there
is no significant difference in their expression in forebrain and hippocampal
samples as measured by t test. This verifies that the hybridisation and
normalisation of data in the PSD95 and SynGAP experiments are equivalent and,













GAPDH 472.57 553.23 37.23 47.88 0.85 0.09
fSActin 7274.03 7049.8 67.17 919.13 1.03 0.71
PSD95 6151.7 6267.5 20.97 624.94 0.98 0.78
Table 3.15 - Expression of Control Genes in Forebrain and Hippocampus. Table details the
average levels, with standard deviations (st. dev.) of GAPDH, pActin and PSD95 in wild type
forebrain and hippocampus. The forebrain to hippocampus (FB/HC) ratio is given, with p value as
calculated by t test.
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A diverse range of genes is represented on the microarrays that will include
transcripts with specialised neuronal function and, thus, restricted expression to
particular brain regions. Analysis of the wild type microarray data found 250
transcripts (4.3% of total detected present) that were expressed at a significantly
higher level (p<0.05, greater than 1.5 fold) in wild type forebrain as compared to
hippocampus. 232 transcripts (4.3% of the total detected present) were expressed at
significantly higher levels in the hippocampus as compared to forebrain. Thus, the
majority of detected transcripts were uniformly expressed in the hippocampus and
the forebrain as a whole.
Table 3.16 shows the 20 transcripts with the highest expression in the forebrain
compared to hippocampus (p<0.05, fold difference>1.5). Many of these have
specialised gene products that function outwith the hippocampus. For example,
preproenkephalin encodes the precursor for the endogenous opiod enkephalin and
is most highly expressed in the amygdala, striatum and cortex (Su et al., 2002). Also,
hypocretin and arginine vasopressin have endocrine function and are expressed,
specifically, in the hypothalamus (Su et al., 2002).
Table 3.17 details the transcripts expressed more highly in the hippocampus,
compared to forebrain, and also shows some selected transcripts that are more
highly expressed in the hippocampus (p<0.05, fold difference>1.5). Identification of
highly expressed hippocampal genes is of particular interest as these transcripts
may be involved in spatial learning or other hippocampal phenomena such as LTP.
3 of the 20 genes showing the greatest expression in the hippocampus compared to
forebrain (neurogenic differentiation 6, RIKEN gene 1200008D14, zinc finger protein
288) have previously been found enriched in the hippocampus compared to other
brain areas (Zirlinger et al., 2001). The transcript that is most highly expressed in the
hippocampus compared to the rest of the forebrain is klotho, a gene hypothesised to
be a regulator of aging. It has been found that the expression of klotho is restricted to
the hippocampus in the CNS (Su et al., 2002) and it has recently been shown that the
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transcript is particularly enriched to the hippocampal CA1 region (Lein et ah, 2004).
Mice carrying mutations in klotho have early onset of cognitive impairment in novel
object recognition and fear conditioning (Nagai et al., 2003). The selected genes/
shown in table 3.17, that are enriched in the hippocampus include NRC proteins
and other molecules involved in synaptic plasticity, for instance AMPA receptor
subunits, signalling proteins such as CaMKIIa and SAP102, a MAGUK protein.
Comparison of wild type gene expression in the forebrain and hippocampus has
revealed that the vast majority of genes are expressed at similar levels in these two
neuronal samples. Identification of genes more highly expressed in the forebrain as
a whole than in the hippocampus has picked out many transcripts with particular
function outwith the hippocampus. The transcripts more highly expressed in the
hippocampus, compared to forebrain, include several genes that are involved in
hippocampal-based function.
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1 7.07 preproenkephalin 1 2245 68.83 317.8 124.5 0.00013
2 6.57 hypocretin 131.3 8.3 19.07 13.35 0.00066
3 4.64 tachykinin 1 136.6 12.97 29.47 7.9 0.00073
4 4.12 arginine vasopressin 82.43 4.35 7.27 2.06 0.00016
5 4.11 RIKENgene 2810052M02 103.9 25.51 25.27 18.39 0.01518
6 4.1 troponin T1 81.93 13.39 11.93 8.34 0.00307
7 4.08 short stature homeobox 2 81.67 2.05 13.23 8.66 0.00364
8 3.91 cAMP phosphoprotein 404.9 47.13 103.7 11.13 0.00582
9 3.88 rgs 4 163.9 12.08 42.23 10.2 0.00022
10 3.78 keratin complex 1 137.0 16.44 36.23 11.81 0.00152
11 3.63 myocyte facta 2C 426.9 26.06 117.5 7.15 0.00128
12 3.57 RIKENgene 5430401D19 103.4 12.13 28.93 2.4 0.00697
13 3.47 oxytocin 291.8 18.6 84.03 11.26 0.00028
14 3.39 farrin-family protein 93.07 3.23 27.43 9.3 0.00325
15 3.39 myocyte facta 2C 768.6 34.67 226.7 21.53 0.00008
16 3.37 GEF1 153.9 7.0 45.67 7.24 0.00005
17 3.29 secreted phosphoproteinl 128.5 20.14 39.03 18.16 0.00478
18 3.25 GABAA3 65.03 13.51 13.6 9.56 0.00773
19 3.18 cadherin 4 74.43 21.62 23.37 19.87 0.03984
29 3.14 angiotensinogen 318.1 25.08 101.5 3.04 0.00399
Table 3.16 - Genes Expressed More Highly In Wild Type Forebrain As Compared To Hippocampus. Table
shows the 20 transcripts with the highest expression in the wild type forebrain, as compared to hippocampus,
ranked in order by forebrain to hippocampus ratio. The Affymetrix IDs and transcript names are detailed along with
their average expression levels, along with standard deviation, in each tissue. The P values of the differential
expression were calculated by Welch t test.
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1 5.4 klotho 27.97 3.35 151.1 33.06 0.022
2 5.31 EST 25 4.56 132.9 21.9 0.011
3 5.18 RIKEN gene 1200008D14 37.4 5.86 193.8 18.95 0.003
4 5.13 RIKEN gene 5730453H04 20.83 2.34 106.8 22.55 0.021
5 4.88 Cytokine factor 1 31.2 0.75 152.1 18.17 0.007
6 4.22 RIKEN gene 1200008D14 16.13 2.73 84.4 11.45 0.007
7 4.21 Neuropeptide receptor Y2 78.2 20.94 328.9 46.98 0.005
8 4.1 zinc finger protein 288 62.23 10.69 255.1 54.9 0.023
9 3.76 neurogenic differentiation 6 58.43 8.46 219.9 22.56 0.003
10 3.66 Transthyretin 572.7 64.86 2099 492.9 0.031
11 3.56 Neuropilin 78.87 14.99 280.8 17.89 0
12 3.51 EST 113.6 55.25 398.9 76.17 0.008
13 3.39 folate receptor 1 (adult) 42.6 9.78 144.6 40.62 0.043
14 3.39 myosin Vb 98.23 14.01 333.2 44.79 0.007
15 3.34 DEXRAS1 39.97 3.83 133.3 8.74 0.001
16 3.16 potential cation channel 42.7 5.99 134.9 21.85 0.013
17 3.11 RIKEN gene 1200003E16 20.8 15.52 64.7 13.04 0.021
18 2.92 EST 11.77 7.63 58.47 19.03 0.037
19 2.88 homer homolog 3 27.77 7.62 79.87 10.33 0.003
20 2.84 procollagen 20.7 10.12 58.7 8.09 0.008
Selected Altered Genes
2.42 AMPA1 168 407.13 13.23 17.26 0
2.38 C/EBP 48.5 115.6 14.48 6.77 0.007
2.35 Eph receptor A6 45.3 106.5 5.03 9.83 0.002
2.34 c-Jun 90.03 210.5 28.85 6.42 0.015
2.04 protein kinase C gamma 522.9 1065 27.98 100.3 0.008
2 protein kinase C epsilon 127.6 255.7 16.46 27.08 0.004
1.86 Sox11 40.63 75.73 6.64 5.35 0.002
1.83 CaMKIIa 94.6 173.4 7.81 29.64 0.037
1.69 SAP102 111.5 188.9 10.44 17.38 0.005
1.66 Nurrl 121.3 201.27 26.33 15.58 0.017
1.58 AMPA2 1830 2892 115.5 100.6 0
1.53 BDNF 545.9 833.9 12.5 42.41 0.004
1.5 GABA a2 77.17 116.1 8.15 2.23 0.010
Table 3.17 - Genes Expressed More Highly In Wild Type Hippocampus As Compared To Forebrain. Table
shows the 20 transcripts with the highest expression in the wild type hippocampus, as compared to forebrain,
ranked in order by hippocampus to forebrain ratio. In addition the details of several selected genes that are
expressed at significantly higher levels in the hippocampus are shown. The Affymetrix IDs and transcript names are
detailed along with their average expression levels, along with standard deviation, in each tissue. The P values of
the differential expression were calculated by Welch t test.
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3.5 DISCUSSION
The data presented in this chapter has shown the application of microarray
technology to analyse transcription in brain tissue carrying mutated NRC proteins.
The resulting data met quality control standards and subsequent analysis revealed
results that were verified by RT-PCR methods.
Experimental design was kept as simple as possible with variability, other than the
biological condition being analysed, maintained at a minimum. This was key to
enable straightforward analysis and interpretation of the results. The experiments
produced data on a vast number of genes that was studied in different ways to
extract useful information. The following discussion considers several of the main
points apparent from the data.
3.5.1 Limited Numbers of Genes are Altered in Mutant Tissue
Analysis revealed that mutation of proteins in the NRC disrupts gene expression in
neuronal tissue, thus establishing a role for PSD95 and SynGAP dependent
pathways in the regulation of transcription. A striking feature of the data was that
very few transcripts had altered expression levels in mutant samples, as compared
to wild type. Only 0.24% of the transcripts detected in PSD95_/" samples and 0.37%
of those in the SynGAP+/- samples were significantly altered. Thus, it appears that
PSD95 and SynGAP play a role in regulating the expression of a restricted group of
transcripts.
Since PSD95 and SynGAP are known to act in pathways downstream of the NMDA
receptor it is likely that altered gene expression in mutant samples is due to
misregulation of NMDA receptor dependent gene expression. Indeed, several of
the significantly altered transcripts are known NMDA receptor regulated genes. It
may be that, as well as regulating the expression of these genes following intense
stimulation, the NMDA receptor and associated proteins control the basal levels of
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these genes. As such, the altered transcripts may represent a subset of the total
genes regulated by the receptor. Examination of the array data revealed the
majority of known activity regulated genes are not significantly altered in the
mutant tissues, even at fold change levels less than 1.5. This supports the idea that
PSD95 and SynGAP play critical roles in the regulation of basal expression of a
particular subset of NMDA regulated genes.
The RNA used for the experiments presented in this chapter came from acutely
dissected tissue, thus analysis reveals the basal levels of transcription in the cells.
To analyse the contribution of NRC proteins to activity dependent gene expression
it would be interesting to study the RNA levels in PSD957" and SynGAP+/_ tissue
following stimulation of the NMDA receptor. This analysis may reveal many more
differences between wild type and mutant tissues, particularly since the Affymetrix
analysis identified downregulated levels of NMDA receptor regulated transcription
factors such as cfos, nur77 and egr2. It may be that, as well as having reduced basal
levels, the induction of these genes is impaired which could impact on the
expression of late response genes.
3.5.2 PSD95 and SynGAP in the Regulation of Gene Expression
PSD95 and SynGAP are both components of the NRC (Husi et al., 2000). As
members of a complex of signalling molecules, capable of interacting with each
other (Kim et al., 1998), the proteins potentially act in common pathways as well as
functioning independently from each other. Animals carrying mutations in PSD95
and SynGAP have different phenotypes in hippocampal LTP, but both have deficits
in spatial learning. Also, the expression patterns of PSD95 and SynGAP do not
completely overlap in the brain (K. Porter, personal communication) suggesting the
proteins could act in diverse, as well as common, phenomena. Consistent with the
idea that PSD95 and SynGAP can function in separate and integrated pathways,
microarray analysis identified alterations in diverse groups of genes in the two
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genotypes, with a degree of overlap seen in the common misregulation of cfos, nur77
and egrZ.
The analysis of tissue of the two genotypes, PSD95"/_ and SynGAP+/~, found changes
in what can be classed as two sets of genes; those that are commonly misregulated
in the two genotypes and distinct misregulated transcripts. This raises two
scenarios in which PSD95 and SynGAP contribute to the regulation of these genes.
It could be that a pathway involving PSD95 and SynGAP regulates the transcription
of genes downregulated in both genotypes {cfos, nur77 and egrZ) and that pathways
in which PSD95 and SynGAP act independently from each other to regulate the
expression of genes exclusively misregulated in each genotype. Alternatively,
PSD95 and SynGAP may contribute to the regulation of transcription entirely in
independent pathways that happen to both regulate the expression of cfos, nur77
and egrZ.
3.5.2.1 PSD95 and SynGAP Act in Independent Pathways
It is apparent that PSD95 and SynGAP can regulate the expression of distinct
transcripts suggesting they act in independent pathways. Both proteins are
members of the NRC, which contains molecules that could orchestrate the response
of a variety of transduction pathways, following NMDA receptor activation, to
regulate gene expression. As such PSD95 and SynGAP could, potentially,
contribute to several different signalling pathways.
PSD95 has many potential binding proteins meaning it could act in multiple
pathways that regulate gene expression. As a major adaptor protein in the NRC,
disruption of PSD95 function could alter the composition of the receptor complex.
As such, the organisation of postsynaptic signalling in response NMDA receptor
activity could be altered in PSD95"/_ animals.
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SynGAP has been shown to have RasGAP function (Kim et al., 1998) and it is likely
that SynGAP contributes to signalling via the ras-ERK pathway. SynGAP can
directly interact with PSD95, which is hypothesised to anchor SynGAP at an
advantaged position for signal transduction following NMDA receptor stimulation.
If such an interaction is required for SynGAP to respond to NMDA receptor activity,
it may be that it can be mediated through an interaction with a PDZ domain
containing protein other than PSD95. For example, SynGAP can associate with
SAP102 (Kim et al., 1998), which the microarray data found to be highly expressed in
the hippocampus relative to the rest of the forebrain. As such, SynGAP could act to
regulate gene expression, via the ras-ERK pathway, independent of PSD95 by
interaction with other proteins.
3.5.2.2 PSD95 and SynGAP and the Regulation cfos, nur77 and egr2 Expression
The downregulation of cfos, nur77 and egrl in PSD95 and SynGAP mutant tissues
suggests the proteins potentially act in a common pathway that regulates the basal
levels of this subset of activity dependent genes. NMDA receptor stimulation can
lead to the increased expression of cfos, nur77 and egrl (Bading et al., 1995; Inokuchi
et al., 1996; French et al., 2001). This is consistent with the signalling pathway
regulating these genes, involving both PSD95 and SynGAP, being downstream of
NMDA receptor activity.
SynGAP can directly interact with, and is hypothesised to function downstream of,
PSD95 (Komiyama et al., 2002) and, given the rasGAP function of SynGAP (Kim et
al., 1998), it is possible that PSD95 and SynGAP both act in the Ras-ERK pathway.
This pathway can regulate SRE and CRE mediated gene expression in response to
NMDA receptor activity (Xia et al., 1996; Impey et al., 1998; Wu et al., 2001). Both of
these elements are found in the 5' regions of the cfos, nur77 and egrl genes
(Treisman, 1986; Sassone-Corsi et al., 1988; Chavrier et al., 1989; Uemura et al., 1994).
A model could, therefore, be proposed whereby PSD95 and SynGAP, downstream
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of the NMDA receptor, contribute to the ras-ERK pathway that plays a role in the
regulation of basal expression of cfos, nur77 and egr2 via SRE and CRE promoter
elements.
3.5.3 Genes Significantly Altered in Mutant Tissue
PSD95"/" and SynGAP+/" animals demonstrate deficiencies in spatial learning and
plasticity (Migaud et al., 1998; Komiyama et al., 2002). Neuronal changes, at a
transcriptional level, may be an underlying cause of these phenotypes. Therefore,
proteins encoded by genes significantly altered in mutant tissue may play key roles
in learning and synaptic plasticity. The following sections details the transcripts
found altered in PSD95 /_ and SynGAP+/- mutant tissue.
3.5.3.1 Genes Significantly Altered in PSD95 Forebrain
11 transcripts were found down regulated in PSD957" forebrain. 7 of these
transcripts are known genes (PSD95, nur77, cfos, egr2, Perl, junB, cyln2 and
GADD45B) and 3 are ESTs. 3 genes, Atp7a, syntenin and serine palmitoyltransferase
subunit 2, are up regulated in the PSD95~/_ forebrain.
3.5.3.1.1 PSD95
The PSD95 transcript is found at a 3.4 fold level lower in PSD95~/_ forebrain than
wild type. The PSD95 mutant allele was generated by a stop codon insertion to the
third PDZ domain. Elowever, the 3' UTR, to which the Affymetrix probes are
targeted, is still intact. As such, a transcript containing this sequence could be
expressed due to the action of promoters downstream of the stop codon insertion.
The translation of any such transcript would give a protein product lacking the
third PDZ domain of PSD95 and, as such, unable to bind NMDA receptor subunits.
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3.5.3.1.2 Nur77, cfos, egr2 and junB
As previously mentioned, several genes found down regulated in PSD95 and
SynGAP mutant tissue are regulated by NMDA receptor activity and 3 of these, cfos,
nur77 and egr2, are found similarly altered in both genotypes. In addition, junB is
found significantly down regulated in PSD95_/~ forebrain. These genes are all
transcription factors induced by NMDA receptor activity and are thought to
regulate the expression of late response genes (reviewed by Platenik et al., 2000). It
is hypothesised that late response genes encode proteins critical for the long lasting
neuronal changes that occur in synaptic plasticity. If it were that the induction of
cfos, nur77, egr2 and junB following synaptic activity is impaired, then this could
have many downstream consequences.
The critical role of cfos in learning and plasticity been further demonstrated by use
of mice carrying mutations in the gene. Mice constitutively lacking cfos suffer motor
impairments that hinder analysis in behavioural paradigms (Johnston et al., 1992;
Paylor et al., 1994). However, a recently published study has shown the effects of
mutating cfos specifically in the CNS (Fleischmann et al., 2003). These animals show
no abnormalities in gross brain architecture and motor function is not affected.
They do, however, show impaired spatial learning in the Morris water maze and
have deficits in contextual, but not cued, fear conditioning. This suggests that cfos is
critical in hippocampal dependent learning behaviour. Hippocampal slices from
the same animals have reduced LTP, compared to wild type, following a single
100Hz tetanus (Fleischmann et al., 2003).
Egr2 deficient mice have severe deficits in peripheral myelination (Topilko et al.,
1994). Mutations of the gene are found in patients with hereditary demyelination
neuropathies, including Charcot-Marie Tooth disease typel (Warner et al., 1998). As
yet, no studies have been published looking at hippocampal based phenomena in
these animals. Interestingly, a potential egr2 binding site has been identified in the
promoter region of SynGAP (N. Komiyama, personal communication). This raises
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the interesting possibility that the expression of SynGAP can be regulated by egr2
via this site. This could represent a feedback loop whereby the expression of egr2,
controlled downstream of SynGAP activity, can act to regulate the expression of
SynGAP RNA.
3.5.3.1.3 Perl
Perl (periodl) belongs to a family of proteins (period 1-3) that, along with Clock,
bmal and cry, are key components of the molecular machinery in the
suprachiasmatic nucleus (SCN) that regulates the body's circadian rhythms
(reviewed by Ding et al., 1997). It has been demonstrated that, in the SCN, the
action of glutamate via NMDA receptors, in response to light, regulates the
expression of Perl (Tischkau et al., 2000). Furthermore, it has been shown that CREB
mediated expression of Perl, hypothesised to be initiated via nitric oxide (NO)
signalling, is required for this light regulated response (Tischkau et al., 2003). Given
that the NMDA receptor is known to regulate the expression of Perl in the SCN, it is
possible that, in the forebrain, the expression of the gene is regulated by a PSD95
dependent pathway, potentially via NO, downstream of the NMDA receptor. As
such Perl could represent another activity regulated gene that is misregulated in
PSD95_/" tissue.
In the forebrain, a molecule called NPAS2 can act as a Clock analogue and
heterodimerise with bmal to regulate the expression of Perl (Reick et al., 2001). In
turn, Perl can act to inhibit the action of the NPAS2-bmal dimer. Animals that are
homozygote for a mutant form of NPAS2 have impaired long term contextual and
cued fear conditioning, suggesting a role for this molecule in the consolidation of
memories (Garcia et al., 2000). It is therefore possible that the molecules involved in
circadian rhythm that regulate each other, including Perl, have an, as yet, unknown
function in the consolidation of long term memory.
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Cylnl (cytoplasmic linker-2) encodes a protein, CLIP-115, which belongs to a protein
family involved in the attachment of microtubules with organelles (Rickard and
Kreis, 1996). It has been found highly enriched in the brain where it facilitates the
localisation of a membranous organelle called the dendritic lamellar body (DLB) (De
Zeeuw et al., 1995; De Zeeuw et al., 1997), an organelle which is found only in
dendritic appendages and is particularly prominent at dendrodentritic junctions (De
Zeeuw et al., 1995).
Cyln2 is found in a 1.6Mb region of human chromosome 7, containing at least 17
genes, which is heterozygously deleted in Williams-Beuren Syndrome (Francke,
1999). This developmental disorder has symptoms that include growth deficits in
infancy, motor disabilities and mental retardation (Francke, 1999). Mice with
targeted mutations of cylnl, encoding CLIP-115, have mild growth retardation and
significantly larger brain ventricle volumes than wild type, however analysis of
brain sections shows no abnormalities in brain morphology (Hoogenraad et al.,
2002). Cyln-'- animals have deficits in contextual, but not cued fear conditioning
(Hoogenraad et al., 2002), suggesting a role for CLIP-115 in hippocampal dependent
learning. These animals also have reduced LTP in the CA1 region of the
hippocampus (Hoogenraad et al., 2002).
3.5.3.1.5 GADD45/3
GADD45/3 (growth arrest and DNA damage inducible gene P) encodes a protein
that belongs to the GADD45-like group of proteins. GADD453 can associate with
MEKK4 and is thought, via this interaction, to act in the p38/JNK pathway
(Takekawa and Saito, 1998; De Smaele et al., 2001). GADD45 proteins are induced
by environmental stresses (Takekawa and Saito, 1998) and related protein
GADD45cx expression is expressed in the hippocampus in response to kainate
injection (Zhu et al., 1997). It may be that this, and other GADD45 family proteins,
can be induced by glutamate activity at the NMDA receptor.
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3.5.3.1.6 Atp7a
Atp7a encodes a copper transporting ATPase that was first isolated in humans as a
candidate causative gene for Menkes disease (Vulpe et al., 1993). In Menkes disease,
loss of Atp7a function results in a failure in copper transport across the blood brain
barrier, gastrointestinal tract and liver. This leads to copper accumulation in the
cells surrounding these tissues and results in low copper levels in the organs. Low
copper levels in the brain lead to severe neurological symptoms including seizures
and mental retardation. Elsewhere in the body, the mistransport of copper due to
functional loss of Atp7a results in bone abnormalities, particularly of the skull
(reviewed by Strausak et al., 2001).
It is unclear what functional effect the upregulation of Atp7a in the forebrain would
have, but it could result in altered levels of copper in this part of the brain.
Abnormal levels of copper in the brain have been found in various disorders with
neurological symptoms such as Alzheimer's and Wilson's disease (Basun et al., 1991;
Strausak et al., 2001). Therefore, altered copper levels in the forebrain of PSD95_/"
animals, due to abnormal Atp7a expression, could result in neuronal phenotype.
3.5.3.1.7 Syntenin
Syntenin is upregulated in the PSD95+ forebrain and encodes a PDZ containing
protein that was first identified as a binding partner for transmembrane
proteoglycans (Grootjans et al., 1997). Syntenin co-localises and co-
immunoprecipitates with syndecan, E-cadherin, 3 catenin and a catenin and, thus, is
suggested to have a role regulating membrane dynamics (Zimmermann et al., 2001).
More recently, syntenin, along with PSD95, has been shown, by yeast two hybrid
and GST pulldowns, to bind the GluR5-2b, Glur5-2c and GluR6 kainate receptor
subunits (Hirbec et al., 2002). In addition, syntenin was detected, along with
GluR6/7 subunits, in synaptosomal and postsynaptic density fractions from rat
brains (Hirbec et al., 2002). The upregulation of syntenin, a PDZ containing protein,
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in PSD95 /_ forebrain may be a compensatory mechanism due to the loss of function
of another PDZ domain protein.
3.5.3.1.8 Serine Palmitoyltransferase Subunit 2
The third gene upregulated in PSD95"/_ forebrain is serine palmitoyltransferase subunit
2. Serine palmitoyltransferase is a key enzyme in the biosynthesis of sphingolipids,
ubiquitous components of membrane lipids in mammalian cells (Hanada et al.,
2000). In humans, serine palmitoyltransferase subunit 2 has been mapped to an area of
chromosome 9 that is the locus of hereditary sensory neuropathy 1 (HSN1).
Furthermore, HSN1 affected families have been found to have mutations in this
gene (Dawkins et al., 2001). It is not apparent what the functional consequence of
the upregulation of this gene would be in PSD95_/" forebrain in terms of synaptic
plasticity and learning.
3.5.3.1.9 ESTs
The ESTs that are found expressed at significantly different levels are yet to be
annotated and are, as such, of unknown function. At the time of writing (Spring
2004) BLAST analysis of the ESTs failed to identify any significant matches to the
sequences of known genes. However, annotations of the mouse genome continue to
be updated, so it is likely that, in the future, the genes that the ESTs correspond to
will be identified.
3.5.3.2 Genes Altered in SynGAP +/' Hippocampi
In the SynGAP+/_ hippocampus the expression of cfos, egr2 and nur77 (see 3.5.3.1.2)
are significantly altered, along with 6 ESTs (see 3.5.3.1.9). In addition 8 known
genes (erythroid differentiation factor, soxll, DUSP6, glucose 6 phosphate
dehydrogenase, UDP-glucuronosyltransferase 8, K* channel, subfamily K 1 [TWIK1],
Nrdl, voltage gated K+ channel [m-eag], N-glycan alpha 2,8-sialtransferase and Elovl6)
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were found down regulated in SynGAP+/_ hippocampi and 3 known genes, encoding
ribosomal protein L44, glyoxalase 1 and NADH dehydrogenase were found
upregulated.
3.5.3.2.1 Sox11
Soxll encodes a gene belonging to the SRY like box (SOX) family of
developmentally regulated transcription factors. It has been found expressed in
developing neurons in various species (Uwanogho et al., 1995; Azuma et al., 1999;
Rimini et al., 1999). If required for neuronal differentiation and development, soxll
may also be induced during changes in neuronal morphology in plasticity.
3.5.3.2.2 DUSP6
DUSP6 encodes MKP3, a dual specificity MAP kinase phosphatase, belonging to a
family of molecules that can reverse the activation of MAP kinases by
dephosphorylating key sites. MKP3 has been shown to block the phosphorylation
of ERK2 in EGF stimulated COS cells (Muda et al., 1996). If this inhibition of ERK
phosphorylation also occurred in neurons, then the down regulation of DUSP6 may
contribute to the enhanced levels of pERK found after NMDA receptor stimulation
of SynGAP+/hippocampal tissue.
In the rat brain, DUSP6 is most highly expressed in the hippocampus and
expression is induced in surrounding cortex following seizure (Muda et al., 1996).
Thus, DUSP6 can be induced by neuronal stimulation and could potentially lie
downstream of NMDA receptor activity. If it were that DUSP6 expression was
regulated by NMDA receptor stimulation, via SynGAP, then this could directly
result in the misregulation of the gene in SynGAP+/- tissue. The regulation of DUSP6
downstream of the NMDA receptor and SynGAP could represent a feedback loop
whereby ras-ERK signalling directly regulates the transcription of a phosphatase
that acts as a negative control of the pathway.
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3.5.3.2.3 M-eag and TWIK1
Genes encoding two different K+ channels are downregulated in SynGAP+/- tissue.
M-eag is the murine form of eag voltage gated outwardly rectifying K+ channels
(reviewed by Ganetzky et al., 1999). There is data to suggest that Eag, the Drosophila
homologue of m-eag, is modulated by CaMKII and may be involved in neuronal
plasticity in Drosophila (Griffith et al., 1994). Potentially, m-eag has similar function
and, as such, could play a role in neuronal plasticity in mice.
In addition to m-eag, another gene encoding a K+ channel is downregulated. TWIK 1
is a weak inward rectifier highly expressed in the hippocampus, cortex and
cerebellum of the adult mouse brain. It is hypothesised to maintain membrane
resting potential (Lesage et al., 1997).
3.5.3.2.4 N-glycan alpha 2,8-sialtransferase
N-glycan alpha 2,8 -sialtransferase (ST8SiaIV) is an enzyme that is required for sialic
acid polymeriasation, which modulates the properties of neural cell adhesion
molecule (NCAM) (reviewed by Rutishauser, 1996). The polysialation of NCAM is
required for LTP in the hippocampus (Muller et al., 1996) and this polysialated
NCAM can be transported to the cell surface (Kiss et al., 1994). It is hypothesised
that the presence of NCAM at the cell membrane could be required for altering the
'adhesive' properties of the synapses, which could contribute to plasticity changes
in synaptic structure. Therefore, the function of N-glycan alpha 2,8 -sialtransferase
in modulating NCAM could be required for plasticity. Indeed, adult mice lacking
N-glycan alpha 2,8-sialtransferase have impaired LTP and LTD in the CA1 region of
the hippocampus, although LTP is intact in CA3 regions (Eckhardt et al., 2000).
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3.5.3.2.5 Glyoxalase 1
The glycation (binding of sugar) of proteins and nucleotides can affect the function
of molecules causing cell and tissue damage. Glyoxalase 1, upregulated in SynGAP+/-
hippocampi, is a key protein in the prevention of glycation, catalysing the
conversion of reactive sugars to inert forms (reviewed by Thornalley, 2003).
The upregulation of glyoxalase 1 has also been found, by microarray, in the
cerebrum of a mouse model of Alzheimer's disease caused by mutant form of the
microtubule-associated protein tau (Chen et al., 2004). It is hypothesised that the
aggregation of tau into neurofibrillary tangles, as seen in Alzheimer's causes cell
stress and leads to an increase in the expression of glyoxalase 1. It is thought that the
induction of glyoxalase 1 in response to stress is the cell's attempt to reduce a
damaging accumulation of glycated proteins. It is not clear why glyoxalase 1 should
be upregulated in SynGAP+/" brain tissue, but the hypothesised role of the protein in
Alzheimer's disease suggests it could be a neuronal response to cell stress.
3.5.3.2.6 Other Altered Genes
There are several other genes that are significantly altered in SynGAP+/"
hippocampal sample (erythroid differentiation factor, glucose 6 phosphate
dehydrogenase, UDP-glucuronosyltransferase 8, Nrdl, Elovl6, ribosomal protein L44 and
NADH dehydrogenase). In some cases (Nrdl, ElovW, ribosomal protein L44) little is
known about the encoded proteins. The other genes (erythroid differentiation factor,
glucose 6 phosphate dehydrogenase, UDP-glucuronosyltransferase 8 and NADH
dehydrogenase) encode molecules that are involved in processes that have no
apparent role in NMDA mediated phenomena.
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3.5.4 Functional Significance of Genes Significantly Altered in Mutant Tissue
As has been discussed, it is apparent that many of the genes significantly altered in
PSD95 and SynGAP mutant tissue have known function in spatial learning, LTP and
other plasticity phenomena. Table 3.18 summarises this data and it is striking that
of the 21 different known genes misregulated in PSD95 and SynGAP mutant tissue,
13 (62%) have known, or implied, functions in cognitive disorders, synaptic
plasticity or learning. This suggests that there is alteration of expression of key
genes involved in synaptic mechanisms and plasticity in PSD95_/~ and SynGAP"- and































N-glycan alpha 2, 8-
sialyltransferase
Glyoxalase 1
Table 3.18 - Summary of Functions of Significantly Altered Genes. Table details genes
significantly altered in PSD95 and SynGAP mutant tissue that are regulated by the NMDA receptor,
encode synaptic proteins, have a role in a neurological disorder/disease or function in memory or
plasticity. Ticks indicate there is evidence for involvement of the gene in the particular category, a
question mark means there is data that suggests the possibility that the gene could be involved.
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3.5.4.1 Misregulation of Inducible Transcriptions Factors
The downregulation of activity regulated transcription factors (cfos, nur77, egr2 and
junB) in PSD95-/- forebrain and SynGAP+/- hippocampus indicates that these genes
may not be correctly induced following NMDA receptor activity in mutant tissue.
These genes could regulate the transcription of key proteins for neuronal response
to stimulation and thus, if they are not correctly induced, there may be resultant
phenotypes in NMDA receptor mediated effects.
As yet, the late response genes that inducible transcription factors regulate are
largely unknown. However, a recent study showed, in rat Schwann cells, genes
responsive to egr2 included Sapl02, Homer-lb, CaMKlV, egrl, cfos, NMDAR2D
subunit and GluRB (Nagarajan et al., 2001). Thus, these are potential targets of egr2
downstream of NMDA receptor activity and include proteins with known synaptic
roles. This would be consistent with the hypothesis that activity dependent
transcription factors can regulate the expression of RNAs that encode proteins
critical to long term neuronal responses to synaptic activity.
3.5.4.2 Misregulated Genes and Spatial Learning
PSD95-/- and SynGAP+/- mice have similar deficits in the Morris water maze, a test of
hippocampal based spatial learning (Migaud et al., 1998; Komiyama et al., 2002).
The misregulation of genes in PSD95_/~ forebrain and SynGAP+/" hippocampus could,
potentially, be an underlying cause of this phenotype. Indeed, cyln2, down
regulated in PSD95_/" forebrain and cfos, down regulated in PSD95 and SynGAP
mutant tissue, have previously been shown to play a role in hippocampal based
learning.
Given that animals lacking cfos in the central nervous system are impaired in the
Morris water maze and contextual fear conditioning, the common downregulation
of cfos in PSD95"/" and SynGAP+/- brain tissue may be a basis for the animals' similar
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deficits in spatial learning. As a transcription factor, the action of cfos, downstream
of the NMDA receptor activation, has many potential target genes that could
include genes required in spatial learning. The genes found similarly down
regulated in PSD95/_ and SynGAP+/- tissue are all activity regulated transcription
factors and the downregulation of nur77 and egr2, as well as that of cfos, could
potentially contribute to the behavioural phenotype of the animals. It may be that
alterations in this specific group of activity dependent genes impacts on spatial
learning, resulting in the common behavioural deficits of PSD95_/~ and SynGAP+/~
animals.
A recent study, using microarrays to analyse amyloid precursor protein and
presenilin-1 mice, has also proposed that misregulation of specific activity regulated
genes may contribute to memory phenotypes (Dickey et al., 2003). The animals,
models of amyloid deposition in Alzheimer's disease, develop age-related deficits in
memory (Arendash et al., 2001). Gene expression was compared in amyloid
containing brain areas (hippocampus, cortex) and amyloid free areas (cerebellum,
striatum and brainstem). Several 'plasticity related genes' were found at lower
levels in amyloid containing brain regions, including the immediate early genes arc,
egrl and nur77 (Dickey et al., 2003). It was hypothesised that the misregulation of
these activity regulated genes may underlie the memory loss in this model of
Alzheimer's disease.
3.5.4.3 Misregulated Genes and Synaptic Plasticity
Hippocampal slices from PSD95"/" and SynGAP+/" animals both have abnormal LTP
induction, however, unlike spatial learning, the phenotypes are dissimilar. PSD957"
slices show enhanced LTP, where as the plasticity is diminished in SynGAP+/- slices.
Given these different phenotypes, it may be that genes that are differentially altered
in PSD95"7" and SynGAP+/_ tissue are the ones that underlie the plasticity phenotypes
of the animals.
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Several of the genes significantly altered in PSD95_/" and SynGAP+/- tissue have been
shown necessary for LTP. Mutation of cyln and N-glycan alpha 2,8-sialtransferase,
down regulated in PSD95_/" and SynGAP+/- tissue respectively, results in impaired
LTP in the CA1 region of the hippocampus. Also, animals expression mutant cfos in
the CNS have impaired hippocampal LTP following 100Hz tetanus stimulation. In
addition to information from transgenic studies, there is data to suggest that m-eag
could have a role in neuronal plasticity.
In the SynGAP+/- hippocampi, the phenotypes of cfos and N-glycan alpha 2,8-
sialtransferase mutants and potential function of m-eag, are all consistent with the
reduction of LTP seen in SynGAP+/- slices. However, in the case of PSD95"/_ data, the
hippocampal LTP phenotypes of cfosCNS''' and cyln2''~ animals are not consistent with
the increased LTP induction of PSD95mutants.
The inconsistency of cfosCNS~'~ and cyln2~'~ hippocampal LTP phenotypes with that of
PSD95-/- slices could have several explanations. It may be due to the tissue source of
material for the PSD95~/_ experiment and lower levels of cyln2 and cfos in the
forebrain might not contribute to the hippocampal LTP phenotype of PSD95_/~
animals. In order to identify genes that are more likely to be relevant to the
hippocampal LTP phenotype of the animals, RNA from PSD95~/_ hippocampi should
be examined. However, it may be that the enhanced LTP measured in hippocampal
slices from PSD95"/_ animals is not a consequence of altered gene expression, but a
result of the abnormal PSD95 protein.
3.5.5 Relevance of Chromosomal Clustered Genes
Analysis of the chromosomal location of significantly altered genes found several of
the genes to be on the same chromosomes. This clustering effect was statistically
significant for the SynGAP data. Table 3.14 shows significantly altered transcripts
organised by chromosome. The genes highlighted in the table have known function
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in NMDA mediated phenomena or function postsynaptically. The other genes that
are altered may have roles in synaptic plasticity that are, as yet, unknown.
The clustering effect may represent loci of genes that function in synaptic plasticity.
It has been shown that genes of related function can be found together on the
regions of chromosomes. A recent microarray study, identifying genes regulated in
the hippocampus during long term memory consolidation also identified significant
grouping of altered genes to particular chromosomes (Levenson et al., 2004). In
particular, significant numbers of altered genes were found on chromosomes 10, 12,
16, 18 and 19. Comparing this to the data presented in this chapter, although no
significantly altered genes were found on chromosomes 16, 18 and 19, multiple
significantly altered genes were found on chromosomes 10 and 12 in both PSD95
and SynGAP data.
However, alterations in genes grouped on the same chromosomes could also
represent functionally diverse genes that display similar expression patterns due to
their proximity on the chromosome. There is evidence of domains, termed as
ridges, in human chromosomes where clusters of functionally unrelated genes show
comparable levels of expression (Caron et al., 2001; Versteeg et al., 2003). It has been
hypothesised that transcription of the human chromosomes could have two levels
of control (Versteeg et al., 2003). As well as activity at the specific promoter regions
of individual genes, there appears to be factors that act to control transcription of
groups of genes within a particular ridge.
Analysis of microarray studies have also found domains of similarly expressed, but
functionally diverse, genes in the Drosophila genome (Spellmen and Rubin, 2002). It
was found that often there appeared to be one or two genes in each domain that
showed high levels of differential expression in a given condition, and other genes
within the domain were altered but not the same extent. It is proposed that when
the chromatin is 'opened' in order for a key gene to be expressed, this may increase
Chapter 3 - Gene Expression in PSD95"'" and SynGAPw" Tissue
124
Analysis of NMDA Receptor Regulated Gene Expression
the accessibility of transcriptional machinery to the promoter regions of genes in the
surrounding area (Spellmen and Rubin, 2002). Thus, alterations in the expression of
multiple genes in a cluster could be seen due to targeted changes in the level of a
key gene.
Some of the chromosomal clustering of the PSD95_/" and SynGAP+/" array data could
be due to similar reasons. It is probable that domains of similarly expressed genes
exist in mouse genome as found in the human and Drosophila genomes. As such, it
may be that regulation of basal expression of genes such as cfos via PSD95 and
SynGAP dependent signalling also exerts a degree of control on the levels of genes
in the surrounding chromosomal domain. Subsequently, if the regulation of cfos is
disrupted in mutant tissue, then the expression of neighbouring genes (e.g. serine
palmitoyltransferase) could also be altered. If this were the case then it could be
expected that some of the significantly altered genes are not changed due to a direct
functional response to PSD95 or SynGAP mutation, but because of chromosomal
proximity to a functionally relevant gene.
3.5 CONCLUSION
This data discussed in this chapter has demonstrated the successful application of
microarray technology in the analysis of tissue carrying mutations in NRC proteins.
Mutations of PSD95 and SynGAP result in transcriptional changes of a limited
number of genes, including several activity regulated genes, genes involved in
learning and others with roles in plasticity. The misregulation of these genes may
contribute to the phenotypes of PSD95_/" and SynGAP+/- animals. Additionally,
evidence of changes in chromosomally clustered genes was found.
Transcriptional alterations in PSD95 and SynGAP mutant tissue imply a role for
these proteins in signalling pathways regulating gene expression. The functions of
these proteins downstream of the NMDA receptor suggest that the transcripts
altered in the mutant tissue could be a subset of the total genes regulated by the
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receptor. Given that the material used in the experiments was isolated from acutely
dissected brain tissue, this implies that the NMDA receptor and associated proteins
regulate basal transcription levels of particular transcripts. Also, analysis of the
data suggests that PSD95 and SynGAP act in independent and common pathways
that contribute to the control of gene expression.
The data discussed in this chapter has demonstrated the potential of using
microarrays in experiments to study brain tissue from transgenic animals. As has
been shown, the amount of information generated by a single experiment is
immense and can be studied if various ways to extract meaningful data. As such,
microarrays could be a useful employed, along with other standard behavioural and
electrophysiological tests, to analyse mice carrying mutations in other NRC
proteins.
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CHAPTER 4
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4. IN VITRO STIMULATION OF THE NMDA RECEPTOR
As discussed in chapter 3, mutations in NRC proteins, PSD95 and SynGAP, alter the
expression of genes in acutely dissected brain tissue. The transcripts found
significantly altered included several activity dependent genes. It may be that the
misregulated transcripts in PSD95_/- and SynGAP+/- tissues represent a subset of the
genes regulated by NMDA receptor dependent signalling. It would therefore be
interesting to identify the total set of genes modulated by NMDA receptor activity
and analyse the contribution of NRC proteins to their regulation.
To study activity dependent gene expression a reliable protocol for NMDA receptor
stimulation is required. In vivo stimulation methods, analysing RNA from relevant
brain regions after seizure induction, LTP or learning, are advantageous as they are
likely to reveal physiologically relevant activity regulated genes. However, in vivo
stimulation can be problematic. In vivo stimulation assays, particularly seizure
models, can activate a variety of receptors and pharmacological isolation would be
required to identify the NMDA regulated genes.
In vitro methods of stimulation are widely applied to analyse the genes regulated by
NMDA receptor activity. In vitro protocols, using chemical or electrical stimulation
of primary cultured neurons, cell lines or brain slices, are advantageous in that they
can be performed with high throughput. As a result they can, more readily, be
exposed to a wide variety of conditions (e.g. different pharmacological treatments).
In addition, the stimulated cells can easily be subject to different types of analysis
e.g. biochemical, immunohistochemical, electrophysiological. Another benefit of in
vitro techniques is that primary cultures from embryonic tissues can be used to
analyse targeted mutations that are lethal postnatal.
Once a reliable stimulation method has been developed then activity induced gene
expression in wild type cells could be analysed. If this were done using microarrays
it would reveal the global alterations in gene expression regulated by synaptic
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activity and could identify novel genes modulated by NMDA receptor activity. By
subsequently analysing mutant cells, such as PSD95~/_ neurons, the contribution of
NRC proteins to activity regulated gene expression could be examined.
4.1 IN VITRO STIMULATION OF NMDA RECEPTORS
For all stimulation experiments, primary cultured cortical neurons from E17.5
mouse embryos were used. The cultures were grown for 10-12 days in 6 x 35mm
well dishes at a surface density of 1 x 105 cells/cm2. Figures 4.1A and 4.1B are
images of such a culture, A shows the phase image and B shows the same field with
DAPI staining. The nuclei stain reveals there are many cells present in the culture.
The majority of these are likely to be neurons, with glia also present. Figures 4.1C
and 4.ID are images of another culture, C in phase and D with cy3-MAP2B staining.
This neuronal marker shows the culture is a dense network of neuronal processes.
It is thought that the maturation of primary cultured neurons follows the same
temporal profile as cells in vivo. It has previously been shown that developmental
changes in NMDA receptor subunit expression in cultured cortical neurons mimics
the temporal changes of that in vivo (Zhong et al, 1994). Also, the expression of
PSD95 protein in cultures, as used in this chapter, increases from DIV11 to DIV26 as
it does between postnatal days 7 to 21 (K. Dickson, personal communication). It can
therefore be assumed that the cells used in stimulation assays from cultures DIV10-
12 would be of equivelent maturity as cells, in vivo, postnatal day 6-8.
4.1.1 Activity Dependent Gene Expression Following NMDA Treatment
NMDA application to the cultures was chosen as the initial in vitro method of
stimulation. This protocol should directly stimulate the receptor of interest and
published studies have used glutamate or NMDA treatment successfully to study
activity regulated gene expression in cultured neurons (Bading et al., 1995; Szekely
et al., 1990; Bulleit et al., 1994; Rage et al., 1993).
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Figure 4.1 - Images of Cultured Neurons. Pictures show images of E17.5 primary cultured
cortical neurons, as those used for stimulation assays. A and B are pictures of the same
culture. A is the phase and B is DAPI staining of the nuclei present. C and D are pictures of a
culture, C is the phase and D shows cy3-MAP2B neuronal staining.
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4.1.1.1 Treatment of Primary Cortical Cultures with NMDA
For stimulation by NMDA cells were treated as detailed in figure 4.2. To reduce
basal cell activity media in wells for stimulation was treated with lpM TTX 2hrs
before agonist treatment. Stimulation was induced by media change to Mg2+ free
solution containing lOOpM NMDA and 10pM glycine, a co-agonist of the NMDA
receptor. A Mg2+ free solution was used to ensure relief of the NMDA receptor
voltage dependent Mg2+ block. RNA was extracted from the cells 30mins after
NMDA treatment. An unstimulated condition, with 2hr TTX treatment and then
media change to Mg2+ free solution without NMDA, was included to test whether
the media change alone could alter activity dependent gene expression. RNA was
extracted from cells, using QIAGEN RNeasy minikits, in 3 different conditions;
untreated, unstimulated and stimulated.
4.1.1.2 Analysis of Activity Dependent Gene Expression
RNA was reverse transcribed to cDNA using Ambion protocols. The expression of
activity dependent genes was then measured by RT-PCR and the products run out
on a 4% agarose gel (figure 4.3) to visualise any changes in expression. Figure 4.3A
shows the products from the primers used in RT-PCR reactions with cDNA from
wild type forebrain samples to confirm that they are of expected size. Figure 4.3B
shows the effects of stimulation on cfos, egrl, egr2 and nur77 levels, with GAPDH
used as a control. 30mins after NMDA stimulation the levels of immediate early
genes cfos, egrl, egr2, and nur77 were increased. However, the unstimulated
samples also showed upregulation of the same activity regulated genes. In most
cases this increase was not as great as that induced by NMDA, but was still clearly
apparent. The increase in gene expression seen in unstimulated samples may be
due to chemical or mechanical stress to the cells caused by removal from the
incubator and subsequent media change.
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Figure 4.2 - NMDA Stimulation Protocol. Flow chart shows the stimulation protocol for
primary cultured cortical neurons using NMDA. There are three conditions from which RNA
is extracted. "Untreated" cells have no treatment following culture. "Unstimulated" cells have
TTX added to the media for 2hrs and are then changed to a Mg2+ free solution for Vihr before
RNA extraction. "Stimulated" cells are changed to TTX containing media for 2hrs before Vihr
treatment with a Mg2+free solution containing 100pM NMDA and 10pM glycine before RNA
extraction.
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GENE FORWARD PRIMER REVERSE PRIMER
EXPECTED
PRODUCT (BP)
GAPDH GTGTTCCTACCCCCAATGTG ATGTAGGCCATGAGGTCCAC 292
Cfos CTTTATCCCCACGGTGACAG CTGCAGCCATCTTATTCCGT 296
Nur77 TTCTGCTCAGGCCTGGTACT GATTCTGCAGCTCTTCCACC 199
Egr2 AAGGCCGTAGACAAAATCCC CTAGGTGCAGAGATGGGAGC 344
Egr1 TCCTTTCCTCACTCACCCAC TGGGATAACTCGTCTCCSCC 295










+RT -RT +RT -RT +RT -RT
Figure 4.3 - RTPCR of Stimulated Samples. A details the primers used in RTPCR reactions
and shows that the PCR products of these primers, in a reaction with wild type forebrain cDNA,
are of expected size as compared to a 1kB ladder. B shows the results of RTPCR reactions
using cDNA transcribed from untreated cells, unstimulated cells (2hr TTX treatment of media,
change of media to Mg2+ free solution 30mins before RNA extraction) and stimulated cells (2hr
TTX treatment of media, change of media to Mg
10g.M glycine 30mins before RNA extraction).
free solution containing 100pM NMDA +
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24hrs 24hrs 24hrs
Untreated Untreated Treated with
Bicuculline
50pM







Figure 4.4 - Bicuculline Stimulation Protocol. Flow chart shows the stimulation protocol
for primary cultured cortical neurons using bicuculline. There are three conditions from which
RNA is extracted. "Untreated" cells have no treatment following culture. "Unstimulated" cells
have a media change to stimulation media 25hrs before RNA extraction. "Stimulated" cells
are changed to the stimulation media for 24hrs, are then treated for 1 hr with 50pM bicuculline
before RNA extraction.
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The results of the experiment revealed problems using the NMDA stimulation
protocol to study activity dependent gene expression. Due to the induction of
immediate early genes in unstimulated samples, it's unclear whether transcriptional
increases in stimulated cell are due to the media change or to the action of the
NMDA.
4.1.2 Activity Dependent Gene Expression Following Bicuculline Treatment
4.1.2.1 Treatment of Primary Cortical Cultures with Bicuculline
Due to the induction of activity dependent genes in unstimulated samples using the
NMDA treatment protocol, an alternative stimulation assay was sought. Bicuculline
treatment of rat hippocampal neurons has been used to analyse CRE mediated gene
expression as it effectively induces NMDA receptor dependent phosphorylation of
CREB (Hardingham et al., 2001; Hardingham et al., 2002). Furthermore this method
has been demonstrated to increase cfos protein, BDNF RNA levels and CRE-
dependent gene expression (Hardingham et al., 2001; Hardingham et al., 2002).
Bicuculline is a GABAa (y-aminobutyric acid) antagonist and its addition to cultured
cells removes inhibitory GABA input to the neurons. This should promote
spontaneous firing of stimulatory neurons, increasing synaptic activity. Bicuculline
treatment is an appealing stimulation protocol as it only activates synaptic NMDA
receptors and is, therefore, more physiologically relevant than pharmacological
stimulation of all NMDA receptors. Also, there is no requirement for a media
change to a Mg2+ free buffer before stimulation as an increase in synaptic activity
caused by bicuculline will depolarise the postsynaptic membrane, relieving the
voltage dependent Mg2+ block of the NMDA receptor.
Cells were treated as detailed in figure 4.4 based on the protocols from
(Hardingham et al., 2002). Cells were changed to 'stimulation media', as detailed in
(Bading et al., 1993) 24 hrs before drug treatment. Since the media change is 24hr
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before stimulation any increases in immediate early gene expression, caused by
media change, should have returned to basal levels before bicuculline treatment.
The cultures were stimulated by application of 50pM bicuculline. As with the
NMDA treatment, RNA was also extracted from unstimulated (media change 24
hours before time of stimulation, no bicuculline treatment) and untreated
conditions. The RNA extractions, using QIAGEN RNeasy mini kits, were
performed lhr after bicuculline treatment.
4.1.2.2 Analysis of Activity Dependent Gene Expression
Following bicuculline stimulation RNA was analysed using QRT-PCR. This
ensured subtle increases in expression could be identified, without concerns about
reaction saturation. For the initial experiment, using the bicuculline protocol, 4
wells of a culture dish were analysed. One well was left untreated, one had a media
change but remained unstimulated and 2 wells were treated with bicuculline.
Following RNA extraction, 0.5pg of RNA from each sample was reverse transcribed
and QRT-PCR performed by lightcycler to measure the levels of cfos and GAPDH.
Each sample was run in duplicate and the average cfos/GAPDH ratio calculated for
each sample. The ratios of the unstimulated and stimulated samples were
compared to that of the untreated samples.
Table 4.1 shows the results of this experiment. The ratio of cfos in the unstimulated
sample compared to untreated was 0.94. This suggests that the media change, 24hrs
prior to extraction, had no effect on the levels of cfos in cultured cortical neurons.
The ratios of cfos expression in the stimulated samples compared to untreated were
0.930 and 13.221. Thus, in one well bicuculline successfully induced the expression
of cfos.
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19313.59 1480.32 13.047 13.221
Table 4.1 - Initial Results Of Bicuculline Treatment. Table shows cfos and GAPDH levels in RNA
samples from untreated, unstimulated (media change, no bicuculline treatment) and stimulated (media
change, 50pM bicuculline) cultured cortical neurons. A ratio of the expression of cfos and GAPDH was
taken from the average of duplicates for each sample. This ratio was then compared to untreated
samples to determine induction of cfos.
To determine if bicuculline treatment reproducibly induces cfos expression,
bicuculline stimulation was repeated several times (see table 4.2). Each experiment
was performed on cells from individual neuronal cultures that had been prepared in
the same way. The bicuculline treatments were carried out as for the initial
experiment, though for control purposes, in some experiments, wells were treated
with Actinomycin D (lOpg/ml) or 50pM APV lhr prior to bicuculline application.
As with the initial experiment, RNA was extracted from experimental wells using
QIAGEN RNeasy mini kits and analysed by lightcycler. The reactions were run in
duplicate and average cfos levels normalised by taking their ratio to GAPDH. The
stimulated cfos levels were then compared to untreated cfos levels to assess
stimulation.
Table 4.2 shows that bicuculline stimulation of 6 cultures produced highly variable
results; on average, cfos levels were 3.19 fold higher in stimulated samples, with a
standard deviation of 4.77. A t test found no significant induction of cfos (p=0.32) in
bicuculline treated samples compared to untreated samples. As such, bicuculline
treatment was considered to be ineffective as a reliable method of inducing activity
dependent gene expression.
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Stimulated 1.49 Standard Dev 4.77




Actinomycin D 0.022 Standard Dev 0.020
0.051 P value 0.00008
0.289 Average 0.46
APV 0.088 Standard Dev 0.48
1.001 P value 0.19
Table 4.2 - Results Of Bicuculline Treatment. Table shows the ratio of normalised cfos levels in RNA
samples from primary cultured cortical neurons treated with 50pM bicuculline alone, 50|.iM bicuculline in
the presence of 10|xg/ml actinomycin D, 50pM Bicuculline in the presence of 500pM APV and those left
untreated. The average ratios and standard deviations are shown. The p values were calculated by t
test.
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Treatment of cultures with transcriptional inhibitor, actinomycin D, prior to
bicuculline stimulation resulted in a significant decrease in cfos expression. On
average the expression was 0.028 of that in untreated samples. From this data the
halflife of cfos RNA can be calculated to be 23.3mins. This is consistent with
published data which has reported the half life to cfos RNA to range between 10 and
30 mins (Rahmsdorf et al., 1987, Chagnovich and Cohn, 1997, Blattner et al., 2000).
The treatment of cultured neurons with APV prior to bicuculline treatment resulted,
in 2 of 3 experiments, in a decrease in the levels of cfos. However, overall this was
not a significant effect (p=0.19).
4.1.3 Activity Dependent Gene Expression Following APV Treatment
In the previous experiment it was noted that treatment of cells with APV before
bicuculline treatment reduced the level of cfos in two of three experiments. It was
therefore decided to further investigate the effect of APV treatment on cfos RNA
levels in cultured neurons.
4.1.3.1 Treatment of Primary Cortical Cultures with APV
The media of wells of cultured cortical neurons, as used bicuculline treatments, was
replaced with 'stimulation media' 24hrs before 50pM APV treatment. APV was
applied to the cells lhr before extraction of RNA using QIAGEN RNeasy mini kits.
4.1.3.2 Analysis of Activity Dependent Gene Expression
After extraction, O.Spg of RNA from each sample was reverse transcribed and QRT-
PCR performed by lightcycler measuring levels of cfos, nur77, egr2 and GAPDH.
Samples were run in duplicate and the average ratios of cfos, nur77 and egrl to
GAPDH calculated for each sample. The ratios of the APV treated samples were
compared to that of the untreated samples.
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Table 4.3 shows the results of these experiments. Treatment of the cultured neurons
caused a reduction in the levels of cfos, nur77 and egr2. On average these reductions
were to levels 0.475 (cfos), 0.588 (nur77) and 0.626 (egr2) of that in untreated samples.
Although the degree of APV induced reduction showed variation, the levels of
expression of cfos, nur77 and egr2 in untreated samples were significantly different
(p <0.05) from APV treated cells as calculated by t test. As such, APV treatment can
be effectively used to analyse the expression of NMDA receptor regulated genes in
spontaneously active neurons.
GENE CULTURE TREATED/UNTREATED STATISTICS
1 0.226
2 0.168 Average 0.475
cfos 3 0.539 Standard Dev 0.149
4 1.006 P value 0.024
5 0.435
1 0.281
2 0.616 Average 0.588
nur77 3 0.214 Standard Dev 0.159
4 1.104 P value 0.032
5 0.711
1 0.252
2 0.259 Average 0.601
egr2 3 0.618 Standard Dev 0.269
4 1.188 P value 0.048
5 0.687
Table 4.3 - Results Of APV Treatment. Table shows the ratio of normalised cfos, nur77 and egr2
levels in RNA samples extracted from primary cultured cortical neurons 1 hr after treatment with 50pM
APV compared to those that were left untreated. The average ratios standard deviations and p values
calculated by t tests, comparing treated and untreated levels, of gene expression are shown.
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4.2 ELECTROPHYSIOLOGICAL ANALYSIS OF PRIMARY CULTURES
Bicuculline treatment of cultured neurons did not result in the expected increases in
activity regulated gene expression. It was therefore decided to use
electrophysiology to analyse the effect of drug treatment on the activity of primary
cultured cortical neurons. To do this, multi-electrode arrays (MEA) were employed.
The arrays used consisted of a glass well with a grid of 60 recording electrodes on
the bottom. By coating the array with poly-D-lysine and laminin, cell cultures could
be grown on this substrate and, subsequently, extracellular recording of activity
taken across the cultures. The electrodes measured spike activity generated by the
firing of action potentials
Primary cultures of mouse E17.5 cortical neurons were prepared as described for
stimulation assays. Cells were plated at a surface density of 1 x 105 cells/cm2 in
neurobasal supplemented with B27 and glutamine and incubated at 37°C for 10-13
days before use. Figure 4.5 shows an example of the cultures grown on the array.
4.2.1 Primary Culture Activity Following Bicuculline Treatment
4.2.1.1 Treatment of Cultures with Bicuculline
MEA recordings have been used previously to study the effects of bicuculline on
cultured neurons (Hardingham et al., 2001, Hardingham et al., 2002). These studies
found that bicuculline increased the number of action potential spikes in the burst of
firing in primary cultured rat hippocampal neurons (Hardingham et al., 2002).
Treating the cultures with bicuculline in the presence K+ channel blocker 4-
aminopyridine (4AP) increased the frequency of burst firing (Hardingham et al.,
2001, Hardingham et al., 2002).
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200pm
Figure 4.5 - Neuronal Cultures Grown on MEA. Figure shows 2 images of the same neuronal
culture grown on MEA at two different magnifications. The cells were primary cultured mouse
E17.5 cortical neurons, 12 DIV.
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After 10-13 days in vitro, cells were removed from the incubator and arrays placed
into the recording equipment. Cells were perfused with Locke's solution
(containing ImM MgCh). This magnesium concentration was used to be consistent
with the stimulation media used for bicuculline treatment for the gene expression
experiments. After recording a period of control activity from the culture, 50pM
bicuculline was added to the Locke's perfusion. Cells were treated with bicuculline
for at least 10 minutes, until activity levels appeared stable. In accordance with
previous studies of bicuculline action on cell culture activity (Hardingham et ah,
2001; Hardingham et ah, 2002) the cells were then perfused with Locke's solution
containing 50pM bicuculline and 50pM 4AP for approximately 10 minutes. The
cells were then washed by perfusion with Locke's solution. Following this wash
period, the cells were perfused with Locke's solution containing lpM TTX to ablate
cell activity and establish the level of background noise measured by the electrodes.
4.2.1.2 Culture Activity Following Bicuculline Treatment
The experiment was performed 3 times. For each array recording electrodes
measuring low noise levels and detectable activity were selected for analysis.
Thresholds for measuring spikes were determined, specific to each array, using the
levels of activity during TTX perfusion to ensure all activity was measured, with no
interference from noise. The number of spikes per second was recorded from each
electrode selected for analysis.
Figure 4.6 is a graph showing the activity measured at several channels from one
microelectrode array over the course of an experiment. The graph shows spike
frequency over time with drug application indicated. The individual channels,
represented by different colours on the graph, behaved in different ways. In basal
conditions a high level of spontaneous activity was detected at each channel. In
general, the application of bicuculline caused an initial decrease of activity, followed
by a slow increase in spike frequency. In the case of the channel shown in yellow,
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this increase was to a level above that of the control period. Following 4AP
application the channels shown in red and blue show increased spike frequency, but
the yellow and black channels show less activity. Activity across the culture was
inconsistent, with different channels displaying variable activity patterns.
To study the overall effect of the drugs on each culture, the average spike frequency
from each channel was calculated for each given condition. This value was
converted to a percentage of the control, pre treatment activity for each channel.
Then, for each array, the average spike frequency in each condition, as a percentage
of control, was calculated. T tests were performed to establish whether activity
during drug exposure was significantly different from control. In addition, the
same calculations were performed with data combined from all analysed channels
from all 3 arrays.
Figure 4.7A shows this data and figure 4.7B graphs the average spike frequency, as
a percentage of control in each condition, for each array (exptl-3) and combined for
all experiments. For each array, and with all data combined, the addition of
bicuculline had no significant effect on spike frequency. In the case of one array
(expt 1) exposure to bicuculline and 4AP caused a significant increase in spike
frequency. For all arrays, activity during the wash period was significantly lower
than control.
Bicuculline treatment of cultured cortical neurons had no significant effect on the
firing rate of the cells. This could explain the lack of induction of activity regulated
genes in cells following bicuculline application. As APV was found to reliably
decrease the expression of activity regulated genes in spontaneously active cultures,
it was decided to study the effect of APV on cultured cell activity.
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Figure 4.6 - Culture Activity Following Bicuculline and 4AP Treatment. Graph shows
the spike frequency over time at four different channels (represented red, yellow, blue and
black) of one multi electrode array. Timing of 50p.M bicuculline and 50pM 4AP application
is indicated.
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A
SPIKE FREQUENCY AS % OF CONTROL (AVE ± SE)
n CONTROL
50pM BIC 50pM Bic + 50pM 4AP WASH
Expt 1 9 100 87.32 (±17.24) 166.95 (±15.45)* 60.78 (±5.63)*
Expt 2 12 100 166.03 (±31.25) 100.59 (±36.26) 44.33 (±7.64)**
Expt 3 10 100 72.85 (±14.45) 87.65 (±20.66) 41.27 (±7.74)**
All Channels 31 100 113.12 (±15.55) 115.68 (±16.83) 48.12 (±4.33)**
B
□ Control
Expt 1 Expt 2 Expt 3 All
Figure 4.7 Table and Graphs Of Spike Frequency Following Bicuculline Treatment. A. For
each experiment (array) n is the number of channels analysed. Table shows average spike
frequency, as a percentage of the control, ± standard error in different drug conditions for each
array. The data from analysed channels from all arrays is combined to give the data termed 'all'.
Stars indicate if frequency is significantly different from control values, as determined by t test.
(*p<0.05, **p<0.01). B. For each experiment (array), the average spike frequency in the presence
of 50pM bicuculline, 50p.M bicuculline + 50pM 4AP and during washing is plotted as a percentage of
control. 'All' shows the data from combination of all channels. As in A, stars indicate a significant
difference from control.
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4.2.2 Primary Culture Activity Following APV Treatment
4.2.2.1 Treatment of Cultures with APV
Experiments were performed in a similar way as detailed for bicuculline to measure
the effect of APV on cultured cell activity. Briefly, after 10-13 days in vitro, cells
were perfused with Locke's solution (containing 1M MgCk). After recording
control activity cells were perfused with 50pM APV in Locke's solution and activity
measured for approximately 10 minutes. Cells were washed with Locke's solution
until activity appeared consistent. The cells were perfused with lpM TTX to
establish baseline noise when neuronal firing is blocked.
4.2.2.2 Culture Activity Following APV Treatment
As with bicuculline, 3 arrays were run and channels chosen from each with low
noise levels and measurable activity for analysis. Spikes per second were measured
from each channel selected for analysis in the different drug conditions.
Ligure 4.8 is a graph showing the spike frequency measured at several channels
from one array over the course of an experiment. Lor all channels shown the
application of APV resulted in a decrease in spike frequency that is relieved quickly
when the drug was removed. Unlike the bicuculline treatment, APV appears to
have a uniform effect at different channels across a culture.
The data was analysed, as described for bicuculline treatment, and figure 4.9 shows
this data tabulated and in graph form. APV significantly reduced the spike
frequency of the culture on all arrays. Also, for 2 arrays the frequency during the
wash period was significantly higher than control. Analysis of data combined from
all channels revealed a significant decrease in activity during APV treatment.
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Time (s)
Figure 4.8 - Culture Activity Following Treatment with APV. Graph shows
spike frequency over time at four different channels (represented red, yellow,
blue and black) of one multi electrode array. Timing of 50pM APV application
is indicated.
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n CONTROL
SPIKE FREQUENCY AS % OF CONTROL (AVE ± SE)
50pM APV WASH
Expt 1 11 100 10.21 (±1.70)** 75.23 (±13.64)
Expt 2 10 100 24.55 (±2.29)** 122.79 (±9.97)*
Expt 3 7 100 64.86(±2.96)** 167.60 (±5.81)*
All Channels 9.3 100 28.99 (±4.34)** 115.31 (±9.50)
B
□ Control
Figure 4.9 Table and Graphs Of Spike Frequency Following APV Treatment. A. For each
experiment (array) n is the number of channels analysed. Table shows average spike frequency, as
a percentage of the control, ± standard error in different drug conditions. The data from analysed
channels from all arrays is combined to give the data termed 'all'. Stars indicate if frequency is
significantly different from control values, as determined by t test. (*p<0.01, **p<0.01) B. For each
experiment (array), the average spike frequency in the presence of 50pM APV and during washing
is plotted as a percentage of control. 'All' shows the data from combination of all channels. As in A,
stars indicate a significant difference from control.
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The objective of the experiments detailed in this chapter was to establish a reliable
protocol for the in vitro stimulation of the NMDA receptor. Gene expression was
measured following treatment of primary culture cortical neurons with NMDA,
bicuculline and APV. Using MEA recordings, the electrophysiological behaviour of
the cultures in basal conditions and in the presence of bicuculline and APV were
analysed. This gave insight to the effects of these drugs on cultured neurons and
the relationship between neuronal activity and gene expression.
4.3.1 NMDA Treatment of Cultured Neurons
The initial experiment presented in this chapter used NMDA to stimulate cultured
neurons. This method involved TTX treatment of the cells, then replacement of the
plating media with a Mg2+ free solution containing NMDA and glycine. NMDA
treatment induced increases in the expression of cfos, egrl, egr2, and nur77.
However, increases in the levels of these genes were also seen in 'unstimulated'
cultures in response TTX treatment followed by media change to Mg2+ free solution.
Due to this the protocol was considered problematic as it was anticipated that there
would be difficulty in identifying increases in gene expression caused solely by
NMDA receptor activity.
Initially, it was thought that induction of gene expression in 'unstimulated' samples
(cells treated with TTX followed by media change to Mg2+ free solution with no
NMDA and glycine) was a result of the media change in the protocol. Changing the
media could cause mechanical or chemical stress to the cells, altering neuronal
activity and inducing transcription of immediate early genes. If this were the case it
would be unlikely that the induced transcription would be mediated via NMDA
receptor activity alone. As such, it would be unsatisfactory to use this protocol to
study NMDA dependent gene expression.
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The simplest way to alleviate a problem caused by media change would be add
NMDA and glycine directly to the cells. However, addition of NMDA and glycine
direct to a Mg2+ containing plating media does not cause stimulation, as measured
by ERK phosphorylation (N. H. Komiyama, personal communication), likely due to
the voltage dependent Mg2+ block of the receptor. Therefore, a media change was
considered essential to the protocol to enable NMDA receptor activation.
However, electrophysiological analysis of cultured cells made apparent another
explanation for the gene expression induction in 'unstimulated' cells. MEA analysis
revealed a high level of spontaneous firing in cultured cortical neurons, with a large
NMDA component in the propagation of activity. By treating cells with TTX, as in
the 'unstimulated' cultures, neuronal activity would be abolished. The subsequent
replacement of the media with a TTX, and Mg2+, free solution would cause
spontaneous activity to resume. Relief of the Mg2+ block, combined with the
increase of synaptic activity, would result in the rapid induction of NMDA receptor
activity and thus mediate receptor regulated gene expression. This could explain
the increases in activity dependent gene expression in 'unstimulated' cells. To
confirm the induced transcription was NMDA receptor dependent, the experiment
could be run in the presence of APV. If it were that gene expression in
'unstimulated' cells was APV sensitive then this protocol could, in fact, be
successfully used to study NMDA receptor regulated gene expression.
4.3.2 Bicuculline Treatment of Cultured Neurons
Treating a cortical cell culture with bicuculline, a GABAa antagonist, should reduce
inhibitory neuron activity. As a result, spontaneous activity of glutaminergic
neurons will increase, activating synaptic NMDA receptors. It would therefore be
expected that treating cultured neuronal cells with bicuculline would rapidly induce
cfos expression. Published data has shown bicuculline treatment to increase activity
of a CRE-mediated expression reporter system based on the cfos promoter,
effectively induce CREB phosphorylation, sensitive to MK801, and increase cfos
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protein levels in rat hippocampal cultures (Hardingham et al., 2001; Hardingham et
al., 2002). Furthermore, published MEA analysis has found bicuculline to increase
the number of spikes in a given burst of activity in rat hippocampal neurons
(Hardingham et al., 2002).
However, the results of bicuculline treatment of cultured cortical neurons, detailed
in this chapter, were inconsistent with published data. Bicuculline was found to be
ineffective in reliably inducing activity regulated gene expression. On average, no
significant increase was observed in cfos RNA lhr after bicuculline treatment.
Additionally, MEA analysis found bicuculline caused no significant increase in
spike frequency of cultured cortical neurons. The individual MEA channels, from
any given array, showed variability in response to the drug, with some channels
appearing to have increased activity in the presence of bicuculline. This uneven
effect may due to a differential GABAergic input across different areas of a single
culture. Overall, bicuculline had no significant effect on the activity of the cultures.
This electrophysiology data was consistent with the results of the gene expression
analysis. If bicuculline failed to increase spike frequency, it would be unlikely to
cause any increase in synaptic NMDA receptor activity that would induce gene
expression.
The disparities between published data and the experiments detailed in this chapter
may be due to differences in the activity of the cultures used. The published
experiments were performed using rat hippocampal cultures, where as the
experiments detailed in this chapter used mouse cortical neurons. During the
control periods of the MEA recordings, there appeared to be a high level of
spontaneous firing. As a result, the effect of bicuculline may be difficult to identify
relative to this. It may be that the cultures used in the published experiments had
less basal activity than those used for the experiments presented here.
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The effectiveness of bicuculline will also depend on the cell content of a culture. If
there are few GABAergic cells present, or if few inhibitory neurons synapse with
stimulatory ones, then treating cells with a GABAa inhibitor will have little effect to
the overall culture activity. Without increasing synaptic activity, bicuculline will be
ineffective at inducting activity regulated gene expression. (Hardingham et al.,
2002) estimated GABAergic cells to make up 10% of the total cells in their cultures.
It may be that this figure was lower for the cultures stimulated in these experiments.
To establish whether this is the case, staining of the cultures, using differential cell
markers, could be used. For example, a double immunohistochemical stain of a
culture with MAP2B and GAD, would stain all neuronal cells and GABAergic
neurons respectively. Counting the stained cells would enable the calculation of the
relative levels of inhibitory neurons in the culture.
4.3.3 APV Treatment of Cultured Neurons
Typically NMDA receptor regulation of activity dependent genes has been studied
by inducing activity at the receptor. However, NMDA inhibition by APV treatment,
included as a control before bicuculline stimulation, revealed a reduction of cfos
expression in 2 out of 3 experiments. This was further examined
cfos, egrl and nur77 are all activity dependent genes induced by NMDA receptor
dependent phenomena (Bading et al., 1995; Inokuchi et al., 1996). Specifically
blocking the NMDA receptor with APV resulted in a reduction in the levels of these
genes in cultured cortical neurons. This suggests that, in spontaneously active
neurons, the NMDA receptor regulates the basal levels of these activity dependent
genes. It has been shown that blocking the NMDA receptor in cortical cultures
reduces the levels of cfos protein (Murphy et al., 1991). This could be due to reduced
levels of cfos mRNA, consistent with the data presented in this chapter.
APV application to a culture would directly remove the NMDA receptor component
of synaptic transmission. MEA analysis revealed a significant reduction in spike
frequency of cultured neurons during APV treatment, indicating a high level of
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NMDA receptor activity contributing to neuronal firing in these cultures. It is
therefore reasonable to assume that, in spontaneously activity cultures, there is
significant activity at the NMDA receptor, and this could regulate the basal levels of
particular activity dependent genes.
Due to difficulties in interpreting the data from other stimulation protocols, APV
treatment proved the most effective in the analysis of NMDA receptor dependent
gene regulation. However, a reliable protocol of stimulating the NMDA receptor
would still be highly desirable to study the regulatory pathways downstream of the
receptor that contribute to induced transcription. As discussed earlier one method
to investigate would be to analyse gene expression following TTX treatment of the
cells. Another method, similar in principal to this, would be to study transcription
in neuronal cultures in wash periods after APV treatment. If there is a high level of
basal activity in the neurons then the expression levels of genes such as cfos may be
too high to see reproducible induction in response to stimulation. However, by
blocking NMDA receptor activity with APV, these levels would be reduced to a
new 'basal' level. Removal of the APV would increase spontaneous cell activity,
and NMDA receptor stimulation, and thus induce activity dependent gene
expression that could then be analysed.
4.4. CONCLUSION
The work in this chapter details analysis of in vitro stimulation of the NMDA
receptor, by measuring activity dependent gene expression. Due to the time
restrictions of this project, the work could not be continued further. However, as
discussed, there are several ways in which the protocols could be altered to develop
a reliable method of NMDA receptor stimulation in primary cultured neurons. This
could then be applied to analyse activity regulated gene expression in wild type and
mutant cells.
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Bicuculline stimulation caused inconsistent induction of activity dependent genes.
MEA analysis revealed that treatment with this drug did not result in the expected
increase of spontaneous activity. This could be due to a low level of GABAergic
input, combined with the high levels of basal cell activity observed in the cultures
by MEA analysis.
Specifically blocking the NMDA receptor, by treatment with APV, reduced the
levels of cfos, nur77 and egr2 in neuronal culture. This suggests that the NMDA
receptor plays a critical role in controlling the basal levels of these activity regulated
genes. MEA analysis established that APV treatment resulted in a significant
reduction in spike frequency.
In the data presented in this chapter, gene expression and MEA analysis were
effectively combined to further the understanding of drug effects on primary
cultured cortical neurons. Integrating such methods may prove valuable in the
development of a reliable in vitro stimulation protocol for cultured neurons.
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5. DESIGN AND VALIDATION OF A CUSTOM MICROARRAY
As demonstrated in chapter 3, commercial microarrays are a powerful method of
analysing gene expression. However, commercial arrays are expensive to use and,
once genes of interest have been identified by large scale analysis, there is limited
value in screening the levels of tens of thousands of transcripts. An alternative is to
use custom designed arrays. Using these many transcripts can be analysed
simultaneously, however, the genes of interest represented on the array can be
specified. They offer a more cost effective high throughput method of gene
expression analysis. However, a disadvantage of using custom arrays is that they
have to be thoroughly validated and do not necessarily have the range of controls
contained on them that commercial systems offer.
This chapter discusses the design and validation of a custom, oligonucleotide based,
microarray. In the context of the work of this project, custom arrays could be used
to examine mutant tissue or to study activity regulated gene expression in wildtype,
as well as mutant, cells.
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5.1 DESIGN AND MANUFACTURE OF A CUSTOM MICROARRAY
5.1.1 Selection of Genes of Interest
The advantage of designing a custom microarray is that the genes of interest can be
specified. For our custom array, genes were chosen that have implied involvement
in synaptic activity. The genes selected can be organised into different categories;
genes encoding proteins of the NRC, genes encoding receptor subunits, activity
regulated genes, genes involved in synaptic signalling pathways, genes that may be
involved in local translation and genes significantly altered in PSD95/_ and
SynGAP+/- mutant tissue (transcripts were chosen from those in the Affymetrix
experiments altered greater than 1.3 fold). 240 genes of interest were chosen, 188 of
which are represented on the Affymetrix u74Av2 arrays used in chapter 3. Some
genes of interest, such as SynGAP isoforms, were not present on the commercial
array but were included on the custom chip. Also present on the custom array were
oligonucleotides representing positive control genes and negative control genes
designed to Arabodopsis and mouse cytomegalovirus sequence. Table 5.1 details the
240 genes of interest, 30 positive control and 28 negative control genes represented
on the array. All genes of interest appear in the table only once, although some
could belong to multiple categories.
5.1.2 Design of Oligonucleotides
Oligonucleotides for all genes of interest were designed in the manner described
below. Control probes, positive and negative, were added to the array from stock
controls used by the Scottish Centre for Genomic Technology and Informatics
(SCGTI), University of Edinburgh. Sequences for the genes to be represented on the
custom arrays were obtained from www.ncbi.nlm.nih.gov/nucleotide. For the
majority of the genes of interest murine sequence could be obtained however, at the
time of design, mouse data was not available for some genes (cpgl, EphA3, EphA7,
Fzd2, gephryn, GiRa2, KA1, mGluR5, neuritin, NT4, SynGAP, trkA and yotiao), in these
cases, rat sequence was used.
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Genes from NRC Complex Translation Genes from Affymetrix Experiment
Scaffolding Modulators 4E-BP2 5HT3 Receptor 4 Protease28 subunit, beta
AKAP150 H-ras aCaMKII Adrenergic receptor, beta 1 PTTG
Homer 1a NF1 CPEB AIF RAB34
Homer 1b + 1c RalA CPSF100 APC Rap1
Homer 2a + 2b sacrospan CPSF160 Atonal homolog 2 Rgs2
Homer 3 synGAP-a CREB Bagl RyR3
NSF synGAP-b eEF1 A Bcl2 Serine palmitoyltransferase
PSD 93 synGAP all forms eEF2 Bel-associated death promoter signal transducing adaptor 2
PSD 95 elF4E CACYBP SOS2
Sap 97 Cytoskeletal elF4GII CD53 Transformation related 53
Sap102 alpha actinin 2 FMR1 Cfos X-box binding protein 1
Shank beta Catenin FMR2 cyln2
Yotiao Cortactin Frapl DUSP 6 ESTS
Desmoglein gephyrin Egr1 AI836641
Signalling Dynamin GlyR2 egr2 AW125272
PKC beta L1 map-2 elF4A AI843358
PKC epsilon Hsp-70 MNK1 Erythroid Diff Factor AI852001
PKC gamma Myosin MNK2 Est2 repressor factor AI848952
CaMK II beta N-Cadherin NAT1/DAP-5 FosB
PYK2 spectrin p38dMAPK GADD45B Glutamate Receptors
Src pp120cas PABpl glycogenin 1 NR1
c-raf1 PABp2 growth factor-inducible IEG NR2A
ERK 1 Others PERK IP3 receptor 3 NR2B
ERK 2 Bassoon PI3Kp85a Insulin-like GF2 NR2C
MKK4 ZO-1 PP1 interferon responsive15 kDa NR2D
MEK 1 Phosphofructokinase PP2A IP3 receptor 1 NR3A
MEK 2 APPL Adaptor Protein Quaking JunB NR3B and NR4
Arg 3.1 Alpha Internexin RC3 K+ channel, subfamily H, 1 GluR1
Calmodulin Tubulin A4 RL17 K+ channel, subfamily K, 1 GluR2
Citron S6K K+ channel Kv4.2 GluR3
cPLA2 Phosphatases Staufen 1 Kinesin family member 3a GluR4
nNOS PP1 Stk13 MEKK4b GluR5
P13 Kinase PP2A Tubulin B4 MKK2 GluR6
PLC gamma PP5
histone
deacetylase 3 neoplastic progression 3
GluR7
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Signalling Molecules ADG Positive Controls Negative Controls
APC PKA C-alpha + beta CBP Alpha tubulin 1;4 alpha
glucanotransferase
C-src tyrosine kinase PLC b1 CHOP 10 BDNF alkaline neutral invertase
EphA1 PLC b2 Cjun beta-actin alpha glucosidase like
protein
EphA2 PLC b3 CNS1 B-raf beta amylase
EphA3 PLC b4 COMT calcium activated neutral
protease large subunit
branching enzyme













EphA7 Wnt 4 DUSP10 cyclin E2 glucosidase alpha subunit
EphA8 Wnt 7(a and b) GADD45G Gapdh phosphoglucomutase
(plastidic)
EphB1 Wnt 7b GAP 43 Histon H2A soluble starch synthase
EphB2 GnrH receptor HPRT sucrose synthase
EphB3 Neurotrophins GR33 integrin alpha6 vMC003
EphB4 TrkA Hsp 27 JNK1 vMC009
EphB6 TrkB Ier5 matrix metalloproteinase
14
vMC014
FRP-1 TrkC Narp myeloid leukemia factor 1 vMC015
FRP-2 BDNF Pim1 PDHA1 VMC017
FRP-3 NGF Pim2 phospholipaseA2 VMC057
FRP-4 NT 3 Pip 92 proalphal (II) collagen VMC059
Fzd1 NT 4 Presenilin-1 proalpha2(l) collagen VMC101
Fzd2/Fzd10 RheB procollagen, IV a 3 VMC109
Fzd3 Somatostatin putative lysophosphatidic
acid acyltransferase
VMC118
Fzd4 Syndecan Ribosomal L15 VMC130
Fzd5 tPA Ribosomal L32 VMC145
Fzd6 Ribosomal L32-3A VMC146







MEK4 tumor necrosis factor
MKK2 Ubiquitin
Table 5.1 - Genes Represented on Custom Microarray. Table details the genes included on the
custom microarray, arranged into categories. All oligonucleotides for genes of interest were designed
using Oligo 6. Positive and negative control probes were taken from stock probes at the SCGTI.
Oligonucleotides for genes of interest and positive controls were designed to murine sequence and, if
that were not available, rat sequence. Negative controls to named genes were designed to
Arabidopsis sequence and, those in italics, mouse cytomegalovirus sequence.
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55 base pair oligonucleotides were designed using 01igo6 software. The
oligonucleotides were designed with 3' bias, ideally around 500 base pairs from the
terminal polyA tail if this sequence information were available. For genes of high
homology, or to distinguish splice variants, similar sequences were compared
pairwise using BLAST (www.ncbi.nlm.nih.gov/BLAST) to identify areas of diversity
and oligonucleotides designed to the most 3' of these areas.
The 01igo6 software selects several oligonucleotides to a specified area of input
sequence, within set melting temperature parameters. From these candidate
oligonucleotides the most suitable probe was picked. Oligonucleotides were chosen
to have a melting temperature within a 10°C range of each other (approximately
90°C to 100°C) so optimal hybridisation temperatures would be similar. To
minimise the secondary structure of selected oligonucleotides, potential hairpins
were analysed and only those with A loop G scores greater than -3 were considered
suitable. Once chosen, the 55mers were checked for specificity to the target genes
using nBLAST. Any oligonucleotide with more than 15 contiguous base pairs
common to a mouse gene other than the target was discarded and redesigned.
Tables 5.2 - 5.3 and figures 5.1 - 5.2 show the design stages of the oligonucleotide
designed for DUSP6. The mRNA sequence (NCBI accession number NM_026260)
was put into 01igo6 and suitable 55mers were searched for within 1000 bases of the
3' end of the sequence. Table 5.2 shows the choice of oligonucleotides returned by
01igo6. The selected oligonucleotide was number 4, which had a melting
temperature (94.6°C) that falls within the 10°C range of the other oligonucleotides
and started 512 bases from the predicted poly A tail in the sequence. Table 5.3
details the loop AG scores for the chosen oligonucleotide. The smallest score is
0.2kcal/mol and thus the secondary structure of the oligonucleotide should not be
problematic. Figure 5.1 shows where the selected oligonucleotide is within the
DUSP6 mRNA sequence. It shows the DUSP6 sequence with the predicted poly A
site and oligonucleotide highlighted.
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Table 5.2 - 55mers Suggested By Oligo6 For DUSP6. Table details the oligonucleotides
suggested by Oligo6 for DUSP6 sequence. 16 55mers were suggested and their distance from
the start of the sequence and predicted melting temperatures (°C) are detailed. The








1 0.2 3 3
2 0.5 3 6
3 0.8 3 9
4 1.1 3 12
5 1.1 3 11
6 1.8 4 26
7 2.3 3 18
8 2.4 3 15
9 2.9 4 26
10 3.3 3 26
11 3.9 3 23
12 4.1 3 33
13 4.2 3 28
14 4.4 3 25
15 4.4 3 26
16 5.2 3 28
17 6.0 3 26
Table 5.3 - Loop AG Scores For DUSP6 Oligonucleotide. Table details the loop AG scores
for hairpin structures in the chosen DUSP6 oligonucleotide. The length of the duplex and size
of loop (both measured by nucleotides) are also shown.
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NM_026268 Mus musculus dual specificity phosphatase 6 (Dusp6), mRNA
Length 2793, Poly A signal: 2774 - 2779










































Figure 5.1 - DUSP6 Gene Sequence and Oligonucleotide. Figure shows the murine sequence for
DUSP6 mRNA, accession number NM_026268. The location of the designed 55mer is highlighted in
yellow (bases 2262 - 2316) and the predicted polyA signal is highlighted in blue (2774 - 2779).
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Addreji fe) http;/Aww.ncb.nlm.nih.gov/biast/Blast.cqi gas File Edit Vte O
(55 letters)
Distribution of 1 Blast Hits oil the Query Sequence
Mouse-over to shuwdetline end scores. Click to show alignments
Color Key for flllgnnefit Scores
Score E
Sequences producing significant alignments: (bits) Value
refINT 039500.21 Mm10 39540 32 Mus musculus chromosome 10 ge... 106 8e-22
Alignments
>refINT 039500.21HmlO 39540 32 Mus musculus chromosome 10 genomic contig, strain C57BL/6J
Length - 32251606
Score - 106 bits (55), Expect - 8e-22
Identities - 55/55 (100*)
Strand * Plus / Plus
Query: 1 gggtatatttgcagcatgcttgaccttgatgtaccaattctgacggcattttcgt 55
II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 12868284 gggtatatttgcagcatgcttgaccttgatgtaccaattctgacggcattttcgt 12868338
Figure 5.2 - DUSP6 Oligonucleotide mBLAST result. Figure shows the results of mBLAST search of
the DUSP6 55mer against the entire mouse genome. Only one match was found, on chromosome 10,
where the DUSP6 gene is located.
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To ensure the selected oligonucleotide was specific to DUSP6 alone, the 55mer was
analysed using mBLAST. This program searches for sequence matches across the
entire mouse genome. Analysis of the oligonucleotide found the 55mer matched
only one sequence in the mouse genome, on chromosome 10 where the DUSP6 gene
is located (see Figure 5.2). It is apparent that the chosen oligonucleotide for DUSP6
should be selective to this gene and not hybridise to other RNAs.
All oligonucleotides for genes of interest were designed in this way. The
oligonucleotide sequences, along with melting temperatures and position in input
sequence, are detailed in Appendix 3. The oligonucleotides were manufactured,
without modification, by Illumina. Liquid handling and array spotting of these
oligonucleotides were performed at the SCGTI, University of Edinburgh according
to their standard protocols.
5.1.3 Layout and Printing of Mioroarray
Figure 5.3 shows a simplified diagram of the chip layout design. The printed areas
of the arrays were divided into 4, each area containing 3 panels of identical
oligonucleotides, thus each gene is represented on the chip in triplicate. The
oligonucleotides were placed randomly across the arrays, although housekeeping
controls were placed in the top left corners of each panel to act as guide lights to
orientate the arrays upon scanning. Also, buffer spots (150mM phosphate buffer +
0.01% SDS) were spotted in the first row of each repeated panel. These can be used
to identify any high levels of background, nonspecific binding. Appendix 4 details
the layout of the genes of interest, control genes and buffer spots on the array.
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Figure 5.3 - Diagram of Chip Layout. The diagram shows a simplified version of the chip
layout. The array is divided into 4 areas, each of 3 identical panels of oligonucleotides, thus
each gene is represented on the chip in triplicate. The probes were randomised apart from
housekeeping controls (in yellow) which were placed in the corners of the arrays to act as guide
lights to orientate the arrays upon scanning.
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The oligonucleotides were spotted onto Corning GAPII slides at 50pM using a
BioRobotics MG2 machine. Initial quality control of the arrays was done using
SpotCheck (Genetix), a kit of random 9mers that checks the presence and quality of
spots on the slides. All array printing and SpotCheck quality control of the slides
was done by Marie Craigon at the SCGTI, University of Edinburgh.
Figure 5.4 shows the results of hybridising SpotCheck to arrays from two batches of
spotted slides. Hybridisation was successful in both cases and the basic layout of
the arrays can be clearly seen. However, examination of the slide shown in figure
5.4A shows a lack of several spots where oligonucleotides should be printed, most
apparent in the top left quadrant. Also, the intensity of SpotCheck binding at
different spots would be expected to be more uniform. These problems were
identified to be due to errors with the machine when printing the arrays. Figure
5.4B shows the SpotCheck hybridisation to a slide from a second batch of printed
arrays. In this case, there appears to be smaller variation in the intensity of binding
and only 1 spot (in the bottom right quadrant) appears to be missing in each panel
replicate.
5.2 VALIDATION OF CUSTOM MICROARRAY
To further validate the spotted arrays, a hybridisation experiment was performed
using RNA samples with profiles of transcription levels. Wildtype forebrain RNA
(as used in the Affymetrix wildtype and PSD95_/~ forebrain experiment) and a
control murine RNA, extracted from CI27 mammary tumour cells, in standard use
at the SCGTI, were hybridised to the arrays.
5.2.1 Hybridisation of the Custom Array
The RNAs were reverse transcribed with Cy3 labelled UTP and hybridised
overnight at 55°C, then washed and immediately scanned. The slides used for this
validation were those from the first run of printing, which had several spots
missing.
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Figure 5.4 - Quality Control Hybridisation of Custom Arrays. A is an image of hybridisation of
SpotCheck (random 9mers) to one of the arrays from the first batch of printing, with certain spots
seen to be missing. B is an image of SpotCheck hybridisation to an array from the second round of
printing.
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Figure 5.5 shows the scanned images of the arrays with forebrain (Figure 5.5A) and
C127 (Figure 5.5B) samples. Hybridisation appears successful, with the distinct
spots from each oligonucleotide clearly identifiable. The C127 hybridisation
appears to have a smear down the right side of the array. This could be due to areas
under the coverslip drying out during the hybridisation.
5.2.2 Analysis of Hybridisation
The hybridisation using wild type forebrain RNA as starting material was more
closely examined to identify whether groups of genes represented on the array
behaved as expected. Figure 5.6 is a box and whiskers plot of the different spot
types on the array (genes of interest, negative controls, positive controls and buffer
spots). The plot shows the range of median cy3 intensity at the probes for each of
these types of spot.
In general, the RNA hybridised to the arrays as expected. The threshold of
expression was calculated to be 1841, using the average expression level at the
buffer spots plus 2 standard deviations of the buffer values. The genes of interest
showed a wide range of expression, 88% of them greater than this threshold of
expression. The negative controls were detected over a narrow range below the
threshold of expression. In contrast, the positive controls were all expressed at a
range of levels above the threshold of expression. Hybridisation at the buffer spots
was similar to that of the negative controls. One outlying buffer spot was found
expressed above the threshold of expression, this could be due to contamination at
this spot. The data suggests successful hybridisation of labelled cDNA to the chips,
with a wide range of expression levels measured.
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B
Figure 5.5 - Hybridisation of Control RNAs to Custom Arrays. A is an image of hybrisdation of
labelled forebrain RNA to custom array. B is an image of hybridisation of labelled C127 RNA to
custom array.
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Figure 5.6 - Box and Whiskers Plot of Array Validation Data. The plot illustrates to range of
expression, median and 1st and 3rd quartile values for GOI (genes of interest), NC (negative control) and
PC (positive control) transcripts. The level of expression detected at the buffer spots is also shown.
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5.3 COMPARISON OF CUSTOM AND COMMERCIAL MICROARRAYS
In order to validate their performance, the custom arrays were hybridised with
labelled samples from wild type and PSD95_/" forebrain, as used for the Affymetrix
experiment. Alan Ross at the SCGTI, University of Edinburgh carried out the
hybridisation and initial data analysis for this experiment.
5.3.1 Hybridisation of the Custom Array
The RNA samples used for the hybridisation were aliquots of the PSD95/_ and
wildtype forebrain samples detailed in table 3.1 in chapter 3. The RNA samples had
been stored at -80°C during the time between conducting the Affymetrix and
custom array experiments. It was confirmed that the RNA had not degraded during
this time using the Agilent Bioanalyser. The 3 wildtype and 3 PSD95-/- samples were
each labelled and hybridised to individual arrays from the second batch of slides
that were printed.
The RNA was reverse transcribed to biotin-labelled cDNA using the QIAGEN
LabelStar kit. The cDNA, in a hybridisation cocktail, was hybridised to the arrays
overnight at 42°C. After washing, QIAGEN RLS (resonance light scattering)
particles were bound to the arrays. These nano-sized gold particles are coated in
biotin antibodies and, when exposed to a white light source, emit energy, the
intensity of which can be measured as the level of particle binding to the labelled
cDNAs. This protocol was adopted since it is highly sensitive and requires less
starting material (4.54pg RNA) as compared to the standard hybridisation of custom
chip (25pg RNA).
Figure 5.7 is an image of a scanned array hybridised with labelled wildtype
forebrain sample. The more intense the light at a particular spot is, the more highly
expressed the transcript is.
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Figure 5.7 - Image of Array Following RLS Hybridisation. Picture shows the scanned
image of an array hybridised, using the RLS protocol, with labelled wild type forebrain RNA.
The higher the intensity of light, the more highly expressed the transcript represented by that
particular probe is.
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5.3.2 Analysis of Hybridisation
The data from the arrays was scaled by a factor calculated from the average 75th
percentile expression value from all arrays divided by the 75th percentile expression
value for each particular array. The mean expression values for each transcript in
wild type and mutant samples were calculated from the scaled median value of the
transcript on each array. Figure 5.8 shows a box and whisker plots showing the
levels of the genes of interest as well as negative and positive controls averaged for
wild type (Figure 5.8A) and mutant (Figure 5.8B) arrays. The plots of wild type and
PSD95-'- data look similar. Ffowever, a notable feature of this data is that the range
of expression of the negative controls overlaps with the positive controls and the
genes of interest. This suggests that these probes are not performing as expected.
The threshold of expression was determined for each array using the 80th percentile
expression level of the negative controls on the array. Table 5.4 shows the number
of genes of interest determined to be present and absent on each array and the
average across all arrays. On average 32.7% of the genes of interest were found
present in the forebrain samples. This is lower than the average percentage of
transcripts detected present on the Affymetrix chips (46.75%) and lower than the
number of transcripts determined present by the previous hybridisation of wild
type forebrain samples to the custom array (88%). Thus the results from the
hybridisation are not consistent with previous experiments and may indicate a
problem with the hybridisations.
WILDTYPE ARRAYS PSD95"'" ARRAYS ALL ARRAYS
1 2 3 1 2 3 AVE
ABSENT 172 170 168 129 152 172 160.17
PRESENT 68 66 64 111 90 68 78.50
% Present 28.8 27.9 27.1 46.7 37.9 28.8 32.7
Table 5.4 - Numbers of Detected Transcripts on Custom Arrays by RLS Hybridisation. Table
shows the number of genes of interest detected absent and present, along with the percentage of
transcripts present out of total on chip, for each custom array. The average values from all arrays are
also shown.
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5.3.3 Comparison of Affymetrix and Custom Array Results
In order to compare the custom array results with that of the Affymetrix data, genes
significantly altered in wild type and mutant samples by custom array were
identified. The 3 scaled expression values for each transcript on each array were
used to compare expression in wild type and PSD95_/~ tissue by t Test.
5.3.3.1 Genes Found Significantly Altered by Custom Array
As with the Affymetrix arrays, to be considered significantly altered in mutant
tissue, a gene had to have a differential expression greater than 1.5 fold with a p
value less than 0.05. Of the 240 genes of interest on the custom array, 108 transcripts
were differentially expressed in wild type and mutant tissue, greater than 1.5 fold.
However, of these 108 transcripts only 1, considered present in the samples, was
altered with a p value < 0.05. This gene was fzd6.
Table 5.5 shows custom and commercial array data for fzd6 expression in PSD95-/-
and wildtype forebrain. Fzd.6 was considered absent by the Affymetrix array, but
was classed as present by custom array analysis. Although the expression levels
cannot be directly compared across the systems, fzd6 was found highly expressed by
the custom array. Indeed, fzd6 was the second most highly expressed of all
transcripts in the wild type samples according to the custom arrays.
ddhdc in WILDTYPE WT/MUTANT WT/MUTANT PPROBE 10
AVE MUTANT AVE RAT|Q RATIO VALUE
Custom Array Data
Fzd6 34607 42719.1 27230.4 1.6 0.63 0.001
Affymetrix Array Data
Fzd6 101142_at 2.43 (absent) 7.13 (absent) 2.93 0.34 0.141
Table 5.5 - Expression of Fzd6 in Wild Type and PSD95"'" Forebrain. Table shows data from custom
and Affymetrix arrays. The table details the expression levels of fzd6 in wild type and PSD95"'" tissue, the
ratio of these expressions and the p value of these differences as measured by t Test.
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Figure 5.8 - Box and Whiskers Plots of RLS Data. A illustrates the range of mean
expressions for GOI (genes of interest), NC (negative control) and PC (positive control)
transcripts on the arrays hybridised with wild type forebrain RNA. B illustrates the same as A,
but using data from the arrays hybridised with PSD95V" forebrain RNA.
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5.3.3.2 Genes Found Significantly Altered by Affymetrix Array
Table 5.6 compares the data from custom and commercial arrays for those
transcripts, present on the custom array, that were found significantly altered in
PSD95_/" forebrain by Affymetrix chips. Of the 9 transcripts present on the custom
array that were found significantly altered by Affymetrix arrays, only 3 showed
similar changes in expression in mutant tissue. None of these were statistically
significant. An obvious difference in the data is that no significant alteration in the
level of the PSD95 transcript is found by the custom array.
5.3.3.3 Comparison of Custom and Affymetrix Array Performance
Table 5.7 compares the overall performance of custom and Affymetrix arrays. The
custom and commercial arrays found 1.66% (4 out of 240 transcripts) and 5.15% (644
out of 12496 transcripts), respectively, of the genes of interest differentially
expressed in wild type and mutant tissues with a p value less than 0.05. The custom
array found 45% of the genes to be altered in mutant tissue greater than 1.5 fold,
where as only 1.9% of the genes on the Affymetrix array showed this level of
change.
The custom arrays found alterations, greater than 1.5 fold, in the expression of many
more genes than the Affymetrix array did. This could be expected since the genes of
interest on the custom array were chosen due to their involvement in postsynaptic
mechanisms. However, of the 108 genes altered greater than 1.5 fold, only 1
transcript, expressed above threshold, was of statistical significance. The
commercial array found 14 significantly altered transcripts that were called as
present in either wildtype, mutant or both tissues.
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PSD 95 1858.7 1730.7 1.07 0.20 3.4 0.004
nur77 1410.4 1591.8 0.89 0.27 2.39 0.001
cfos 1100.6 2232.6 0.49 0.99 2.22 0.002
egr2 316.0 1041.5 0.30 0.35 2.19 0.014
Perl 907.5 397.3 2.28 0.53 2.16 0.024
junB 4059.3 5778.7 0.70 0.75 1.97 0.019
cyln2 3739.4 1959.7 1.91 0.15 1.97 0.017
GADD45B 656.9 369.3 1.78 0.26 1.75 0
Higher in Mutant
Serine palmitoyltransferase 774.6 555.0 0.72 0.37 1.57 0.014
Table 5.6 - Comparison of Affymetrix Results with Custom Array Data. Table shows the levels of
genes, found significantly altered in PSD957" forebrain by Affymetrix analysis, as measured by custom array.
Those that show similar changes in both systems, regardless of p value, are in bold.
CUSTOM ARRAY AFFYMETRIX ARRAY
3 of genes of interest on array 240 12496
# of genes with > 1.5 fold change between wild type
and PSD957" tissue 108 238
- as % of genes of interest on array 45% 1.90%
# of genes of interest significantly different in wild type
and PSD95"'" tissue (p<0.05)
4 644
- as % of genes of interest on array 1.66% 5.15%
# of genes, called as present, with > 1.5 fold change
between wild type and PSD957" tissue (p<0.05) 1 14
- as % of genes of interest on array 0.42% 0.11%
Table 5.7 - Comparison of Statistics From Custom and Commercial Arrays. Table details the
differences in gene expression found in PSD957" forebrain compared to wild type as found by custom
and Affymetrix arrays.
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5.4 DISCUSSION
5.4.1 Designing and Printing a Custom Array
There are several advantages in designing and using a custom microarray. Wide
scale analysis can be maintained, while genes of interest can be specified. Therefore
all transcripts represented on a chip can be chosen to be relevant to the system being
studied. This means genes of interest, that are not present on commercial chips, can
be included on a custom array. For example, SynGAP is not present on the
Affymetrix u74v2A array, but was included on our custom array. Using a
oligonucleotide based array allows for specification of probes to particular regions
of a gene, which can be exploited to identify splice variants or to distinguish highly
conserved genes.
The limitation of using an oligonucleotide based array is that design depends on the
availability of sequence. At the time the oligonucleotides for this array were
designed (Autumn 2002), complete murine sequence was not available for all genes
of interest, and in some cases no mouse sequence was available from public access
databases. If the probes on the array were to be redesigned at the present time, it is
likely that more sequence information would be available to aid this process.
Another disadvantage of using custom based arrays, which will be discussed, is that
they require thorough validation before they can be used reliably.
5.4.2 Comparison of Custom and Commercial Arrays
5.4.2.1 Comparison of Custom and Commercial Array Data
The genes represented on the custom array were selected due to their involvement
in synaptic plasticity processes, including several transcripts that were found
significantly altered in PSD95 and SynGAP mutant tissue by Affymetrix arrays.
RNA aliquots of the same material extracted from the forebrain of wild type and
PSD95_/" animals and hybridised to Affymetrix arrays, as detailed in chapter 3, were
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used to compare the custom arrays to the commercial systems. The results from the
custom arrays were not similar to those from the Affymetrix experiment.
The custom arrays identified alterations greater than 1.5 fold in 45% of the genes
represented on the chip, however of these 108 transcripts only 1 gene determined
present was significantly changed (p<0.05). This suggests that there was a
variability in the expression levels measured by hybridisation to the custom arrays,
such that many differences greater than 1.5 fold were detected but that high levels
of variation meant few of these were of statistical relevance.
The only gene that was detected present in forebrain samples and was significantly
altered, greater than 1.5 fold, in the PSD95"'" forebrain was fzd.6. However this
transcript, encoding a receptor acting in Wnt signalling pathways, was not found
significantly altered in PSD95-/_ tissue using commercial arrays. Indeed, the
transcript was not even detected present by Affymetrix analysis. The disparities in
the custom and commercial array results could be due to problems with the probes.
It may be that the custom oligonucleotide is cross hybridising to another, highly
expressed RNA, although it should be noted that mBLAST analysis found the probe
to be specific to fzd.6 (data not shown). Alternatively, it may be that the Affymetrix
probes for fzd6 did not effectively hybridise their target.
Of the 9 transcripts represented on the custom array that were found significantly
altered in PSD95_/" forebrain by Affymetrix analysis, only 3 showed similar changes
on the custom array. None of these alterations were significant. While it could not
be expected that the custom array would replicate the results of the Affymetrix
experiments, a degree of overlap would have been assumed. A particularly striking
difference in the custom and commercial array results is the data from the PSD95
probe. The PSD95 transcript was reliably found expressed at significantly lower
levels in the PSD95_/~ forebrain by Affymetrix array and RT-PCR protocols. The
custom array detected the PSD95 transcript, however the level of the expression was
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found to be unchanged in PSD95+ and wild type samples. These results could be
due to poor performance of the custom oligonucleotide. Also, the hybridisation
temperature of the custom array could have been inappropriate, resulting in
nonspecific binding to the probe.
5.4.2.2 Differences Between Custom and Commercial Systems
There appears to be clear differences in the results obtained by commercial and
custom systems, for which there are several possible reasons. While no system can
be 100% reliable, the Affymetrix arrays meet the high levels of quality control
expected of a commercial system. The process of gene expression analysis by
Affymetrix chip involves several stages of control to confirm whether the labelling
and hybridisation protocols have been efficient. Thus, if experiments produce
unexpected results, the control steps can help pinpoint the specific stages where
problems may have occurred. As detailed in chapter 3, the Affymetrix
hybridisation reactions met all quality standards and some of the results were
validated using RT-PCR methods. Therefore, the Affymetrix data should be
considered reliable, particularly since the limited genes identified as significantly
altered include several with known roles in synaptic plasticity and neuronal
function.
A disadvantage of the custom arrays is that they have fewer built in controls than
the commercial system and hybridisation protocols have to be optimised before they
can be used reliably. The custom arrays included positive and negative controls.
However, in the RLS hybridisation of wild type and PSD95_/~ samples some of the
negative controls on the custom arrays were expressed at levels above the threshold
of expression. This could be due to problems with these oligonucleotides, however,
the negative controls were probes in standard use at the SCGTI. This suggests there
may be a problem with the hybridisation reaction, with unusual background
hybridisation occurring.
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The limited numbers of genes classed as present (on average 32.7%) in the forebrain
samples also indicates there may be a problem with the RLS hybridisation. The
Affymetrix experiments found, on average, 46.75% of the transcripts represented on
the array to be expressed in forebrain (wild type and PSD95-/~) samples. Since the
genes of interest specified on the custom array are known to be involved in
postsynaptic mechanisms, it would be likely that the majority would be expressed
in resting neuronal tissue. Of the 188 genes present on both the custom array and
Affymetrix chip, 72% were detected present in wild type forebrain by Affymetrix
analysis. It would therefore be expected that the custom arrays would detect at least
this percentage of genes present, if not more to account for the probes on the custom
array that are not included in the Affymetrix analysis. Consistent with this, the
initial hybridisation of the custom arrays with Cy3 labelled samples found 88% of
the genes of interest above the threshold of expression. The subsequent RLS
hybridisation would have been expected to detect similar numbers. Since the
threshold of detection for the RLS experiment was determined using the data from
the negative controls, the unexpected levels of expression at the negative probes will
have contributed to the reduced levels of detected transcripts.
The apparent problems with the RLS hybridisation could be due to a lack of
optimisation of the reaction conditions. It may be that the hybridisation or washing
temperatures used could be unsuitable. Unexpected expression of particular probes
could also be due to inappropriate length of time for hybridisation or incubation
with the RLS particles. Due to time constraints of this project, the comparison of
wild type and PSD95 7" forebrain RNA was carried out before thorough validation of
the custom arrays using RLS array hybridisation protocols. The ideal conditions for
reaction may not have been used for the experimental hybridisation and, as a
consequence, it produced unreliable results.
Another contributing factor to the differing results from custom and commercial
arrays could be the number of probes, per transcript, used in each experiment.
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Affymetrix arrays use at least 16 different probes to represent every transcript on
each array. However, the custom arrays only have 3 identical probes present for
each target gene. As such, in order to replicate the number of data points used by
Affymetrix on a single array to calculate the expression of a transcript, at least 6
custom arrays would be required. A lack of replication may account, in part, for the
results of custom array analysis of PSD957" forebrains. By using replicate slides for
each sample, the custom array data may have sufficient data points contributing to
measures of expression to reduce variation in results.
Another source of differences in results between the custom and commercial arrays
could be the performance of particular probes on the arrays. Probes, either on the
custom or Affymetrix array, for particular transcripts may not be behaving as
expected to detect their intended target. In such cases, the measured level of
expression would be inaccurate. Custom arrays oligonucleotides met particular
criteria and were specific to target genes. However, some oligonucleotides
(approximately 5-10%), even when designed to standard criteria with specificity to
their target, do not perform as expected and may require redesigning (K. Veirlinger,
personal communication). Thus, some of the unexpected results could be due to
poor performance of such oligonucleotides. The probes designed by Affymetrix
would be expected to meet strict quality standards, but they too could perform
poorly with no obvious reason. However, Affymetrix arrays have multiple different
probes, designed to each transcript, present on every chip. As such, individual
probes that do not perform as expected would have a smaller impact on the
measured expression levels of target genes on the Affymetrix arrays compared to
the effect of a poorly performing probe on the commercial chips.
Before drawing firm conclusions from the comparison of wildtype and mutant RNA
on custom arrays, the chips should be further validated. Standard RNAs could
hybridised to multiple arrays and conditions of reaction optimised to ensure
reproducibility of the data. Subsequently, RNA samples with known profile could
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be used to ensure particular oligonucleotides are performing in the expected
manner.
5.5 CONCLUSION
The data presented in this chapter has shown the development of a custom
microarray. The genes of interest were selected and 55mers specific to each
transcript were designed.
The arrays were printed and initial validation confirmed that the chips had been
effectively printed and control oligonucleotides were behaving as expected.
However, comparison PSD95_/~ and wild type RNA from the forebrain of adult mice
using the custom chip failed to replicate results found with the Affymetrix system.
In this experiment, the control probes did not act as predicted with several of the
negative control genes being determined to have unexpected high levels of
expression. It may be that, due to a lack of thorough validation of the custom array,
the reaction conditions for the chip were not optimal and thus the experiment
yielded the unanticipated results.
The custom array that was designed would be valuable in studying NRC mutated
RNA and NMDA receptor stimulated samples. It would enable the wide scale
analysis of relevant genes with high throughput. However, further validation of the
array is required to optimise reaction conditions in order for the chip to be used as a
reliable tool for measuring gene expression.
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6. DISCUSSION
The NMDA receptor and it's protein complex is critical for spatial learning, synaptic
plasticity and pathological conditions such as neuropathic pain. Therefore, further
knowledge of the regulation of transcription by the NMDA receptor and associated
molecules could be significant to the understanding of these important phenomena.
The objective of this project was to study the contribution of NRC proteins to
NMDA receptor regulated gene expression. To achieve this microarray technology
was used and methods of in vitro stimulation of the NMDA receptor studied, the
results of which have been discussed in the appropriate chapters.
6.1 MICROARRAY ANALYSIS OF BRAIN TISSUE
6.1.1 Mutation of PSD95 and SynGAP Alters Gene Expression
It has been successfully demonstrated, for the first time, that mutations of NMDA
receptor complex proteins disrupt gene expression. PSD95_/" and SynGAP+/" animals
have significant alterations in a limited number transcripts in acutely dissected
brain tissue, which include several genes induced by NMDA receptor activity.
Given that PSD95 and SynGAP are known to act in pathways regulated by the
receptor, it appears that the basal levels of particular genes are regulated by the
NMDA receptor. Consistent with this, in vitro studies found that AP5 treatment of
primary cultured cortical neurons significantly downregulated the levels of cfos,
nur77 and egr2 RNA. The data suggests spontaneous synaptic activity regulates
NMDA receptor dependent expression of particular genes and this is altered in
PSD95_/" and SynGAP+/- tissue.
Analysis of NMDA receptor regulated gene expression is typically studied
following induced activity of the receptor, for example, following LTP induction or
pharmacological stimulation of the receptor. It is with such methods that cfos, nur77
and egrl have been found to be activity regulated (Bading et al., 1995; Inokuchi et al.,
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1996). In contrast, the work presented in this thesis has found evidence of activity
dependent gene regulation in acutely dissected brain tissue and spontaneously
active neuronal cultures. The data from these experiments suggests that, in addition
to any roles following intense stimulation, the NMDA receptor and associated
proteins are critical to the regulation of basal transcription of particular genes.
Given that known activity regulated genes are altered in PSD95+ and SynGAP+/"
samples it suggests that the genes significantly altered in the mutant tissues could
be a subset of the total genes regulated by the NMDA receptor. This raises the
possibility that, although not previously identified as such, some of the significantly
altered genes, other than cfos, nur77, egr2 and junB, are also activity regulated
transcripts. Indeed, there is already evidence to suggest some of these genes could
be regulated via the NMDA receptor. Perl expression is regulated by the NMDA
receptor in the SCN (Tischkau et al., 2000) and this could also be the case in the
hippocampus. DUSP6 can be induced by seizure (Muda et al., 1996), although it has
not been shown whether this is NMDA receptor dependent. Also, GADD45J3
belongs to a family of proteins that are induced by environmental stress (Takekawa
and Saito, 1998) and related transcript GADD45a is regulated by kainate seizure
(Zhu et al., 1997). As such, GADD45/3may also be a transcript regulated by synaptic
activity.
In addition to the activity regulated genes, several other genes that have known or
hypothesised role in cognitive disorders, learning and plasticity were significantly
altered in the mutant tissues. It appears that mutation of PSD95 and SynGAP
results in the misregulation of key genes that are required for NMDA receptor
mediated effects. As such, the Affymetrix analysis has identified several interesting
candidate genes, such as Perl, which could have previously unreported function in
learning processes and synaptic plasticity. In addition, significantly altered ESTs
may represent novel genes that are involved NMDA receptor mediated effects.
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The microarray analysis has also suggested ways in which the regulation of genes
via NRC proteins could act as feedback to control signalling pathways downstream
of the NMDA receptor. Egr2 and DUSP6 are both expressed at significantly lower
levels in SynGAP+/" tissue, suggesting they could be regulated by the NMDA
receptor via a SynGAP-ERK pathway. An egr2 binding site has been found in the
SynGAP promoter. Thus the induction of egr2, via a SynGAP-ERK pathway, could
result in a subsequent increase in SynGAP levels. Increases in SynGAP could then
act to negatively regulate the ERK pathway. If DUSP6 was induced by NMDA
receptor activity via a SynGAP-ERK pathway, then the phosphotase could act as a
negative regulator of ERK activity.
The misregulation of genes in PSD95_/" and SynGAP+/- animals could be the
underlying cause of the phenotypes of these mice. In particular, the common
alterations of cfos, nur77 and egr2 in PSD95"'" and SynGAP+/- tissue appear to correlate
with the similar deficits in spatial learning seen in the animals. Also, mutation of
several of the significantly altered genes (cfos, cyln2 and N-glycan alpha 2,8-
sialtransferase) results in phenotypes in LTP. As such, it appears that the basal
expression of particular genes, critical for NMDA mediated effects in learning and
plasticity, is regulated via the NMDA receptor and associated protein complex.
6.1.2 Further Application of Microarrays
There are several ways in which microarray analysis could be further employed to
study NRC proteins and gene regulation in brain tissue. A key experiment, to
follow the analysis of PSD95/_ forebrain and SynGAP"'" hippocampi, would be to
analyse PSD95_/" hippocampi by microarray. This experiment may reveal similar
changes to those seen in PSD95"'" forebrain, but may detect additional genes that
specifically contribute to the hippocampal phenotypes of the animals. This
experiment would also enable direct comparison of PSD95_/" and SynGAP+/"
hippocampal data, an additional way to identify commonly misregulated genes in
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these genotypes. It would also be interesting to carry out such analysis on tissue
from animals carrying double mutations in PSD95 and SynGAP.
The successful analysis of PSD95-/- and SynGAP+/_ tissue has proved microarrays to
be a useful approach in the study of transgenic animals. As such, they could be
effectively employed as a standard tool to analyse animals with plasticity
phenotypes or carry targeted mutations in other NRC proteins. This analysis could
help reveal which NMDA associated proteins are involved in the regulation of
neuronal gene expression and could identify key genes that are similarly
misregulated in animals sharing plasticity and learning phenotypes.
An important consideration in using the microarrays as a standard analysis tool for
transgenic studies is ensuring experimental conditions are consistent. Since
microarrays analyse the levels of thousands of transcripts simultaneously they are
sensitive to variation between samples. The Affymetrix analysis of PSD95 and
SynGAP mutant RNA was performed on material extracted from age, sex and,
where possible, litter matched mutant and wild type animals. Dissections were all
performed at the same time of day and subsequent RNA extraction and treatment
carried out in parallel. The experimental design was deliberately kept simple and
treatment of all samples consistent in order to maintain variation at a minimum.
Any future analysis of mutant tissue should be carried out in the same way in order
to yield reliable experimental results and ensure comparison of data sets from
different genotypes is valid.
Commercially available microarrays were successfully used to study transgenic
tissue. A custom array was subsequently designed of selected genes of interest that
could be used more cost effectively for higher throughput analysis. The validation
of the custom array using PSD95/_ RNA did not replicate the Affymetrix results as
expected which, due to the time constraints of this project, could not be further
analysed. It is likely that the custom array hybridisation protocol requires more
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optimisation. Once the custom arrays are validated they could be applied to study
mutant tissue and also used in the analysis of activity regulated gene expression
following stimulation of the NMDA receptor.
6.2 ANALYSIS OF ACTIVITY REGULATED GENE EXPRESSION
The misregulation of genes in PSD95 and SynGAP mutant tissue is likely due to
alterations in signalling downstream of the NMDA receptor. It would therefore be
very interesting to study the effects of these mutations in stimulated cells. As has
been discussed, there were problems in developing a reliable in vitro protocol for
stimulating cultured cortical neurons. There are several ways in which the
protocols could be modified that could make them more effective. The use of
electrophysiology in combination with gene expression analysis could prove
valuable in establishing the effects of pharmacological treatment on the behaviour of
the cultures, and thus aid the development of stimulation methods.
If a suitable in vitro stimulation protocol were established this would enable the
profile of wild type activity regulated gene expression to be identified. Also, the
analysis of NMDA dependent gene expression in PSD95_/" and SynGAP+/" cells could
confirm if the transcriptional alterations detected in mutant tissue were, indeed, a
consequence of changes in NMDA mediated signalling. Due to the postnatal
lethality of mice homozygote for SynGAP mutation, tissue from heterozygote
animals was analysed by microarray. An in vitro method of stimulation could
enable the study of SynGAP '- cells as embryonic cultured cells could be used.
In vitro stimulation analysis could be applied to other mutant genotypes and could
be conducted in the presence of inhibitors of different signalling pathways (e.g.
CaM kinase inhibitors, MEK inhibitors). This would establish key pathways and
molecules in the regulation of particular genes downstream of NMDA receptor
activity. Furthermore, if the custom arrays were successfully validated, then the
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gene expression analysis could be preformed on a relatively large scale with high
throughput.
6.3 CONCLUSION
The work detailed in this thesis has demonstrated, conclusively, for the first time
that mutation of NRC proteins results in altered gene expression. Transcripts
significantly altered in PSD95/_ and SynGAP+/_ tissue include activity regulated
genes suggesting these changes could be due to disruption of NMDA receptor
dependent transcription. The altered gene expression in PSD95/" and SynGAP+/-
mice correlates with phenotypes in spatial learning and could be the basis of the
behavioural deficits of these animals. Development of a reliable in vitro stimulation
protocol and optimisation of custom microarrays could be valuable to further
analyse the contribution of NRC proteins to activity dependent gene expression.
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